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18 Abstract 
Polymer chemistry enables the design and development of synthetic cationic gene 
delivery systems with varying polymer architectures. Branched polymers have been 
shown to have advantages for drug delivery purposes including nucleic acid delivery. The 
objective of this work is to utilise advanced polymer synthesis methods to synthesise a 
range of cationic polymers with well controlled branched architectures and investigate 
their cytotoxicity, nucleic acid complexation, resulting polyplex morphology, and gene 
transfection efficiency. 
Firstly, the synthesis of hyperbranched polymers using thiol-yne chemistry is explored 
with a semi-batch process to form hyperbranched polymers with well-defined molecular 
weights and dispersities. Following this, cationic moieties are introduced onto thiol-yne 
hyperbranched polymers using the ring opening polymerisation of 2-ethyloxazoline and 
an additional hydrolysis step to form PEI-POx copolymers with hyperbranched 
architectures. An investigation of plasmid DNA complexation, and in vitro toxicity and 
GFP plasmid gene transfection is then conducted.  
RAFT polymerisation is then utilised to form highly branched polymer architectures by 
copolymerisation of a divinyl branching comonomer. This strategy has the advantage of 
being able to introduce tuneable degradation and nucleic acid release. Finally, the 
possibility of using RAFT to synthesise branched polymers with phosphonium cationic 
moieties is also investigated, and their DNA complexation, toxicity, and gene transfection 
efficiency compared to the equivalent cationic polyammoniums. 
Overall, this thesis describes a number of advanced polymer synthesis methods to create 
hyperbranched and highly branched cationic polymers suitable for nucleic acid 
complexation, and also investigates their structure-function characteristics relating to 
aspects of nucleic acid delivery.  
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1.1 Nucleic acid therapy 
Gene therapy involves the introduction of genetic material (i.e. nucleic acids: DNA, 
mRNA, dsRNA, siRNA) into target cells, with the goal of treating various forms of 
disease with genetic origins.1,2 These nucleic acid therapies have the potential to treat a 
wide range of disease with currently limited therapeutic options including: cystic fibrosis, 
cancer, cardiovascular disease, hemophilia, and neurodegenerative disorders among 
others.3-7 Another use for this nucleic acid technology lies in the agrochemical sector, in 
theory an individual species of pest could be targeted with complete specificity. 
There are three main gene therapy strategies: 1) introduction of a DNA or mRNA to cells 
in order for it to transcribe a gene or protein that would otherwise not be produced; 2) 
introduction of a dsRNA or siRNA in order to induce the RNA interference pathway and 
silence production of a certain gene or protein of interest; 3) In recent years, the potential 
impact of gene therapy has been expanded even further by the development of 
CRISPR/Cas9 gene editing technology.8,9 RNA interference (RNAi) is a biological 
process which involves the silencing of certain genes by RNA molecules, with high 
efficiency and specificity.10 The mechanism results in the destruction of specific 
messenger RNA molecules. In 1998, the seminal study on RNA interference was 
conducted by Fire and Mello, and showed gene silencing in nematode worm 
Caenorhabditis elegans.11 In recognition of the importance of this work they were 
awarded the Nobel Prize for medicine in 2006.  
 
1.1.1 Delivery barriers 
Naked nucleic acid formulations are in clinical trials for certain physiological 
environments like the brain, lung, and eye, however most tissues in the body require a 
delivery system to facilitate the transfection process.12 This is due to multiple 
extracellular and intracellular delivery barriers that need to be overcome (Figure 1.1).13-
17 
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Extracellular barriers to successful gene delivery include the problem of DNA and RNA 
having poor resistance to enzymes such as RNases and other nucleases. In agrochemical 
applications these enzymes can be present in the soil and also most pest midguts.18 In 
human health applications these DNA and RNA degrading enzymes exist in the 
bloodstream.1,19 Other extracellular barriers include recognition and clearance by the 
immune system, for example, macrophages can readily uptake polyplex nanoparticles.20 
In addition, RNA is hydrolytically unstable due to the additional hydroxyl group at the 2’ 
position on the ribose compared to DNA.15,21  
There are also a number of intracellular barriers that need to be surpassed before the 
desired exogenous genetic material can be incorporated into the new cell’s machinery. 
Nucleic acids, and their vectors, typically enter the cell by endocytosis.22 This process of 
crossing cellular membranes can depend to a large extent on size and charge, with naked 
DNA usually being too negatively charged to enter cells efficiently via endocytosis. Once 
inside the cell, the vector then needs to escape from the endosome.23 The therapeutic 
nucleic acid needs to be released or become bioavailable in the cytosol, either for the 
mechanism of action to occur in the cytosol, or for diffusion through the cytosol to the 
nucleus. For successful DNA transfection the DNA needs to pass the double membrane 
nuclear envelope and enter the nucleus to be transcribed. Entry to the nucleus occurs 
through the nuclear pore complex through either passive or active transport mechanisms, 
again, with size being a determining factor.24-26 
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Figure 1.1. Pathway to successful intracellular delivery of nucleic acids. Figure adapted 
from reference 17. 
 
1.1.2 Non-viral gene delivery 
Various viral and non-viral vectors have been investigated for their potential to help 
overcome the mentioned delivery barriers. Viral vectors such as adeno associating 
viruses, retroviruses, and herpes simplex viruses have been studied extensively for 
nucleic acid protection and enhanced delivery, but have specific drawbacks including 
undesirable mutagenic and immunogenic effects.27,28 Such drawbacks can be 
circumvented by using synthetic delivery vectors based on polymeric nanostructures of 
defined architecture for optimal binding of nucleic acids.29 Synthetic vectors also have 
the benefits of reproducible and easily scalable production. The most popular commercial 
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gene delivery polymers are shown in Figure 1.5, and include linear polylysine, linear and 
branched polyethyleneimine (PEI), polyamidoamine dendrimers (PAMAM).   
 
 
Figure 1.2. Structures of commercially available gene delivery polymers. Figure 
adapted from reference 17. 
 
Linear polylysine was one of the first polymers utilized for gene delivery.30 However its 
clinical application has been very limited, commonly thought to be due to poor escape 
from the endocytic pathway. Polyethyleneimine (PEI) was first used in 1995 and has since 
been well investigated as a carrier for nucleotides.31 In one study, intrathecal 
administration of siRNA PEI complex was shown to silence a targeted pain receptor 
(NR2B) in rats.32 PEI has been the subject of a number of successful in vivo gene delivery 
studies to a range of tissues, including the central nervous system, kidney, lung and 
various tumors. However translation of PEI in the clinic is currently limited, commonly 
thought to be due to high cytotoxicity related to its positive charge. 
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Chitosan and cationic cyclodextran based polymers have also been investigated for 
application in non-viral gene delivery systems.4,33 The effect of polymer size, nature of 
amine protonation or quaternisation, and charge density on gene delivery and complex 
toxicity was reported. Both chitosan and amine modified cyclodextran are reported to be 
less cytotoxic than PEI.29 
 
1.2. Polymer architecture 
1.2.1. Increasing complexity 
Polymers have a key role in drug delivery systems and have the potential to provide 
solutions by simplifying administration, reducing toxicities, and improving efficiencies 
through additional functionality.34 The progression of polymer architectures from linear 
to more complex branched topologies by use of easily accessible chemistries while 
maintaining reasonably large scale production, offers further opportunities to improve 
therapeutic delivery.35,36 Recent advances in polymer chemistry, including new step-
growth polymerisation routes, continued advancement of controlled radical and ring-
opening polymerisation methods, and further development of simple, high yielding, and 
orthogonal coupling chemistries, has brought unprecedented access to complex polymer 
architectures.37,38 Branched polymers are a special class of polymer architecture 
characterised by their high branching densities.39 The branched polymer topology imparts 
a number of favourable properties compared to their linear polymer equivalents 
including: high surface functionality, globular conformation, low intrinsic viscosities, 
high solubilities, and interesting rheological modifying properties.39-41 This has led to 
branched polymers being increasingly important for biomedical applications over the past 
20 – 30 years.42-44  
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Figure 1.3. Cartoon representation of various branched polymer architectures able to 
be synthesised with modern polymerisation and coupling synthetic strategies. 
 
In certain polymers such as thermosets and rubbers, branching is typically on a 
macrocscopic/crosslinked scale, leading to interesting physical properties of these 
materials. This thesis focuses of branching in soluble nanoscale forms, and will refer to 
branched polymers of the following definitions (illustrated in Figure 2). The term highly 
branched polymer refers to high frequency main chain branching of linear polymers, with 
the branch points in a highly branched polymer being distributed randomly throughout 
the polymer. The major advantage of highly branched polymers is their simple synthetic 
methodolgies. In general, the term dendritic polymer is used to refer to a class of branched 
polymers including dendrimers, dendrons, hyperbranched polymers, and hybrid variants 
containing dendrons and hyperbranched polymers. The term originates from the Greek 
word Dendron, δένδρον, which translates to tree. The various subclasses of dendritic 
polymers can be further defined. Dendrimers were first synthesised in laborious multi-
step procedures, in the late 1970s and early 1980s, and are defined by their perfectly 
symmetrical and layered branching patterns (with no irregular or non-branching points, 
DB), and therefore single molecular weight with a dispersity of 1.45-47  
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𝐷𝐵 =
𝐷 + 𝑇
𝐷 + 𝑇 + 𝐿
        (𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏 𝟏) 
Degree of branching (DB) was defined by Frechet and coworkers, Equation 1, where D, 
T and L are the fractions of dendritic, terminal or linear monomer segments in the 
resulting dendritic polymers (obtained from NMR spectroscopy).48 Dendrimers have 
DB’s of 1. Hyperbranched polymers are synthesized by step-growth polymerization via 
condensation or addition of ABn monomers in one-pot reactions. Here, A and B are the 
two functionalities that can react with each other but not with themselves. In an AB2 
monomer system, the degree of branching is controlled by statistics and only reaches 
around 0.5, far from the value of 1 usually achieved with dendrimers.49 Further 
functionality and control over branching distributions can be introduced by the AB2 
polymerisation of macromonomers leading to long chain hyperbranched polymers.50 
Recently, evolution of these branched topologies has progressed towards dendritic-linear 
hybrid polymers from combination of well controlled linear polymers with dendritic 
polymers, via creative coupling and polymerisation chemistries.51 These structures 
include linear hybrids of dendrimers and hyperbranched polymers, and can be in the form 
of branched-linear block copolymers, branched-core star polymers, and dendronised 
polymers. 
From a synthetic chemistry perspective, these structures can by produced from an ever 
expanding toolbox of polymer chemistry and coupling chemistry techniques. A summary 
of these procedures can be found in Figure 3. Dendrimer formation has typically 
proceeded using a series of iterative growth and activation steps.52 Dendrimers can be 
synthesized following the divergent approach which can lead to branching irregularities 
at higher generations, and also the convergent approach, which was introduced in 
pioneering work by Fréchet and Hawker and can lead to higher purity.53 Due to their 
structural precision this has been achieved with robust organic reactions, including 
amidification and esterification reactions (Figure 3). Recently improvements to 
dendrimer synthesis, in terms of reaction times and purity, have been achieved using 
accelerated techniques based on efficient and orthogonal chemistries.54 
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Figure 1.4. Schematic representations of some of the synthetic strategies to achieve 
branched polymer architectures with modern polymerisation and coupling synthetic 
strategies: a) branched and linear polymers via step growth polymerisations, i) 
esterification condensation, ii) amidification condensation, iii) thiol-ene addition, iv) 
thiol-yne addition, v) asymmetric epoxide ring opening, vi) michael addition type, b) 
branched and linear polymers via controlled chain growth polymerisations, i) living 
anionic, ii) Cu(0) radical polymerisations, iii) ring opening polymerisations, iv) RAFT 
polymerisation, c) various coupling strategies for formation of branched-linear hybrid 
materials, and also therapeutic conjugation, i) ester, ii) amide, iii) michael addition, iv) 
thiol-ene, v) thiol-yne, vi) azide-alkyne cycloaddition, vii) disulphide formation, viii) 
hydrazone. 
 
Synthetic strategies for formation of highly branched and hyperbranched polymers arose 
as an alternative and simpler route to polymers with similar favourable properties to 
dendrimers, but without demanding multi-step syntheses and purifications. 
Hyperbranched polymers are synthesised by the step growth polymerisation of ABn 
monomers (where n ≥ 2), and also the step growth copolymerisation of combinations of 
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monomers, as in the A2 + Bm  approach (where m ≥ 3).39 These reactions were theorised 
by Flory decades ago and require monomers different A and B functionalities that can 
react with each other but not with themselves.55 Step growth polymerisations can also be 
performed with telechelic AB2 macromonomers leading to long chain hyperbranched 
polymers.56 
The design and synthesis of highly branched polymers by chain growth polymerisations 
is a more recent development in polymer chemistry. In the self-condensing vinyl 
polymerisation (SCVP) route, which was introduced by Fréchet and co-workers, a vinyl 
monomer bearing an initiating group can propagate through the vinyl bond and also form 
branching points through the initiating group.57 This SCVP has been extended to RAFT, 
ATRP, NMP, and SCROP. Another popular chain growth strategy for highly branched 
polymers is the Strathclyde route, which involves the copolymerisation of vinyl 
monomers with small amounts of divinyl monomers and in the presence of a chain 
transfer agent.58 Similarly to SCVP, this method has also been extended to the controlled 
radical polymerisations RAFT and ATRP. Linear polymers with pendant vinyl moieties 
are formed, which then have the opportunity to polymerise into other linear chains to form 
highly branched polymers. 
Since the development of living anionic polymerisations by Szwarc in 1956, there have 
been many chain growth polymerisations developed for synthesis of linear polymers with 
controlled molecular weights, narrow molecular weight dispersities, and precise 
functionality.59,60 RAFT polymerisation in particular is becoming increasingly popular 
for biomedical applications, in part due to its ease of use and compatibility with a wide 
range of monomers.61 In addition to synthesis of highly branched polymers by chain 
growth methods as mentioned previously, by combining these chain growth systems with 
efficient coupling chemistries, researchers can now easily synthesise new types of 
branched-linear hybrid architectures including, branched-linear block copolymers, 
branched-core star polymers, and dendronised polymers. The expansion of highly 
efficient coupling chemistries, after the seminal work of the Sharpless group, has led to 
further options for synthesis of these types of architectures.62 Available click-type 
reactions include, the Huisgen alkyne-azide cycloaddition, thiol-ene/yne radical 
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additions, various thiol-ene Michael additions, and tertiary isocyanate amine coupling 
among others.37,63 
Therapeutic molecules can be carried by these polymer systems by two main methods: 
encapsulation with either hydrophobic or electrostatic interactions, and also covalent 
attachment to the polymeric carrier. Encapsulation methods have been widely 
investigated, and branched polymer architectures offer the benefits of having globular 
three-dimensional topologies capable of encapsulating high loadings of cargo. A benefit 
of this approach is the ability to obtain unimolecular micelle type of structures without 
concentration dependent disassembly at low concentrations.64 However it can be difficult 
to control the release of molecules from the polymer. Many interesting chemistries 
(Figure 3) have been developed for covalent attachment guest molecules, including 
stimuli responsive linkers able to release therapeutic molecules on certain specific 
triggers, including pH, redox environments, glucose, and enzymatic cleavage.65 Branched 
polymers also offer advantages for this drug attachment method, due to their high number 
of functionalisable groups on the periphery of the constructs.  
 
Table 1.1. Summary of current state-of-the-art in branched polymer therapeutic 
delivery systems, including design strategies for various branched polymer 
architectures, and specific application details in drug/ gene delivery. 
Architecture Structure 
Polymer synthetic 
method 
Therapeutic 
conjugation 
method 
Application Ref 
 
Highly branched 
Divinyl 
copolymerisation  
RAFT 
copolymerisation with 
divinyl monomer 
Electrostatic 
nucleic acid 
complexation 
Plasmid DNA 
delivery 
66 
 
 
 
 
ATRP 
copolymerisation with 
divinyl monomer 
Encapsulation of 
SPIONs 
SPION delivery 
for 
therapy/diagnosis 
67 
 
 
ATRP 
copolymerisation with 
divinyl monomer 
Electrostatic 
nucleic acid 
complexation 
Plasmid DNA 
delivery 
68 
SCVP 
 
ATRP SCVP of 
degradable inimer and 
dmaema 
Drug 
encapsulation 
Niclosamide and 
amonafide drug 
delivery 
69 
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RAFT SCVP of 
Disulphide inimer and 
pegma 
 
Hydrophobic drug 
encapsulation 
 
Delivery of Dox 
to breast cancer 
cell line 
70 
 
 
 
 
RAFT SCVP of 
Disulphide inimer and 
pegma/gma 
covalent 
attachment, with 
acid and redox 
cleavable groups 
Camptothecin 
intracellular 
delivery 
71 
 
 
RAFT SCVP of 
Disulphide inimer and 
pegma/gma/cptm 
Disulphide linked 
drug monomer 
(Gd MRI imaging 
via epoxide) 
Camptothecin 
intracellular 
delivery 
72 
 
Hyperbranched 
 
ABn 
 
AB2 polycondensation 
(isocyanate-hydroxy) 
Covalent 
attachment 
Doxorubicin 
delivery and DNA 
delivery 
73 
 
 
 
 
AB2 polycondensation 
Hydrophobic drug 
encapsulation 
Taxol anticancer 
therapy 
74 
 
 
Ab2 ROP of epoxide 
containing glycidol 
Enzyme cleavable 
covalent 
attachemnt 
Doxorubicin and 
methotrexate 
anticancer drugs 
75 
 
 
 
AB3 ROP of epoxide 
containing monomer 
 
Ester linked 
covalent 
attachemnt 
MTX anticancer 
drug 
76 
 
A2+Bm 
 
 
A2 +B3 
Michael addition 
Electrostatic 
nucleic acid 
complexation 
Tumour siRNA 
delivery in vivo 
77 
 
 
A2 +B2 +B3 
polycondensation 
Cell penetrating 
peptide mimick 
Intracellular 
delivery via 
endosome 
disruption 
78 
 
 
 
 
A2 +B2 +B3 
Michael addition 
Electrostatic 
nucleic acid 
complexation 
Plasmid DNA 
delivery for skin 
gene therapy 
79 
Longchain 
hyperbranched 
 
Proton transfer AB2 
polymerisation 
Ester linked 
covalent 
attachemnt 
MTX anticancer 
drug 
80 
Chapter 1 
13 
 
 
A2 +B4 Michael 
addition 
polymerisation 
 
Electrostatic 
nucleic acid 
complexation 
Plasmid DNA 
delivery 
81 
 
 
CROP and thiol-yne 
AB2 photoaddition 
polymerisation 
 
Hydrophobic drug 
encapsulation 
DOX drug release 
in vitro 
82 
 
Dendrimer 
 
 
 
Divergent dendrimer 
synthesis 
(commercial) then 
michael addition 
modification 
Electrostatic 
nucleic acid 
complexation 
siRNA gene 
delivery to lung 
vasculature 
83 
 
 
divergent strategy 
using standard peptide 
coupling chemistry 
 
Electrostatic 
nucleic acid 
complexation 
Plasmid DNA 
delivery 
84 
 
 
 
 
Divergent dendrimer 
synthesis 
(commercial) then 
activated ester 
coupling 
 
Disulphide linked 
covalent 
attachment 
NAC Anti 
inflamitory agent 
delivery to B2-V 
microglial cells 
85 
 
 
G4 PPI dendrimer 
Reductive amination 
coupling of maltose 
shell 
Electrostatic drug 
complexation 
fludarabine 
triphosphate 
delivery 
86 
 
 
 
 
Divergent dendrimer 
synthesis 
(commercial) then 
pyBOPcoupling 
Disulphide linked 
covalent 
attachment 
NAC and 
Valproic acid 
Antiinflamitory 
87 
 
Branched-linear 
hybrid 
 
Branched-linear 
block 
  
Divergent lysine 
Dendron synthesis and 
amidificaion with PEG 
and functionality 
Hydrophobic drug 
encapsulation 
Delivery of Dox 
to lymphoma 
tumour 
88 
 
 
 
 
NCA ROP, divergent 
dendrimer synthesis, 
Activated ester 
coupling 
Hydrophobic drug 
encapsulation 
PTX drug delivery 89 
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Commercial PEG, 
divergent dendrimer 
synthesis, activated 
ester coupling 
Disulphide linked 
covalent 
attachment 
Camptothecin 
delivery in vivo 
90 
 
 
Alkyn azide click 
coupling of PAMAM 
dendrons and PEG 
Hydrophobic drug 
encapsulation 
DOXorubicin 
encapsulation and 
release 
91 
Branched-linear 
star 
 
 
Polycondensation 
(commercial H40) ph 
sensitive polypeptide 
shell coupling 
Electrostatic 
nucleic acid 
complexation 
siRNA gene 
delivery 
92 
 
 
 
 
CROP and thiol-yne 
photoaddition 
polymerisation 
Hydrophobic drug 
encapsulation 
Hydrophobic dye 
as drug model 
93 
 
 
Polycondensation 
(commercial H40) 
activated ester PEG 
coupling 
Hydrophobic drug 
encapsulation 
Doxorubicin 
anticancer drug 
delivery 
94 
 
 
Azirine ROP 
(commercial PEI) 
Michael addition arm 
coupling 
Electrostatic 
nucleic acid 
complexation 
Plasmid DNA 
delivery 
95 
 
 
ATRP with divinyl 
comonomer 
Electrostatic 
nucleic acid 
complexation 
siRNA gene 
delivery to lung 
vasculature 
96 
 
Dendronised 
 
 
Divergent lysine 
dendron synthesis and 
azide alkyne click 
coupling to heparin 
Covalent 
attachment, 
through acid 
cleavable 
hydrazone 
Doxorubicin 
delivery in 4T1 
breast tumor 
model 
97 
 
 
Polystyrene based 
backbone grafted with 
polyester dendrons 
In vivo 
biodistribution 
studies with 
radiolabel 
Radiolabel as 
proof-of-concept 
for drug delivery 
98 
 
 
PEG azido polymer 
backbone grafted with 
polyglycerol dendrons 
Hydrophobic drug 
encapsulation 
Hydrophobic dye 
as drug model 
99 
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1.2.2. Highly branched polymers 
Synthesis of highly branched polymers by use of chain growth polymerisations, is a 
versatile and scalable approach for the synthesis of functional polymers.40 Radical chain 
growth polymerisation methods have always produced branching in some cases through 
the radical polymerisation side reactions of intramolecular backbiting, intermolecular 
transfer to polymer, and polymerisation of vinyl terminated disproportionation 
products.100 However, introduction of branching in radical polymerisations through 
design was more recently established.  
 
1.2.2.1. Divinyl monomer copolymerisation 
Network formation through the radical polymerisation of vinyl monomers with 
difunctional comonomers is analogous to step growth polymerisations of multifunctional 
monomers. These polymerisations have been considered theoretically by Flory and 
Stockmayer, among others.101-104 Whilst considerable experimental work has also been 
carried out with various monomer pairs, including: MMA and EGDMA, styrene and 
divinyl benzene, vinyl acetate and divinyl adipate. Theory predicts that macroscopic 
crosslinking will occur when the number of difunctional branching monomers per 
polymer chain is greater than one. In practise there is often a discrepancy between the 
theory and the observed polymerisation gel points. Theoretical gel point values are 
generally underestimated due to pendant vinyl group of the multifunctional commoner 
species causing intramolecular cyclisation during the polymerisation or becoming less 
reactive as one group is polymerised and remaining as an unreacted pendant vinyl group 
throughout the polymerisation.105 These free radical polymerisation systems are often 
difficult to predict and can require considerable optimisation in order to achieve high 
conversions without macroscopic gelation.106,107  
However, in 2000 Sherrington et al., introduced an improvement to free radical 
polymerisations of divinyl monomers to form highly branched but soluble polymer 
architectures, by inclusion of thiol chain transfer agent (CTA).58,108,109 This method, 
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known as the ‘Strathclyde route’, reduces the primary chain length, can delay gelation, 
and can allow inclusion of additional functionality through functional CTAs. Atom 
transfer radical polymerisation (ATRP) was then employed to synthesise similar branched 
polymers with a more controlled polymerisation.108 The difunctional copolymer method 
to branched polymers was first employed with reversible addition fragmentation chain 
transfer (RAFT) polymerization by our group in 2005,110,111 and further investigated by 
Armes and coworkers.105 
Early work on application of these branched polymer systems to DNA delivery was 
established by the Davis group, who synthesised highly branched PDMAEMA-b-PEG 
using RAFT polymerisation.112,113 The structures were formed with a redox sensitive 
divinyl comonomer, to yield high molecular weight polymers able to be cleaved into 
lower molecular weight polymer chains. Efficient binding of DNA was shown to occur 
through electrostatic interactions. This method has also been adopted by Thurecht et al. 
who have used the RAFT copolymerisation of DMAEMA and EGDMA to synthesise 
highly branched structures for a variety of biomedical applications including gene 
delivery.66,114 Polymer ability to deliver DNA was investigated using in vitro cell uptake 
assays in HeLa cells with flow cytometry. Branched pDMAEMA conjugated with the 
targeting ligand Folate (overexpressed on HeLa cells) showed improved cell uptake 
compared to oligofectamine and non-folate branched pDMAEMA, however polymer 
toxicity was observed above N/P ratios of 10. 
More recently, Rannard et al., have shown that ATRP copolymerisations with small 
amounts of EGDMA leads to branched polymers which can form stable nanoparticles 
with tuneable sizes and functionalities.115 It was shown, with a gut epithelium model, that 
these nanoparticles are able to cross mucus barriers and have potential of use as orally-
administered nanocarrier systems. Additionally, it has been demonstrated that these 
highly branched polymers, synthesised by ATRP, can form stable nanoparticle 
composites with super-paramagnetic iron oxide nanoparticles (SPIONs) with future uses 
for delivery of drugs, imaging agents, or hyperthermia agents within cancer therapies.67 
Wang and coworkers have investigated the effect of branching on transfection of plasmid 
DNA coding for G-luciferase and also green fluorescent protein (GFP).68 Variation of 
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primary chain length and density of branching between individual polymer chains was 
achieved using ATRP with redox responsive divinyl commonomer. The authors found 
that the most highly branched polymer had the least adverse cytotoxic effects, whilst 
having higher transfection efficiencies than the linear pDMAEMA control. 
 
 
1.2.2.2. Self-condensing vinyl polymerisation 
In 1995, Frechet et al. showed that polymerisation of a vinyl monomer bearing an 
initiating group allowed polymerisation through the vinyl group and also through the 
initiating site, leading to the formation of highly branched polymers.57 The authors termed 
this self-condensing vinyl polymerisation (SCVP). The SCVP process has been extended 
to various chain growth polymerisation methods, such as, nitroxide mediated 
polymerisation (NMP),116 reversible addition chain transfer polymerisation (RAFT),117 
atom transfer radical polymerisation (ATRP),118 and ring opening polymerisation 
(ROP).119,120 Chain growth methods to highly branched polymers, such as divinyl 
commoner method, and SCVP, allow for facile incorporation of stimuli responsive 
groups, prodrug monomers, and imaging moieties for theranostic applications.121 
The group of Gao has investigated branched polymers by SCVP for breast cancer 
therapies. The researchers used ATRP of inimers in microemulsion, and were able to load 
a drug combination of DNA damage repair agents and also STAT-3 inhibitors (amonafide 
and niclosamide respectively).69 Selective growth inhibition of triple negative breast 
cancers was seen with the synergistic combination of drugs encapsulated in the branched 
polymer delivery system. Luo et al., synthesised branched hydroxypropyl 
methacrylamide copolymers by a RAFT SCVP method, incorporating a DOX prodrug 
monomer and cathepsin-B enzyme cleavable branching units.122 The high molecular 
weight and large (102 nm diameter) branched polymers could be degraded into lower 
molecular weight and smaller (8.2 nm diameter) species. These branched drug conjugates 
were investigated for breast cancer therapy both in vitro and with a mouse model. 
Enhanced antitumour efficacies in a 4T1 tumour model was observed by TG1, 
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immunohistochemical results, and the in vivo toxicity assays, highlighting potential 
benefits of designing polymer drug delivery systems with stimuli responsive and 
degradable properties compared to the non formulated free drug. Recently RAFT SCVP 
was also employed by Wei and colleagues, to form highly branched polymer prodrug 
conjugates with both redox sensitive disulphide groups and acid sensitive groups 
carbonate groups.71 The presence of acidic pH conditions or glutathione environments 
enhances the release of captothecin, with the polymer system having IC50 values of 365.1 
ug/ml, to HeLa cell-line with an MTS cell viablilty assay. 
 
1.2.3. Hyperbranched polymers 
Hyperbranched polymers have a more defined branching pattern than highly branched 
polymers, as branch points are introduced at high proportion of monomer units, compared 
to randomly along a chain growth polymer chain with highly branched polymers.41 This 
feature makes hyperbranched polymers interesting for therapeutic delivery applications 
as the degree of branching in terms of branching units, linear units, and terminal units is 
much more easily defined and characterised.42  
 
1.2.3.1. Step growth polymerisation of ABn monomers 
Much of the theory of branched and hyperbranched polymers was outlined by Flory in 
the mid-20th century, based on polycondensation reactions.55 In order for ABn 
hyperbranched polymers to be formed, a number of requirements were outlined by Flory: 
the A moiety must react selectively with B groups, B groups must have equal reactivity, 
and no cyclisation reactions should occur. These reactions proceed in a manner similar to 
most step growth polymerisations with rapid loss of monomer early in the reaction, high 
conversions required for high molecular weights, and the case of ABn polymerisations 
there is no possibility of crosslinking (in theory). The resulting polymers contain dendritic 
units (fully reacted B moieties), linear units (singly reacted B moieties), terminal units 
(unreacted B moieties), and one focal A group. One of the most well-known examples of 
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a hyperbranched polymer formed from ABn polycondensation is the commercial polymer 
Boltron, synthesised from the monomer bis(methylol)propionic acid (bis-MPA).123 
Boltron hyperbranched polymers with multiple surface hydroxyl functional groups have 
been synthesised, which have been used in a large number of applications, both as the 
native polymer and also post-polymerisation modified via the hydroxyl groups to impart 
further functionality or different solubility properties.124 In this case control over the 
reaction (resulting molecular weight, molecular weight distribution, and degree of 
branching) can be achieved by addition of monomer in discrete portions, later developed 
into the ‘slow monomer addition’ method.125,126 
Klok and coworkers have investigated the effect of degree of branching of polylysine on 
DNA complexation and delivery.84 Transfection efficiency was affected by both polymer 
architecture and molecular weight. At similar molecular weights the hyperbranched 
polylysines showed greater transfection and gene knockdown compared to their linear 
and dendrimer analogues. In the 1990’s, Mulhaupt and Frey developed the chemistry of 
hyperbranched polyglycerols which are formed from the step growth polymerisation of 
glycidol, a latent AB2 monomer.
127 The polymers have very high biocompatibility 
similarly to the established linear polyethylene glycol, however great control over the 
branching and architecture can be achieved, opening up the application of these materials 
as nanocarriers for therapeutic purposes. In 2014, the Frey group showed that conjugating 
the MUC1 glycopeptide B-cell epitope and the tetanus toxoid T-cell epitope to the surface 
of hyperbranched polygycerol, enabled optimal presentation of antibodies due to the 3d 
topology of the branched structure.128 This synthetic vaccine led to significant immune 
responses in a mouse study, highlighting the potential of these systems to be used in 
anticancer immunotherapy. Haag and colleagues have further expanded these 
hyperbranched polyglycerols as drug delivery systems, by attaching enzymatically 
cleavable therapeutics to the surface of these nanocarriers.75 Further work by the group 
has shown that conjugating doxorubicin via an acid cleavable hydrazine linker had high 
drug loadings and an improved antitumour efficiency compared to free doxorubicin in a 
mouse tumour model.129  
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Figure 1.5. Synthetic scheme and confocal laser scanning microscopy images of HeLa 
cells incubated with hyperbranched and self-immolative polymers conjugated with 
doxorubicin and cRGD peptide. Figure adapted from reference 73. 
 
Hyperbranched and self-immolative polymers undergo a cascade depolymerisation 
process after stimuli responsive removal of a trigger at the focal point of the 
hyperbranched polymer. Liu and coworkers synthesisd hyperbranched self immolative 
polymers in a onepot AB2 polycondensation method, after which, the polymer were 
funtionalised with various imaging, targeting, and therapeutic groups including, cRGD 
peptides, Doxorubicin, coumarin, choline, and DMAEMA for nucleic acid 
complexation.73 Depolymerisation triggered by blue light was investigated, and the 
polymer was determined to be completely degraded after 6 hours. Additionally 
intracellular release (HeLa cell-line) of doxorubicin conjugated to the exterior of the 
hyperbranched polymer was followed with confocal microscopy (Figure 5). 
Colocalisation studies indicated polymer cellular uptake via endocytosis and release of 
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doxorubicin into the cytosol, which overtime was seen to enter the nucleus with use of 
acridine orange stain. 
Step growth polymerisation of ABn monomers, where n ≥ 3, has also been used to 
synthesise hyperbranched polymers for therapeutic delivery. For example, Zhu et al. 
synthesised biodegradable hyperbranched polyglycerol by in situ formation of an AB3 
monomer, to which they then conjugated the anticancer drug methotrexate (MTX) and 
fluorescent dye rhodamine.76 The polymers showed good biocompatibility and 
biodegradability through the polymer ester bonds, and MTT assay against a cancerous 
cell line suggested high anticancer efficiency of the hyperbranched polymer drug delivery 
system. 
 
1.2.3.2. Step growth polymerisation of A2+Bm monomers 
Synthesis of branched polymers via a double monomer methodology, A2 + Bm, is 
attractive due to the range of much more readily available monomers, however the 
approach can lead to gelation at high conversions and critical concentrations.42 These 
syntheses also require careful optimisation of the ratio of functional groups, monomer 
concentrations, purity of reagents, reaction time and temperature, in order to achieve 
controlled and reproducible reactions of high molecular weights without purification 
methods.130,131 The growth and final structure profile of A2 + Bm systems is also not fully 
comparable to ABn systems with their cascade type of branching patterns, leading to some 
in the community not considering them true hyperbranched polymers.39 
A particularly simple but elegant step growth polymerisation method was developed by 
Lynn, Anderson, and Langer in the early 2000’s, involving Michael additions of amines 
to multifunctional acrylate groups to form poly(-aminoesters).132,133 This was further 
developed to hyperbranched poly(-aminoesters) by A2 + Bm routes more recently by a 
number of research groups. In 2016, Wang et al, investigated highly branched poly(-
aminoesters) for gene therapy, synthesised by the Michael addition polymerisation of an 
A2 amine monomer with B3 and B2 triacrylates and diacrylates.
79 The authors found that 
the branched polymer topology imparts favourable properties of improved transfection 
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efficiencies and reduced toxicities in vitro. Additionally, the highly branched poly(-
aminoesters) effectively delivered genetic material in vivo, and resulted in the expression 
of significant functional proteins in the skin. A similar strategy was employed by Oupicky 
and colleagues, who prepared hyperbranched poly(-amido amines) through the michael 
addition polymerisation of and A2 diacrylamide monomer and a B3 amine monomer 
(Figure 6).77 The polymers were degradable with a glutathione redox stimuli through use 
of a disulphide containing diacrylamide, and were also functionalised with fluorine 
moieties. Good ability to bind siRNA by the polymers was confirmed, and gene silencing 
was successfully demonstrated with an in vivo luciferase expressing tumor model.  
 
Figure 1.6. Hyperbranched poly(amido amines) and in vivo luc gene silencing, a) 
bioluminescence images of mice with B16F10-luc tumours, b) quantification of whole-
body images, c) ex vivo anaylsis of luc activity in isolated tumour samples. Figure 
adapted from reference  77. 
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In a different example, the A2 + Bm system has also been recently employed to synthesise 
hyperbranched lysine based polymers that mimic cell-penetrating peptides. Chen et al. 
used a polycondensation reaction involving A2 + B3 + B2 monomers, and showed that the 
resulting hyperbranched polymers had high cellular internalisation rates which were 
dependent on pH.78 The branched architectures enhanced the membrane lytic properties 
of the polymers compared to the linear version, and thus showed potential for cytoplasmic 
delivery of therapeutic molecules. 
 
1.2.3.3. Long chain hyperbranched polymers 
Hyperbranched polymers from macromolecular units are a particularly interesting class 
of dendritic polymer architecture due to the ability to introduce additional functionality 
along the macromonomer chain, and the control over distance between branch points by 
tuning the degree of polymerisation of the linear macromonomer.50 Synthetic strategies 
involve combination of chain growth polymerisation methods to gain well defined AB2 
macromonomers which can be further polymerised in an AB2 step growth method.  
Long chain hyperbranched PEG materials have been synthesised in this manner by Zhu 
and coworkers, and used for anticancer drug molecule delivery and plasmid DNA 
delivery.80 The researchers were able to combine the advantages of a long chain 
hyperbranched architecture with the favourable biological properties of PEG to produce 
promising branched materials for use as drug delivery systems. An alternative route to 
hyperbranched polymers has been developed by our group, utilising thiol-yne radical 
chemistry.56,93,134-136 This reaction involves the addition of a thiol to a reactive alkyne 
followed by the addition of another thiol to the resulting vinylthioether at a faster rate. 
This leads to hyperbranched polymers with very high degrees of branching. This 
approach can be used for both small molecules and polymers with thiol and alkyne end 
groups.137,138 The AB2 thiol-yne step growth approach to long chain hyperbranched 
polymers has also been employed by Dong et al., who synthesised hyperbranched 
polypeptide with a PEG shell for encapsulation and delivery of doxorubicin.82 The 
researchers produced poly(e-benzyloxycarbonyl-L-lysine) with thiol and alkyne end 
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groups which formed hyperbranched polylysine under UV irradiation, to which a linear 
PEG shell was attached. The hyperbranched polymer gave a higher drug loading than the 
linear counterpart block copolymer, and a slower drug release rate.  
 
1.2.4. Dendrimers 
 
Dendrimers are possibly the most studied of branched polymers for therapeutic delivery 
applications. This is due, in part, to their structurally perfect branching patterns and also 
to being very well defined unimolecular species.139 Poly(amido amine) (PAMAM) 
dendrimers were the first dendrimers to be widely studied and are now commercially 
available, in addition to the large variety in backbone structures and coupling chemistries 
that have since been developed.54 The dendrimer architecture offers the attractive 
property of multivalent surface functionality for increased interaction with biointerfaces, 
while also allowing efficient drug conjugation to the surface or encapsulation in the 
unimolecular micelle-like core. 
Anderson et al., employed a combinatorial approach to obtain a library of modified 
dendrimers of varying generation PAMAM and p(propylenimine) (PPI), with different 
alkyl chain substituents (C10 – C16).140 SiRNA formulated dendrimers were found to 
preferentially accumulate in Tie2-positive endothelial cells in the lung, when studied with 
an in vivo mouse model. The materials showed promise for the delivery of nucleic acid 
therapeutics in diseases or injuries involving dysfunctional endothelium, whilst having 
clinical translation advatages relating to molecularly defined dendrimer cores. 
Glutathione responsive PAMAM dendrimers have been developed by Kannan et al., and 
recently been investigated in a large animal model of hypothermic circulatory arrest 
induced brain injury.87 Systemically injected dendrimer drug conjugates were able to 
deliver the antineuroinflamitory therapeutic N-acetyl cysteine, and the antiexcitotoxicity 
therapeutic valproic acid. The dendrimer delivery system produced 24 hr neurological 
score improvements of similar values to a 10 fold higher dose of free drug, and with much 
reduced adverse side effects. 
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In 2016, the group of Siegwart, reported modular and degradable dendrimers that had low 
toxicities and high antitumor efficiencies, and gave a significant survival benefit in the in 
vivo cancer model studied.141 The ester based dendrimers were synthesised using 
sequential thiol or amine Michael additions, which allowed a large library of dendrimers 
to be produced with differing functionalities and generations. Initial in vitro and in vivo 
siRNA luciferase gene silencing screens were performed to evaluate dendrimer 
candidates to be taken forward to a further aggressive liver cancer model. An optimal 
degradable dendrimer was identified that was able to inhibit growth in the studied 
cancerous tumour model, while having low toxicity and biodegradability. 
 
 
Figure 1.7. Modular degradable dendrimers for therapeutic delivery to liver cancer, a) 
fluorescent imaging showing cancerous liver accumulation of siRNA, b) histology 
staining comnfirmed livers contained tumours, c) confocal imaging confirmed siRNA 
intracellular location. Figure adapted from reference 141. 
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1.2.5. Branched-linear hybrid polymers 
 
As the field of branched and dendritic polymers has rapidly developed, new classes of 
hybrid polymers have emerged.51,142 These branched-linear hybrid polymer architectures 
can contain either dendrimers or hyperbanched polymers and include block copolymers, 
branched core star polymers, and dendronised polymers.  
 
1.2.5.1. Branched-linear block copolymers 
Hybrid block copolymer structures of branched polymers can be synthesised by either a 
chain first strategy, dendron/branched polymer first strategy, or a coupling strategy. A 
particular advantage of hybrid branched-linear block copolymers is the combination of 
branched topology traits with the self-assembly possibilities of block copolymers, which 
enables further development of drug delivery systems based on micelle like structures. 
This is illustrated by Hammond et al., who synthesised amphiphilic Dendron-linear block 
copolymers with poly(-benzyl-L-aspartate) linear hydrophobic chain and hydrophilic 
polyester dendron unit functionalised with folate groups.89,143 The anticancer therapeutic 
paclitaxel was encapsulated in the micelle core with loading efficiencies of up to 40%, 
while the exterior of the drug carrier presents a multivalent targeting by the folate groups. 
Both targeted and non-targeted micelles accumulated in tumour sites by the EPR effect 
after injection in mice, however the folate system was able to enter tumour cells from the 
extracellular environment by receptor mediated endocytosis, and had a 4 fold improved 
anticancer efficiency compared to the non-targeted system. 
The Luo group has investigated amphiphilic dendritic-linear copolymers for anticancer 
drug delivery (Figure 9).88,144 The synthesised polymers form micelles having a 
hydrophilic linear PEG shell and hydrophobic dendron core functionalised with rhein, or 
cholic acid, or riboflavin, which are able to bind to the drug doxorubicin thus forming 
stable nanoparticles. The strong doxorubicin dendron interactions leads to very high drug 
loadings. The dendritic-linear polymer systems investigated formed particles with high 
stabilities, long circulation times, reduced toxicities, whilst also showing favourable 
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anticancer efficiencies in the particular subcutaneous Raji lymphoma xenograft mouse 
model that was employed. 
 
 
Figure 1.8. Dendritic-linear hybrid block copolymers for doxorubicin delivery, 
synthesised by a rational design and high throughput development process. Figure from 
reference 88. 
 
Shen et al., studied dendritic-linear block copolymers for delivery of camptothecin.90 The 
therapeutic agents were conjugated to the hydrophobic dendron segment of the polymer 
via a redox responsive disulphide bridge, while the linear PEG segment provided 
solubility and biocompatibility. Due to the active ingredient being convalently attached 
to the multivalent dendron, high drug loadings were achieved. The polymer drug 
conjugate self-assembled into micelles of different morphologies depending on the 
number of conjugated drugs and thus the hydrophobicity of the core forming block. It 
was found that medium length rod-like micelles of these branched-linear block 
copolymers had long circulation times, and released camptothecin intracellularly, 
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demonstrating the advantages of branched-linear block copolymers for therapeutic 
delivery to tumours. 
 
1.2.5.2. Branched-core star polymers 
Star polymers involving linear polymer chains extending radially from a globlular three 
dimensional branched polymer, are another interesting class of branched-linear hybrid 
polymers. This polymer architecture can be rationally designed for use as efficient 
encapsulation devices for various guest molecules, as well as direct conjugation to the 
star exterior. In cases where a high number of polymer arms can be attached to the 
branched polymer core, the star polymer can act as a unimolecular nanocarrier.64,145 When 
considering amphiphilic core shell systems with high number of arms, the architecture 
can offer the advantage of not dissembling into individual polymer chains upon dilution, 
as would be the case for micelle systems. However, there are also studies looking at the 
self-assembly of star polymers with low number of arms. 
Branched core star polymers have been investigated as nucleic acid delivery vehicles by 
a number of research groups, either utilising cationic branched cores or cationic linear 
polymer shells for electrostatic complexation of the therapeutic payload. Gong and 
colleagues utilised a hyperbranched polyester core (Boltron H40) coupled with linear 
cationic polymer arms through pH sensitive imine bonds, to complex and deliver siRNA 
to GFP expressing triple negative breast cancer cells in vitro.92 The linear polymer arms 
consisted of poly(aspartic acid) with disulphide linked 2-aminoethyl groups for nucleic 
acid complexation and also disulphide linked imidazole groups to promote enosomal 
escape. This RNA delivery system showed GFP down regulation capabilities comparable 
to commercial transfection reagents but with lower toxicity, particularly when further 
functionalised with GE11 targeting peptide and tested on EFGR overexpressing cell-
lines. In contrast, Matyjaszewski et al. investigated cationic core star polymers, 
synthesised in an onepot ATRP approach, for siRNA complexation and cellular 
uptake.96,146 While Wang and coworkers synthesied star polymers combining a branced 
PEI core and linear poly(-amino ester) arms.95 This star poly(-amino ester) showed 
excellent gene transfection efficiencies of primary rat adipose derived mesenchymal stem 
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cells, of between 200 and 15000 times higher than either the PEI core, or the poly(-
amino ester) arms on their own.  
Similar bPEI core star polymers have been synthesised by the Voit group for small 
molecule encapsulation, who employed an oligosaccharide shell to stabablise the PEI 
structures.147 The researchers studied encapsulation efficiencies of the branched core star 
polymers with various small molecules, including vitamin-B, an estradiol derivative, and 
pantoprazole. Interestingly, the core shell glycopolymer architecture was found to be 
necessary for stable complexes with high encapsulation efficiencies, and the maltriose 
polymer in particular showed good potential for use as a drug delivery system. Cationic 
core star polymers have been used to deliver platinum based anticancer drugs with high 
efficiencies, by Nie, Wang, and colleagues.148 PAMAM dendrimers were conjugated with 
platinum prodrug, and poly(ethylene glycol)-block-(2-azepane ethyl methacrylate) linear 
polymer arms, which had pH based size switching behaviour for enhanced tumour 
penetration and drug delivery in vivo. 
Another option for small molecule drug delivery with branched core star polymers, is to 
employ an amphiphilic system to either conjugate or encapsulate hydrophobic molecules. 
Amphiphillic star based hyperbranched Boltron H40 has been used by a number of 
research groups for both encapsulation and drug conjugation.94,149 A hydrophilic linear 
polymer such as PEG is typically used as the hydrophilic shell. Our group has recently 
utilised amphiphilic branched core star polymers for hydrophobic molecule encapsulation 
and cellular internalisation.93 A hydrophilic and biocompatible poly(2-ethyl oxazoline) 
shell was conjugated to a hyperbanched and hydrophobic polyester core polymer that was 
based on a thiol-yne polymerisation system. The core shell architecture allowed 
encapsulation of hydrophobic Nile Red as a model drug, and the polymers were readily 
uptaken by A2780 ovarian cancer cells via an energy dependent mechanism, suggesting 
endocytosis. 
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1.2.5.3. Dendronised polymers 
Dendronised polymers (linear polymers grafted with dendrons), and hypergrafted 
polymers (linear polymers grafted with hyperbranched polymers) are hybrid polymer 
architectures which have only more recently been established for use in therapeutic 
delivery.142 The first study evaluating rigid-rod dendronised polymer toxicity, 
biodistribution, and pharmacokinetics in vivo, was undertaken by Fréchet and Szoka.98 
The poly materials comprising a poly(4-hydroxystyrene) backbone with 4 generation 
polyester dendrons were evaluated for cytotoxicity against MDA breast cancer cells in 
vitro, which displayed 70% viablilty at a polymer concentration of 3 mg/mL. In vivo 
biodistribution studies were performed with tumoured and non tumoured mice. The 
smaller molecular weight dendronised polymers (67 kDa) exhibited urinary excretion, the 
largest polymer (1740 kDa) was cleared by the reticuloendothelial organs, while the 
medium molecular weight system (251 kDa) accumulated the most in tumour 
environments. The long blood circulation times of the dendronised polymers was 
attributed to their large molecular weights and rigid-rod shapes.  
Dendronised amphiphilic polymers have been synthesised using an alkyne azide click 
reaction to graft polyglycerol dendrons to a PEG based linear backbone.99 The systems 
formed supramolecular aggregates able to efficiently encapsulate hydrophobic guest 
moelcules, and then be internalised by cells as followed by flow cytometry and confocal 
microscopy. In addition, the polyglycerol shell imparted non cytotoxic properties to the 
nanocarriers over a range of concentrations, and the dendronised polymers performed 
better than similar linear-dendron block copolymers which could be destabalised at lower 
concentrations. 
Gu et al. investigated in vivo doxorubicin delivery using a dendronised heparin based 
polymer system.97 The researchers utilised a pH sensitive hydrazine bond to conjugate 
doxorubicin to a lysine based Dendron, which was then attached to a linear heparin chain 
with the use of azide alkyne cycloaddition chemistry. Drug loadings of 9 wt% could be 
achieved and the polymer architecture further self assemebled into nanoparticles of 
around 100 nm. In a mice 4T1 breast tumour model the polymer delivery system produced 
strong antitumour results, high antiangiogenisis effects, and apoptosis compared to the 
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free drug as observed by a variety of mice and tumour weight analysis, 
immunohistochemical analysis, and histology. 
 
Figure 1.9. Dendronised heparin-doxorubicin conjugates as a pH responsive therapeutic 
delivery system, including in vivo studies showing a) relative tumour volumes, b) 
mouse body weights, c) tumour size analysis, and d) tumour weight analysis. Figure 
adapted from reference 97. 
 
Dendronised polymers have also been used for gene delivery applications. Guon et al. 
synthesised a range of biodegradable dendronised polypeptides with variations in 
structure that were tuned in order to identify superior delivery vectors.150 A dendronised 
polymer based on a second generation lysine dendron functionalised with 75% histidine 
and 25% tryptophan, was found to have the optimal combination of charged and aromatic 
residues required for successful delivery. The polymers showed good efficiencies when 
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complexed with siRNA to eGFP expressing NIH-3T3 cells in vitro, while also exhibiting 
minimal toxicity. 
 
1.2.6. Architecture property relationships 
With increased access to complex polymer architectures through new chemical 
technologies, researchers have been able to start hypothesising relationships between 
polymer architecture and subsequent properties as therapeutic delivery systems as well as 
physiochemical properties. The physiochemical properties of linear polymers are largely 
determined by the monomer repeat unit, however the properties of branched polymers 
result mainly from the polymer end groups at the surface of the polymer.39 The 
biocompatibility of polymers is a complex assessment and is mainly affected by non-
architecture related factors such as polymer functionality, however branched structures 
can offer ability to modulate biocompatibility. Known toxic molecules or functionalities 
can be embedded within the core of branched topologies, and new polymer architectures 
could be used to alter the protein corona by recruiting or repelling specific endogenous 
biomolecules to polymer surfaces by variation branching densities.151 Polymer toxicity is 
also known to be affected by polymer flexibility with a number of studies reporting 
reduced toxicity for branched polymer systems.152 The globular and approximately 
spherical conformation of branched polymers in solution is a significant attraction for 
drug delivery applications. This size and shape of polymers is an important parameter and 
can alter significantly the final properties of the delivery system, in particular, whether 
the polymer forms unimolecular and stable objects, or forms larger self-assembled 
structures, which in turn impacts the circulation times and biodistribution of the polymer 
systems.153,154 The tunablity of polymer architecture and shape offers opportunities to 
increase drug loading either through manipulating the polymer core or self-assembled 
structure, or by the increased number of functionalisable groups on the exterior of a 
branched polymer.64 When considering in vivo therapeutic delivery barriers, branched 
polymers offer opportunities for stimuli responsive endosome escape by proton 
sponge/osomotic pressure changes and subsequent polymer swelling of charge 
alteration.29 Cell uptake has also been reported to depend on polymer architecture, with 
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increased branching potentially resulting in a higher number of multivalent interactions 
with cell surface receptors, thereby increasing internalisation. 
 
1.3 Motivation for this work 
Recent advances in synthetic polymer chemistry have led to the design and development 
of a variety of cationic gene delivery systems with different polymer architectures. In 
particular, branched polymers have received significant attention due to their interesting 
properties such as, globular three dimensional conformations, low intrinsic viscosities, 
and high surface functionality. However, there is still need for further understanding of 
structure-function relationships of well controlled polymer architectures in nucleic acid 
delivery applications. The aim of this work is to utilise advanced polymer synthesis 
methods to create and characterise various new cationic polymers with well controlled 
branched architectures and varying charged moieties; with the additional aims of 
investigating polymer toxicity, nucleic acid complexation, polyplex morphology, and 
gene transfection efficiency.  
Initially, the synthesis of AB2 hyperbranched polymers using thiol-yne chemistry will be 
explored in a systematic study involving a semi-batch process to form hyperbranched 
polymers with well-defined molecular weights and dispersities. Subsequently, the focus 
will shift to introducing cationic moieties on thiol-yne hyperbranched polymers. This is 
will be achieved by the ring opening polymerisation of 2-ethyloxazoline to form a 
polyoxazoline thiol-yne macromonomer. The macromonomer will then by polymerised 
by irradiation with UV light in the presence of a photoinitiator, with an additionally 
hydrolysis step to form PEI-POx copolymers with hyperbranched architectures. An 
investigation of plasmid DNA complexation, and in vitro toxicity and gene transfection 
will then be undertaken.  
RAFT polymerisation will be utilised to form another type of branched polymer 
architecture, but with the advantage of being able to introduce tuneable degradation and 
nucleic acid release. The hypothesis was that rates of polymer hydrolysis and subsequent 
nucleic acid release due to polymer charge alteration from cationic to anionic, could be 
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tuned by incorporating a non hydrolysable monomer. Finally, the possibility of using 
RAFT to synthesis branched polymers with phosphonium cationic moieties will also be 
investigated, and their DNA complexation, toxicity, and gene transfection efficiency 
compared to the equivalent cationic polyammoniums. The aim of this chapter was to 
investigate potential cationic species as alternatives to the commonly employed 
ammonium moieties. 
Overall, this thesis will describe advanced polymer synthesis methods to create 
hyperbranched and highly branched cationic polymers suitable for nucleic acid 
complexation, and investigate their associated structure-function characteristics.  
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Abstract 
Described here is a versatile approach to the production of hyperbranched polymers with 
high degrees of branching and low dispersity values (Đ), involving slow monomer 
addition of a thiol/yne monomer to multifunctional core molecules in the presence of 
photoinitiator and under UV irradiation. The small thiol/yne monomer was synthesized 
via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCl) 
esterification and batch polymerizations were performed at varying concentrations. The 
batch thiol–yne polymerizations had fast reaction kinetics and large dispersity values that 
increased with increasing concentration. Introduction of monomer by slow addition to a 
multifunctional alkyne core (tri(prop-2-yn-1-yl) 1,3,5-benzenetricarboxylate) or alkene 
core (triallyl 1,3,5-benzenetricarboxylate) was found to lower dispersity at monomer 
concentrations of 0.5 M to 2.0 M. Degrees of branching were determined by 1H NMR 
spectroscopy to be greater than 0.8 in most cases. Increasing the fraction of core molecule 
was found to decrease dispersity to values as low as 1.26 and 1.38 for the alkene core and 
alkyne core respectively, for monomer concentrations of 0.5 M with 10 mol% core 
molecule. Molecular weights of the hyperbranched structures were also determined by 
light scattering size exclusion chromatography (SEC) detection, and intrinsic viscosities 
determined by viscometry SEC detection. The Kuhn-Mark-Houwink-Sakurada  
parameter decreased from 0.35 for the batch process to values as low as 0.21 (10 mol% 
alkene core) or 0.16 (10 mol% alkyne core), indicating that the thiol–yne structures 
became more globular and dense with the slow monomer addition strategy. This simple 
and versatile approach is a promising new development for the design of hyperbranched 
polymers of well-controlled molecular weight and molecular weight distributions, with 
very high degrees of branching. 
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2.1 Introduction 
Highly branched and three dimensional macromolecular structures, or dendritic 
polymers, have become an important class of materials over recent decades.1,2 These 
structures, including dendrimers and hyperbranched polymers, have received increasing 
interest due to their unique properties including large number of terminal functional 
groups, globular three dimensional structures, and low intrinsic viscosities.3,4 Dendrimers 
were first reported in the late 1970’s and early 1980’s, and were synthesized via a 
divergent approach which involves many synthetic steps and tends to lead to branching 
irregularities at higher generations.5,6 The convergent approach to dendrimer synthesis 
was introduced in pioneering work by Fréchet and Hawker in the early 1990’s and can 
lead to higher purity.7 While perfectly branched dendrimers with degrees of branching 
(DB) of 1 are very promising structures, the sometimes complicated synthetic and 
purification steps have led to attempts to replicate their structural properties via synthesis 
of hyperbranched polymers with high degrees of branching in one pot processes. 
Flory established the theory of AB2 hyperbranched polymers that could be prepared 
without gelation in 1952,8 but it wasn’t until 1988 that AB2 hyperbranched polymers were 
synthesized for the first time in practice.9-11 Traditional AB2 hyperbranched polymers 
where both B groups have the same reactivity have a maximum degree of branching of 
0.5 due to the statistical nature of the reaction.12 But by designing monomers where the 
second B group reacts at a faster rate, DB can be dramatically increased producing 
hyperbranched polymers with degrees of branching in the region of dendrimers.13 An 
interesting chemistry that shows this enhanced reactivity are radical-mediated thiol–yne 
additions, which were re-introduced by the group of Bowman in 2009,14 and applied in 
the synthesis of hyperbranched polymers with high degrees of branching by our group.15-
18 Another recent example involves copper-catalyzed azide–alkyne click chemistry, 
where the second B group reacts at a faster rate, due to the first triazole formed 
complexing the copper catalyst and causing faster reaction of the second moiety.19 
Accelerated strategies to dendrimer synthesis using orthogonal click chemistry have 
greatly improved applications of dendrimers and increased their availability to the 
scientific community, by reducing number of reaction steps and need for demanding 
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purifications.20-23 Further to this, the development of methods to produce hyperbranched 
polymers with narrow molecular weight distributions is an important target as it would 
allow the preparation of materials with greater control and more similarities to 
dendrimers, in a convenient manner. This could improve the application of 
hyperbranched polymers in a number of areas including biological systems, and as 
rheology additives. A number of strategies have been employed to control the molecular 
weight and dispersity of hyperbranched polymers including polymerization of inimers in 
confined space;24,25 however this has yet to be used to produce polymers with degrees of 
branching higher than 0.5. Slow feeding of AB2 monomer to multifunctional core has 
been described previously theoretically,26,27 and in practice,28 as another method to 
control molecular weight and dispersity of hyperbranched polymers. Further to this, 
increasing the reactivity of the core molecule has been shown to have a greater effect on 
the narrowing of hyperbranched polymer dispersity.29-31  
In this chapter, a new strategy to generate hyperbranched polymers via radical thiol–yne 
chemistry is reported. The method dramatically improves previously published 
procedures by producing hyperbranched polymers with high degrees of branching and 
remarkably low dispersity values, via slow addition of the thiol/yne monomer to a 
trifunctional alkyne core and a trifunctional alkene core, tri(prop-2-yn-1-yl) 1,3,5-
benzenetricarboxylate and triallyl 1,3,5-benzenetricarboxylate, respectively. The first 
part of this chapter involves the investigation of the effect of concentration and reactivity 
of the core molecule on the hyperbranched structure formed with slow monomer addition. 
The degree of branching for this system and also the kinetics of the thiol–yne batch 
polymerization were studied in order to establish appropriate slow monomer addition 
parameters. The second part of this chapter discusses the effect of the type and amount of 
core molecules on the production of hyperbranched structures. The molecular weight 
distributions of the hyperbranched polymers, their molecular weight and dendritic 
conformation in solution were determined by multidetector SEC, and the degrees of 
branching by nuclear magnetic resonance (NMR) spectroscopy. 
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2.2 Results and Discussion 
2.2.1 Preparation of thiol/yne monomer and batch thiol–yne photopolymerization 
The traditional batch polymerization of AB2 monomers typically gives hyperbranched 
polymers with poor control and broad molecular weight distributions. Batch 
copolymerization of AB2 and Bf (core molecule with f number of B functionalities) 
monomers in the molten state was first shown to decrease dispersity in 1995, with a 
degree of control over molecular weight achieved by varying the core to monomer ratio.32-
37 In 1998, the theory and computational studies of slow monomer addition to 
multifunctional core were developed by Frey and Müller,26,27 which showed that the slow 
monomer addition method could be used to lower dispersity further. The slow monomer 
addition to multifunctional core strategy was employed to control the synthesis of 
hyperbranched polymers by Moore et al. for the preparation of hyperbranched 
phenylacetylenes with low dispersity values, however the degree of branching was not 
determined.28 Frey et al. used slow monomer addition to a core initiator in the synthesis 
of polyglycerols by ring-opening polymerization, to give hyperbranched polymers with 
low dispersity values and DB’s of ~0.55.38 Thus, in order to determine appropriate slow 
addition parameters for the thiol–yne system, an initial set of experiments was conducted 
in which thiol/yne monomer was polymerized in a batch system allowing characterization 
of the kinetics of the reaction and degree of branching. 
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Scheme 10.1. Preparation of thiol/yne monomer and batch photopolymerization to form 
hyperbranched thiol–yne polymers. 
 
The thiol/yne monomer used in this study was synthesized via a two-step procedure, as 
shown in Scheme 10.1. The first step involved the esterification of propargyl alcohol with 
3,3-dithiodipropionic acid. This reaction procedure allows large scale synthesis and 
convenient storage of thiols in their disulfide form, compared to the reduced form, which 
is subject to reasonably fast oxidation under air. However, storage of the reduced thiol 
form of the monomer under inert atmosphere is also possible for periods of up to a week 
(longer storage not tested), and subsequent polymerisations showing no effect on polymer 
characteristics. Facile reduction of the disulfide (i.e., thiol-protected) monomer was 
achieved using dithiothreitol (DTT) over 2 hours, and extraction of the DTT with water, 
to give the pure thiol/yne monomer, prop-2-ynyl 3-mercaptopropanoate, in good yields. 
The monomer was polymerized under UV light (365 nm) with the radical photoinitiator 
2,2-dimethoxy-2-phenylacetophenone (DMPA) in a 1.1 M solution in DMF, following a 
method similar to that previously published by our group.15,17,18 A summary of the results 
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is shown in Table 2.1. The reaction proceeds through the radical-mediated addition of a 
thiol to an alkyne followed by the addition of a second thiol to the formed vinylthioether 
to give a dendritic unit. The rate of the second addition is much faster than the first 
addition, which leads to hyperbranched polymers with very high degrees of branching. 
 
Table 10.1. Conversions, molecular weights, dispersity, and degree of branching values 
for hyperbranched thiol–yne polymers prepared by batch process. 
Time (min) Conv. a 
Mn,SEC 
(g/mol) b 
Mw,SEC 
(g/mol) b 
Đ b DB c 
2 35% 1600 2400 1.50 0.84 
5 61% 2300 3900 1.66 0.89 
10 86% 3400 6500 1.89 0.87 
20 98% 4700 10900 2.30 0.84 
30 > 99% 5400 14400 2.67 0.83 
60 > 99% 5600 16100 2.88 0.84 
60 (ppt) - 9500 19900 2.09 0.85 
a  Determined by 1H NMR spectroscopy, from disappearance of thiol triplet at 1.7 ppm.  
b From DMF SEC with DRI detector and PMMA standard, c DB = degree of branching, 
following equation DB = (D+T)/(D+T+L).39 
 
Figure 2.1a shows the conversion of the thiol/yne monomer over time. Conversion was 
monitored by 1H NMR spectroscopy, by comparing the integral of the thiol triplet at 1.7 
ppm to the integrals corresponding to the dendritic monomer units at 4.3 ppm, the 
terminal monomer units at 4.7 ppm, and the linear monomer units at 6.4 ppm (see Figure 
A2.9). The reaction proceeds very rapidly and reaches 98% conversion after 20 minutes, 
with no observable monomer peaks remaining in the 1H NMR spectrum after 60 minutes. 
The molecular weight increases in a linear fashion until high conversion, where above 
90% conversion, polymer–polymer coupling is observed as expected from a step growth 
hyperbranched polymer synthesis (Figure 2.1b). The step growth nature of the thiol–yne 
hyperbranched system also leads to broadening of the molecular weight distribution as 
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conversion increases, as seen in Figure 2.1c. Note that purification by precipitation 
removes the smallest hyperbranched oligomers thus leading to a small decrease in the 
dispersity (Figure 2.1c). 
 
Figure 2.1. a) Conversion of thiol/yne monomer as a function of time, b) Number 
average molecular weight as a function of conversion, c) SEC chromatograms of 
polymer samples at different times during the polymerization, d) 1H NMR spectrum of 
the precipitated hyperbranched thiol–yne polymer showing peaks corresponding to 
dendritic, linear, and terminal units for calculation of degree of branching (see appen.). 
 
The concept of ‘degree of branching’ (DB) was introduced by Flory in the 1940’s with 
polymers in the state of gelation,40 and expanded to highly-branched polymers in solution 
with the theory of AB2 polymerizations in 1952.
8 An important associated equation for 
the characterization degree of branching in hyperbranched polymers was proposed by 
Hawker and Fréchet in 1991.39 The polymerization of the thiol/yne monomer allows for 
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easy determination of the degree of branching by 1H NMR spectroscopy, as the peaks for 
terminal, dendritic, and linear units appear at distinct chemical shifts.41 For batch 
polymerization of thiol/yne monomer at 1.1 M concentration, the precipitated polymer 
had a degree of branching of 0.85 (Figure A2.11), which corresponds to 15% linear units. 
It is remarkable to achieve such a high degree of branching for hyperbranched polymers, 
especially considering the simplicity and versatility of the process, although the final 
materials exhibit relatively high dispersity. 
 
2.2.2 Slow addition of thiol/yne monomer to multifunctional core 
In order to lower this dispersity, the thiol/yne monomer was fed to a trifunctional alkyne 
core, tri(prop-2-yn-1-yl) 1,3,5-benzenetricarboxylate, at varying concentrations (Scheme 
2.2). The proportion of core molecule was chosen to be 10 mol% core for an initial series 
of feeding experiments. Thiol/yne monomer was introduced gradually into the reaction 
vessel at a rate that allows the majority of monomer to react with the core before more 
monomer is added, thus limiting monomer–monomer reactions and promoting monomer–
polymer reactions, ie. polymerization from core. This process creates a core region of the 
hyperbranched polymers analogous to dendrimers, and indicates that there are no thiol 
focal points which could cause polymer–polymer coupling at high conversions and 
broaden the molecular weight distribution. Based on the initial thiol–yne batch 
polymerization kinetic experiments (with 98% conversion after 20 minutes) and previous 
studies,15,17 slow monomer addition conditions were employed with the monomer fed 
over 20 minutes. The matching of the rate of feeding to rate of polymerization means 
there is always a low concentration of unreacted AB2 in the reaction vessel. 
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Scheme 10.2. Preparation of hyperbranched thiol–yne polymers by slow monomer 
addition to multifunctional core molecules, tri(prop-2-yn-1-yl) 1,3,5-
benzenetricarboxylate or triallyl 1,3,5-benzenetricarboxylate. 
 
Figure 2.2 shows the SEC chromatograms of hyperbranched thiol–yne polymers 
prepared at varying concentrations either by slow monomer addition or in a batch process. 
Molecular weights and dispersity values are shown in Table 2.2, and were determined 
using a conventional calibration with PMMA standards and also multi angle light 
scattering (MALLS) SEC detection. With increasing concentration the batch thiol–yne 
hyperbranched polymers have higher molecular weights and broader molecular weight 
distributions, with the batch polymerization at 2.0 M having a very high apparent 
molecular weight and large dispersity values. At 0.5 M the use of slow monomer addition 
to multifunctional alkyne core allows the reduction of the molecular weight to Mw,MALLS 
= 13,300 g/mol and the molecular weight distribution is narrowed to 1.38. Using the slow 
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monomer addition strategy with the alkyne core, and with careful choice of monomer 
concentration, the molecular weight can be targeted to between 13,300 g/mol and 77,700 
g/mol with considerably lower dispersity values than the equivalent batch polymerization. 
 
Figure 2.2. Normalized DRI response SEC chromatograms of hyperbranched thiol–yne 
polymers prepared by both batch and slow monomer addition process to multifunctional 
alkyne and alkene core molecules at varying concentrations. 
 
With respect to the monomer concentrations discussed above, the semi-batch methods 
were designed to have the same concentration of monomer after the initial feeding period. 
This does lead to differences in concentrations of various reaction components in the two 
polymerisation processes. In the feeding polymerisations, the total amount of initiator and 
solvent were kept the same for the batch and semi-batch after the initial feeding period. 
For the feeding period, equal volumes of solvent and initiator were used in both the 
reaction vessel and the feed syringe (see experimental). 
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Increasing the reactivity of the core functional groups compared to the monomer can 
further enhance control and lower dispersity.42-45 This approach has been used in batch 
polymerizations to reasonable effect. Fossum et al. have shown that copolymerization of 
an AB2 monomer with multifunctional Cf cores, where the reactivity towards A of the C 
group is higher than that of the B group, permits to reduce dispersity of the resulting 
hyperbranched polymers.29 Similar results were obtained by Ramakrishnan et al. for the 
copolymerization of AB2 with a higher reactivity core molecule.
30 In an attempt to reduce 
dispersity further, use of slow feeding combined with higher reactivity core can be used.31 
Since alkenes are usually more reactive in radical thiol yne/ene reactions,46 thiol/yne 
monomer was fed to a trifunctional alkene core, triallyl 1,3,5-benzenetricarboxylate, at 
varying concentrations.  
Use of the alkene core gave narrower molecular weight distributions compared to the 
same polymerization protocols using the alkyne core. The most remarkable results were 
obtained with reducing monomer concentration, leading to dispersity as low as 1.26 – a 
value close to that expected from controlled polymer synthesis techniques such as 
controlled radical polymerizations – whilst keeping very high degrees of branching 
(above 0.8).  
Molecular weights can also be relatively well-controlled, with lower Mw obtained at lower 
monomer concentrations. Note that increasing molecular weight by increasing monomer 
concentration leads to higher Đ, as expected from theory and previous reports in the 
literature.17,28,29,38 A monomer concentration of 1.1 M was found to give a good 
combination of control over molecular weight and molecular weight distribution, with 
very high degree of branching. These conditions were used to investigate the effect of 
mole fraction core molecule, and conduct a more detailed study of polymer conformation 
and molecular weight using multidetector SEC. 
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Table 10.2. Conversions, molecular weights, dispersity, and degree of branching values 
for hyperbranched thiol–yne polymers prepared by batch polymerization or by slow 
monomer addition process to multifunctional alkyne and alkene core molecules at 
varying concentrations. 
Conc. (M) Core mol% Conv. a 
Mn,SEC 
(g/mol) b 
Mw,SEC 
(g/mol) b 
Đ b 
Mw,MALLS 
(g/mol) c 
DB d 
0.5 
0% > 99% 6700 10300 1.53 17100 0.80 
10% yne > 99% 6700 9200 1.38 13300 0.79 
10% ene > 99% 5400 6800 1.26 12100 0.82 
1.1 
0% > 99% 9500 19900 2.09 46800 0.85 
10% yne > 99% 7200 10400 1.44 19600 0.82 
10% ene > 99% 7200 9700 1.35 13600 0.82 
1.5 
0% > 99% 13800 73400 5.30 175400 0.86 
10% yne > 99% 8100 16800 2.07 25700 0.83 
10% ene > 99% 6300 10300 1.62 16500 0.84 
2.0 
0% > 99% 13900 291600 21.0 1698000 0.87 
10% yne > 99% 9600 42600 4.44 77700 0.88 
10% ene > 99% 9400 33500 3.55 54000 0.86 
a Determined by 1H NMR spectroscopy, from disappearance of thiol triplet at 1.7 ppm. 
b From DMF SEC with  DRI detector and PMMA standard. c Absolute MW from DMF 
SEC, MALLS detector. d DB = degree of branching, following equation DB = 
(D+T)/(D+T+L).39 
 
2.2.3. Variation of amounts of multifunctional core 
The thiol/yne monomer was slowly fed to multifunctional core alkyne and core alkene at 
1.1 M final monomer concentrations, with the fraction of core molecule ranging from 2 
mol% to 20 mol% (Table 2.3). The molecular weights of the resulting hyperbranched 
structures were determined by SEC using a DRI detector and comparing retention time 
to retention time of PMMA. As retention time is based on hydrodynamic volume, the 
molecular weight determined by this conventional calibration is significantly 
underestimated, hyperbranched polymers having a smaller hydrodynamic volume than 
their linear counterparts, at equivalent molecular weight.47 For this reason molecular 
weight was also determined by MALLS SEC detection which determines molecular 
weight based on scattered light of the polymer.  
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Figures 2.3a and 2.3b show the 1H NMR spectra of the hyperbranched polymers 
synthesized by both batch and slow monomer addition to core molecules. The degrees of 
branching and also the extent to which the core molecule functional groups have reacted 
were calculated. For the polymers synthesized with slow monomer addition, the degrees 
of branching are all ~0.82 (Table 2.3), which corresponds to ~18% linear units in the 
main structure of the hyperbranched polymers. For the hyperbranched polymers 
specifically with trifunctional alkyne core, the fraction of core alkyne functional groups 
and core thiovinylether groups remaining after polymerization is the same for all initial 
core ratios. These remaining core functionalities are ~19% vinylthioether groups, and 
40% alkyne groups. In the case of slow monomer addition to alkene core the polymers 
have 30% alkene functionality remaining on the core after polymerization, with very 
similar degrees of branching for the main thiol–yne polymer structure as expected. This 
fraction of residual functionality located on the core molecule after polymerization is the 
same for all initial core ratios, and is most likely due to steric hindrance around the core 
as the hyperbranched polymer grows. 
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Figure 2.3. 1H NMR spectra of hyperbranched thiol–yne polymers prepared by both 
batch and slow monomer addition process to varying amounts of multifunctional a) 
alkyne and b) alkene core molecules at 1.1 M concentration. 
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Table 10.3. Conversions, molecular weights, dispersity, degree of branching values, 
and KMHS parameter  for hyperbranched thiol–yne polymers prepared by slow 
monomer addition process to varying amounts of multifunctional alkyne and alkene 
core molecules at 1.1 M concentration. 
 
Core 
mol% 
Conv. a 
Mn,SEC 
(g/mol) b 
Mw,SEC 
(g/mol) b 
Đ b 
Mw,MALLS 
(g/mol) c 
DB d  e 
 0% > 99% 9500 19900 2.09 46800 0.85 0.35 
Alkyne 
Core 
2% > 99% 8500 15100 1.79 34200 0.81 0.32 
5% > 99% 8200 12800 1.56 24600 0.81 0.27 
10% > 99% 7200 10400 1.44 19600 0.82 0.21 
15% 98% 6300 9000 1.42 14200 0.79 0.35 
20% 97% 6100 8600 1.43 12600 0.73 0.40 
Alkene 
Core 
2% > 99% 9400 16200 1.72 29400 0.82 0.34 
5% > 99% 7900 11900 1.52 23000 0.81 0.20 
10% > 99% 7200 9700 1.35 13600 0.82 0.16 
15% 99% 6500 8800 1.36 13400 0.82 0.31 
20% 97% 6300 8300 1.31 12400 0.82 0.34 
a  Determined by 1H NMR spectroscopy, from disappearance of thiol triplet at 1.7 ppm.  
b From DMF SEC, DRI detector, PMMA standard. c Absolute MW from DMF SEC, 
MALLS detector. d DB = degree of branching, following equation DB = 
(D+T)/(D+T+L)39. e  = Kuhn-Mark-Houwink-Sakurada parameter, from DMF SEC 
viscometry detector.  
 
Figures 2.4a and 2.4b show that as the proportion of multifunctional alkyne core is 
increased the molecular weight distribution becomes narrower. As previously discussed 
the batch polymerization has a broad dispersity of over 2, with 2 mol% core this decreases 
to 1.7-1.8 for both core molecules. For 5 mol% this is reduced further to around 1.5 for 
both core molecules. At 10 mol% the dispersity reaches 1.35 for alkene core and 1.44 for 
the alkyne core, with higher core ratios not having a significant further effect on the 
dispersity. High molar ratios of 20% core did however reduce the molecular weight 
further, and cause a reduction in the degree of branching most notable for the alkyne core. 
The distributions also become monomodal due to reduction in polymer–polymer coupling 
with higher amounts of core.  
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Lack of entanglements in hyperbranched polymers leads to lower solution viscosities 
compared to their linear analogues.47 Figure 2.4c and 2.4d show the Kuhn-Mark-
Houwink-Sakurada (KMHS) plots of intrinsic viscosity as a function of molecular weight, 
which describe polymer conformation in solution, obtained using a viscometry detector 
on the SEC. KMHS  values, which correspond to the gradient of these plots, are 0 for a 
hard sphere, 2 for a rigid rod and ~0.7 for linear polymers.48 An  of between 0.2 – 0.4 
corresponds to globular structures with a high degree of branching, consistent with 
hyperbranched polymers.2,49 For the batch polymerization of thiol–yne hyperbranched 
structures the  value was 0.35, indicating globular hyperbranched polymer structures. 
With increasing core fraction the  value decreases to 0.21 for the 10% alkyne core 
hyperbranched polymer and 0.16 for the 10% alkene core hyperbranched polymer, as the 
structures become more uniform in size and more dense, consistent with the molecular 
weight distribution traces. Intrinsic viscosity decreases for the alkene core compared to 
the alkyne core as seen in Figure 2.4c and 2.4d, which also indicates a more uniform 
structure with fewer entanglements, as expected from a more reactive core. 
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Figure 2.4. Normalized DRI response SEC chromatograms of hyperbranched thiol–yne 
polymers prepared by both batch and slow monomer addition process to varying 
amounts of multifunctional a) alkyne and b) alkene core molecules at 1.1 M 
concentration. Kuhn-Mark-Houwink-Sakurada plots of intrinsic viscosity as a function 
of molecular weight, determined by viscometry detector on DMF SEC, for 
hyperbranched thiol–yne polymers prepared by both batch and slow monomer addition 
process to varying amounts of multifunctional c) alkyne and d) alkene core molecules 
at 1.1 M concentration. 
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2.3. Conclusions 
A method for the preparation of hyperbranched polymers with high degrees of branching, 
predictable molecular weights and narrow molecular weight distributions has been 
described, involving slow monomer addition of a thiol/yne monomer to multifunctional 
core molecules in the presence of photoinitiator and UV irradiation. A small thiol/yne 
monomer was synthesized via simple esterification, giving a route to high purity 
monomers. Addition of the thiol/yne monomer to multifunctional alkyne and alkene cores 
was found to lower dispersity of the resulting hyperbranched polymers, whilst 
maintaining very high degrees of branching. Increasing the fraction of core molecule was 
found to decrease dispersity, with the ideal value being approximately 10 mol% core 
molecule. Molecular weights of the hyperbranched structures were determined by 
conventional calibration SEC and also light scattering SEC detection, and intrinsic 
viscosities determined by viscometry SEC detection. The KMHS parameter was found 
to be below 0.4 in all cases indicating dense and highly branched structures. Using the 
slow monomer addition strategy reduced the value to 0.16 in the case of 10% the alkene 
core molecule, and 0.21 when using 10% alkyne core. In summary, this approach proves 
to be a simple and versatile process for the synthesis of hyperbranched polymers of 
remarkably well-controlled molecular weight and molecular weight distributions, with 
very high degrees of branching. 
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2.4. Experimental 
2.4.1. Materials 
Propargyl alcohol, 1,3,5-benzenetricarboxylic acid, 3,3-dithiodipropionic acid, 
dithiothreitol (DTT), 4-dimethylaminopyridine (DMAP), and 2,2-dimethoxy-2-
phenylacetophenone (DMPA) were all purchased from Sigma Aldrich. 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCl) was purchased from Iris 
Biotech. Triethylamine was purchased from Fischer Scientific. Triallyl 1,3,5-
benzenetricarboxylate was purchased from Acros. All other materials were purchased 
from Fisher Scientific or Sigma Aldrich. 
 
2.4.2. Characterization 
Size Exclusion Chromatography (SEC) was performed in DMF, using an Agilent 390-
LC MDS instrument equipped with differential refractive index (DRI), viscometry, dual 
angle light scattering, and dual wavelength UV detectors. The system was equipped with 
2 x PLgel Mixed D columns (300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent 
was DMF with 5 mmol NH4BF4 additive, and samples were run at 1 mL/min at 50 °C. 
Analyte samples were filtered through a nylon membrane with 0.22 μm pore size before 
injection. Apparent molar mass values (Mn,SEC and Mw,SEC) and dispersity (Đ) of 
synthesized polymers were determined by DRI detector and conventional calibration 
using Agilent SEC software. Poly(methyl methacrylate) (PMMA) standards (Agilent 
EasyVials) were used for calibration. Molar mass (Mw,MALLS) was determined on Agilent 
SEC software using a dual angle light scattering detector, and also DRI detector to 
determine the incremental refractive index dn/dc. The Kuhn-Mark-Houwink-Sakurada 
parameter , relating to polymer conformation in solution was determined from the 
gradient of the double logarithmic plot of intrinsic viscosity as a function of molecular 
weight, using the SEC viscometry detector and Agilent SEC software. Proton nuclear 
magnetic resonance spectra (1H NMR) were recorded on a Bruker Advance 400 or 500 
spectrometer (400 MHz or 500 MHz) at 27 °C in CDCl3, with chemical shift values (δ) 
reported in ppm, and the residual proton signal of the solvent used as internal standard 
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(δH 7.26). Proton-decoupled carbon nuclear magnetic resonance spectra (13C NMR) were 
recorded on a Bruker Advance 400 or 500 spectrometer (100 MHz or 125 MHz) at 27 °C 
in CDCl3, with chemical shift values (δ) reported in ppm, and the residual proton signal 
of the solvent used as internal standard (δC 77.16). Fourier transform infrared spectra 
(FTIR) were recorded on a Bruker Vector 22 FTIR spectrometer. Electrospray ionisation 
mass spectra (ESI-MS) were recorded using an Agilent 6130B single Quad mass 
spectrometer or an Apex Ultra 7T Fourier transform ion cyclotron resonance (FTICR) 
from Bruker Daltonics. 
 
2.4.3. Preparation of tri(prop-2-yn-1-yl) 1,3,5-benzenetricarboxylate (trialkyne 
core)  
1,3,5-benzenetricarboxylic acid (5.00 g, 23.8 mmol) in 100 mL of DCM, in a round 
bottomed flask was cooled to 0 ˚C. 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC.HCl) (16.47 g, 85.9 mmol) and 4-dimethylaminopyridine (DMAP) 
(1.08 g, 8.8 mmol) were dissolved in 100 mL DCM and added to the round bottomed 
flask under vigorous stirring. Propargyl alcohol (5.30 g, 94.5 mmol) was then added over 
1 minute; the reaction mixture was allowed to reach room temperature and stirred for 24 
hours. The DCM phase was washed with MilliQ water (2 × 150 mL, 2 × 100 mL), dried 
with MgSO4, filtered, and the solvent was removed by rotary evaporation. The light 
brown solid was purified over a short silica column with DCM as the eluent, and the 
solvent removed by rotary evaporation to give a white powder (5.83 g, 76% yield). 1H 
NMR (CDCl3, 500 MHz), δ ppm: 8.93 (s, 3H, CH phenyl) 4.99 (s, 6H, O-CH2-C≡), 2.56 
(s, 3H, C≡CH). 13C NMR (CDCl3, 125 MHz), δ ppm: 164.06 (C=O), 135.36 (CH phenyl), 
130.87 (C phenyl), 77.24 (CH2-C≡CH), 75.76 (C≡CH), 53.24 (O-CH2-C≡). High 
resolution ESI-MS, expected: m/z 347.05 [M+Na]+, found: m/z 347.0526 [M+Na]+. 1H 
and 13C NMR spectra can be found in the Supporting Information (Figure A2.1 and 
A2.2). 
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2.4.4. Preparation of di(prop-2-yn-1-yl) 3,3'-disulfanediyldipropionate (protected 
thiol/yne monomer) 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCl) (21.88 g, 
114.14 mol), 3,3-dithiodipropionic acid (10.0 g, 47.56 mol), and 4-
dimethylaminopyridine (DMAP) (1.14 g, 9.52 mol) were dissolved in 250 mL of DMF 
and cooled in an ice bath under stirring. Propargyl alcohol (6.4 g, 114.14 mol) was added; 
the reaction was allowed to reach room temperature and stirred for 24 hours. The reaction 
mixture was concentrated via rotary evaporation to yield a yellow oil which was 
redissolved in DCM, and washed with water (3 × 100 mL) to remove trace DMF. The 
DCM phase was then washed with HCl (1 M, 1 × 100 mL), NaOH (1 M, 1 × 100 mL), 
and water (1 × 100 mL), then dried with Na2SO4, filtered and the solvent removed by 
rotary evaporation. The product was purified by column chromatography (eluent: DCM 
with 2.5% MeOH), and the resulting viscous liquid (10.3 g, 87% yield) crystallized at 4 
°C. 1H-NMR (CDCl3, 400 MHz) δ ppm: 4.71 (s, 2H, O-CH2-C≡), 2.94 (t, 2H, C(O)-CH2-
CH2), 2.80 (t, 2H, CH2-CH2-S), 2.49 (s, 1H, C≡CH). 13C-NMR (CDCl3, 100 MHz) δ 
ppm: 170.91 (C=O), 76.84 (CH2-C≡CH), 75.25 (C≡CH), 52.32 (O-CH2-C≡), 33.86 
(C(O)-CH2-CH2), 32.79 (CH2-CH2-S). FTIR  cm-1: 3240-3270 (≡C-H), 2125 (C≡C), 
1732 (C(O)=O), 561 (S-S). ESI-MS, expected: m/z 309.02 [M+Na]+, found: m/z 309.0 
[M+Na]+. Characterisation data agree with literature.50 The different spectra are available 
in the Supporting Information (Figure A2.3–A2.5). 
 
2.4.5. Preparation of prop-2-yn-1-yl 3-mercaptopropanoate (monomer 
deprotection) 
Disulfide protected thiol/yne monomer (0.79 g, 5.5 mmol) was dissolved in DCM (10 
mL), DTT (1.85 g, 12.1 mmol) and triethylamine (1.75 mL, 12.5 mmol) were added and 
solution deoxygenated with nitrogen bubbling for 10 min. The solution was stirred at 
room temperature for 2 hours. The organic layer was washed with 1 M HCl (1 × 20 mL) 
and water (2 × 20 mL), dried with Na2SO4, and solvent removed by rotary evaporation. 
The resulting viscous liquid (0.73 g, 92% yield) was stored under nitrogen, to prevent 
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disulfide formation. Characterization data agrees with previously published synthetic 
method.15 1H-NMR (CDCl3, 400 MHz) δ ppm: 4.71 (s, 2H, O-CH2-C≡), 2.79 (m, 2H, 
C(O)-CH2-CH2), 2.71 (m, 2H, CH2-CH2-SH), 2.49 (s, 1H, C≡CH), 1.66 (t, 1H, CH2-SH). 
13C-NMR (CDCl3, 100 MHz) δ ppm: 170.81 (C=O), 76.84 (CH2-C≡CH), 75.20 (C≡CH), 
52.15 (O-CH2-C≡), 38.16 (C(O)-CH2-CH2), 19.56 (CH2-CH2-SH). FTIR cm-1: 3270-
3290 (≡C-H), 2565-2570 (S-H), 2127 (C≡C), 1732 (C(O)=O). ESI-MS, expected: m/z 
311.04 [2M+Na]+, found: m/z 311.0 [2M+Na]+. The spectra are reported in the 
Supporting Information as Figures S6–S8. 
 
2.4.6. Typical thiol–yne batch polymerization procedure 
A typical polymerization is as follows: deprotected thiol/yne monomer (50 mg, 0.347 
mmol) was dissolved with DMPA (2 mg, 0.195 mmol) in DMF (300 mg) in a 1.5 mL vial 
equipped with a small stirrer bar and a rubber septum screw cap. Monomer to initiator 
ratio was kept the same for all polymerizations. The vial was wrapped in aluminium foil 
and deoxygenated with nitrogen for 5 min. The vial was placed under a 365 nm UV lamp 
(UVP, UVGL-55, 6 watt, 365 nm) in an aluminium foil lined dark box over a magnetic 
stirrer plate. For the kinetic samples, each time point corresponds to a separate vial 
removed after the allocated polymerization time. After the predetermined reaction time 
the vial was removed and analyzed by NMR spectroscopy and SEC. Polymer reaction 
mixture was precipitated in diethyl ether and the polymer recovered by centrifugation. 
Conversion was determined by disappearance of thiol peak at ~1.7 ppm, compared to 
total polymer. The monomer contribution to the integral of the terminal polymer CH2 next 
to the alkyne (4.7 ppm) was subtracted. 
 
2.4.7. Typical thiol–yne polymerization procedure with slow monomer addition 
A typical polymerization is as follows: a solution of deprotected thiol/yne monomer (50 
mg, 0.347 mmol) was dissolved with DMPA (1 mg, 0.0975 mmol) in DMF (150 mg) and 
deoxygenated by bubbling with nitrogen. This was then added to a 250 μL Hamilton 
gastight glass syringe fitted with stainless steel cannula, and wrapped in aluminium foil 
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and placed on syringe pump. Trialkyne core molecule (11.25 mg, 0.0347 mmol) and 
DMPA (1 mg, 0.0975 mmol) were dissolved in DMF (150 mg) with a small stirrer in a 
1.5 mL vial with a rubber septum screw cap. The vial was wrapped in aluminium foil and 
deoxygenated with nitrogen for 5 min. Initiator was split between feed syringe and 
reaction vessel to keep rate of radical formation high and approximately constant, after 
preliminary experiments showed having all the initiator in the syringe led to slower 
polymerization due to low concentration of radicals in the reaction vessel. Monomer and 
initiator concentrations were chosen to keep final concentrations after feeding period the 
same as the batch polymerizations to enable comparison of results. The vial was placed 
under a 365nm UV lamp (UVP, UVGL-55, 6 watt) in an aluminium foil lined dark box 
over a magnetic stirrer plate and feeding started at the same time as irradiation. The 
feeding was performed over a period of 20 min. For thiol/yne monomer feeding to 
trialkene core the procedure was the same. After the predetermined reaction time the vial 
was removed, exposed to air, and analyzed by NMR spectroscopy and SEC. Polymer 
reaction mixture was precipitated in diethyl ether and the polymer recovered by 
centrifugation. After a maximum of 80 min, the reaction was stopped. 
 
Appendix to Chapter 2 
FTIR spectroscopy spectra, 1H and 13C NMR spectroscopy spectra, representative 
conversion and degree of branching calculations, representative multidetector SEC 
chromatograms, and polymerisation kinetics of slow monomer addition.  
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Figure A2.1. 1H NMR spectrum (500 MHz, CDCl3) of tri(prop-2-yn-1-yl) 1,3,5-
benzenetricarboxylate (trialkyne core) synthesized by EDC/DMAP esterification. 
 
Figure A2.2. 13C NMR spectrum (125 MHz, CDCl3) of tri(prop-2-yn-1-yl) 1,3,5-
benzenetricarboxylate (trialkyne core) synthesized by EDC/DMAP esterification. 
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Figure A2.3. 1H NMR spectrum (400 MHz, CDCl3) of di(prop-2-yn-1-yl) 3,3'-
disulfanediyldipropionate (protected thiol/yne monomer) synthesized by EDC/DMAP 
esterification. 
 
Figure A2.4. 13C NMR spectrum (100 MHz, CDCl3) of di(prop-2-yn-1-yl) 3,3'-
disulfanediyldipropionate (protected thiol/yne monomer) synthesized by EDC/DMAP 
esterification. 
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Figure A2.5.  FTIR spectrum of di(prop-2-yn-1-yl) 3,3'-disulfanediyldipropionate 
(protected thiol/yne monomer) synthesized by EDC/DMAP esterification. 
 
 
Figure A2.6. 1H NMR spectrum (400 MHz, CDCl3) of prop-2-yn-1-yl 3-
mercaptopropanoate (deprotected monomer). 
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Figure A2.7. 13C NMR spectrum (100 MHz, CDCl3) of prop-2-yn-1-yl 3-
mercaptopropanoate (deprotected monomer). 
 
 
Figure A2.8. FTIR spectrum of prop-2-yn-1-yl 3-mercaptopropanoate (deprotected 
monomer). 
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Figure A2.9. Kinetic 1H NMR spectra of hyperbranched polymers by batch thiol–yne 
polymerization at 1.1 M. Inset shows thiol triplet from monomer as reaction proceeds. 
 
 
 
 
 
 
 
 
Appendix to Chapter 2 
83 
 
 
 
𝐶𝑜𝑛𝑣. =
𝑃𝑜𝑙𝑦𝑚𝑒𝑟
𝑃𝑜𝑙𝑦𝑚𝑒𝑟 + 𝑀𝑜𝑛𝑜𝑚𝑒𝑟
 
𝐶𝑜𝑛𝑣. =
𝐷 + 𝑇 + 𝐿
𝐷 + 𝑇 + 𝐿 + 𝑀𝑜𝑛𝑜𝑚𝑒𝑟
 
𝐶𝑜𝑛𝑣. =
7.25
2 +
20.70 − (5.83 × 2)
2 + 1
7.25
2 +
20.70 − (5.83 × 2)
2 + 1 + 5.83
 
𝐶𝑜𝑛𝑣. =
9.15
9.51 + 5.83
= 61% 
 
Figure A2.10. Example conversion calculation of hyperbranched polymers by batch 
thiol–yne polymerization at 1.1 M (t = 5 min). The monomer contribution to the integral 
of the terminal polymer CH2 next to the alkyne (4.7 ppm) was subtracted. Calculation is 
the same for polymers by slow monomer addition but accounting for proportion of 
monomer fed. 
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𝐷𝑒𝑔𝑟𝑒𝑒 𝑜𝑓 𝐵𝑟𝑎𝑛𝑐ℎ𝑖𝑛𝑔 (𝐷𝐵) =
𝑁𝑜. 𝑜𝑓 𝑑𝑒𝑛𝑑𝑟𝑖𝑡𝑖𝑐 𝑢𝑛𝑖𝑡𝑠 + 𝑁𝑜. 𝑜𝑓 𝑡𝑒𝑟𝑚𝑖𝑛𝑎𝑙 𝑢𝑛𝑖𝑡𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑜. 𝑜𝑓 𝑢𝑛𝑖𝑡𝑠
 
𝐷𝐵 =
𝐷 + 𝑇
𝐷 + 𝑇 + 𝐿
 
𝐷𝐵 =
6.34/2 + 5.32/2
6.34/2 + 5.32/2 + 1
 
𝐷𝐵 = 0.85 
 
Figure A2.11. Example degree of branching calculation for hyperbranched polymer by 
batch thiol–yne polymerization at 1.1 M (final precipitated sample). Calculation is the 
same for polymers by slow monomer addition. For DB calculation of unprecipitated 
kinetic samples the monomer contribution to the integral of the terminal polymer CH2 
next to the alkyne (4.7 ppm) was subtracted. 
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Figure A2.12. Multi-detector SEC chromatograms for hyperbranched polymer by batch 
thiol–yne polymerization at 1.1 M (final precipitated sample). 
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Table A2.1. Kinetic data for hyperbranched thiol–yne polymerization with slow 
monomer addition to 10 mol% alkene core at 1.1 M. 
 
Time 
(min) 
Monomer 
fed 
Thiol/yne 
mon. conv. 
a 
Core alkene 
conv. b 
Mn,SEC 
(g/mol) c 
Mw,SEC 
(g/mol) c 
Đ  c DB d 
2 10% 60% 10% 1200 1300 1.06 0.32 
10 50% 63% 37% 1600 2000 1.22 0.43 
20 100% 63% 51% 2400 3500 1.43 0.84 
30 - 75% 59% 2500 4200 1.68 0.92 
50 - 89% 69% 2800 4900 1.74 0.88 
80 - 99% 71% 3200 5900 1.88 0.86 
ppt - - - 6700 9300 1.38 0.82 
a  From disappearance of thiol triplet at 1.7 ppm. b From comparison of unreacted core alkene peak at 5.4 
ppm and total core peak at 8.9 ppm. c From DMF SEC, with DRI detector and PMMA standard. d DB = 
degree of branching, following equation DB = (D+T)/(D+T+L). 
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Figure A2.13. Kinetic plots for hyperbranched thiol–yne polymerization with slow 
monomer addition to 10 mol% alkene core at 1.1 M, a) Conversion of thiol-yne monomer, 
and alkene core as a function of time, b) Number average molecular weight as a function 
of conversion, c) SEC chromatograms of polymer samples at different times during the 
polymerization. 
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Figure A2.14. Kinetic 1H NMR spectra of hyperbranched thiol–yne polymerization by 
slow monomer addition to 10 mol% alkene core at 1.1 M. Inset shows thiol triplet from 
monomer as reaction proceeds. 
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Figure A2.15. Multi-detector SEC chromatograms for thiol–yne hyperbranched polymer 
by slow monomer addition to 10 mol% multifunctional alkene core at 1.1 M (final 
precipitated sample). 
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Figure A2.16. Radical mediated thiol-yne addition mechanism. 
 
 3. 
Hyperbranched poly(ethylenimine-co-oxazoline) by 
thiol-yne chemistry for non-viral gene delivery: 
investigating the role of polymer architecture 
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Abstract 
Cationic polymers have been widely employed as gene delivery vectors to help 
circumvent extracellular and intracellular delivery barriers. Among them, 
polyethyleneimine (PEI) is the most commonly used despite its associated high 
cytotoxicity. PEI is typically obtained by uncontrolled ring opening polymerisation of 
aziridine, leading to either linear polymer architectures with only secondary amines, or 
branched architectures containing primary, secondary, and tertiary amines. In contrast, 
this chapter describes the preparation of hyperbranched poly(ethyleneimine-co-
oxazoline)s that contains only secondary amines, via a fast thiol-yne based one pot 
reaction. A small library of these compounds with varying PEI contents was then used to 
study the effect of polymer architecture on pDNA polyplex formation, cytotoxicity, and 
in vitro transfection studies with GFP plasmid DNA reporter gene. Hyperbranched 
poly(ethyleneimine-co-oxazoline) was found to have reduced toxicity compared to the 
commercial standard 25K branched PEI (bPEI), with transfection efficiencies  only 
slightly lower than its bPEI counterpart. The synthesised hyperbranched PEI copolymers 
represent alternatives to the long standing favourite bPEI, with similar transfection 
efficiencies and reduced toxicity, whilst also highlighting the importance of 
understanding polymer architecture in gene delivery systems. 
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3.1. Introduction 
Gene therapy is an important and hugely promising pharmaceutical development that 
aims to treat diseases by delivering genes or recombinant DNA to target cells.1,2 In the 
clinic, this can take the form of replacing, adding, or editing a gene that is absent or 
abnormal and which is responsible for a disease. This technique opens the door for 
treatment of a number of previously undruggable targets. The versatility of gene therapy 
makes it relevant for a wide variety of disease, including different type of cancers, 
Parkinson’s disease, cystic fibrosis, macular degeneration, and muscular dystrophy 
among others.3-7 In recent years, the potential impact of gene therapy has been expanded 
even further by the development of CRISPR/Cas9 gene editing technology.8,9 
Since the early genetic engineering studies in the 1970s, the major hurdle associated with 
gene delivery lies in effectively delivering the genetic material inside target cells.2 This 
is typically achieved using either viral vectors or synthetic non-viral vectors. Viral 
vectors, such as retroviruses, adenoviruses, or adeno-associated viruses (AAV) have the 
advantage of providing higher transgene expression but are typically limited by 
immunogenicity and safety-related issues, packaging constraints, as well as the 
requirement of cell mitosis.10 Comparatively, non-viral gene delivery vectors offer access 
to large scale production, low host immunogenicity, easily tuneable 
architecture/functionality, long term storage stability, and batch to batch reproducibility 
of materials. Commonly used synthetic vectors include cationic polymers, liposomes, and 
covalent polymer conjugates. Cationic polymers such as poly-L-lysine (PLL), 
polyethylenimine (PEI), poly(2-(dimethylamino)ethyl methacrylate) (PDMAEMA), and 
polyamidoamine dendrimers (PAMAM) are promising systems for the non-viral 
trafficking of genetic material. Despite their popularity, high cytotoxicity associated with 
their polycationic nature, which tends to cause disruption of cellular membranes, remains 
a major limitation.10 
The current gold-standard when referring to polymeric non-viral gene delivery systems 
is bPEI. Reports indicate that polymer molecular weight plays an important role in 
achieving optimal gene transfection.11 However, these systems are notoriously difficult 
to characterise and there is still much debate about the individual influence of polymer 
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molecular weight and architecture on the transfection efficiency and toxicity of the 
resulting polyplexes.12-15 Problems arise from difficulties in synthesising comparable 
polymer systems with differing architectures, without affecting several properties of the 
polymers at once. The importance of controlling branching in polyplex formation was 
demonstrated by Tang et al., who showed that semi-degraded PAMAM dendrimers 
provide better transfection efficiency in comparison with whole PAMAM dendrimers.16 
In the case of bPEI, which is commonly prepared via uncontrolled ring-opening 
polymerisation of aziridine, the nature and frequency of the branching points are 
uncontrolled and highly dependent on the reaction conditions. In addition, the resulting 
polymer consists of a mixture of primary, secondary, and tertiary amines, whose pKa 
values, and hence ability to interact with genetic material or membranes differ 
significantly.17 
An alternative route to preparing PEI uses cationic ring-opening-polymerisation of 
oxazolines, followed by a hydrolysis step. The method allows preparation of polymers 
containing only secondary amines, with a defined molecular weight and well-controlled 
molecular weight distribution. This approach was used by Wightman et al. to demonstrate 
that branched and linear PEI differed in their ability to transfect cells, both in vitro and in 
vivo.15 In 2015, the Grayson group prepared cyclic PEI and the exact linear equivalent 
and studied the effect of cyclic architecture on transfection efficiency and cytotoxicity.18 
Over the past few years, our group has developed thiol-yne chemistry as a strategy to 
synthesise hyperbranched polymers with remarkably high degrees of branching and 
tuneable functionality.19-22 Hyperbranched polymers from AB2 monomers have received 
increasing interest due to a number of unique features including globular three 
dimensional conformations and high number of surface functionalities. The thiol-yne 
chemistry allows fast one pot synthesis of hyperbranched polymers with degrees of 
branching similar to that of perfectly branched dendrimers. Such control over the 
branching process is attributed to the reactive nature of pi bonds to thiyl radical additions. 
Recently, the Schubert group has reported the synthesis of poly(ethylenimine-co-
oxazoline) copolymers and their application as gene delivery vectors.23,24 The copolymers 
show reduced toxicity as compared to linear PEI homopolymers and incorporation of 
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‘stealth’ properties including reduced non-specific interactions with serum and other 
biological compounds.25 However, the lack of access to more complex architectures, such 
as branched structures, has so far limited the potential application of these copolymers. 
This chapter describes the combination of thiol-yne chemistry with well-defined 
poly(ethylenimine-co-oxazoline) copolymers, which allows synthesis of hyperbranched 
PEI containing only secondary amines for the first time. The study then moves onto a 
systematic study of this novel polymer architecture, including comparison with a precise 
linear equivalent, as well as comparison with commercially available bPEI. The polymers 
were then evaluated for their performance as non-viral gene delivery vectors. Results 
include plasmid DNA complexation ability, polyplex morphology, buffering capacity, 
polymer cytotoxicity, and gene transfection efficiency in vitro using green fluorescent 
protein encoding reporter plasmid. 
 
3.2. Results and Discussion 
3.2.1. Hyperbranched poly(ethylenimine-co-oxazoline) copolymers 
The thiol-yne macromonomer used for the formation of hyperbranched poly(2-ethyl-2-
oxazoline) (PEtOx) was prepared following a two-step process (Scheme 3.1). Firstly, 
cationic ring opening polymerisation (CROP) was employed to polymerise 2-ethyl-2-
oxazoline (EtOx) in acetonitrile at 80 °C, using propargyl tosylate as an initiator and 
potassium ethyl xanthate as nucleophilic end-capping agent. This afforded separate 
functionalities at both ends of the polymer chains, an alkyne functional α-chain end and 
a protected thiol functional ω-chain end, whilst maintaining well-defined molecular 
weights and low dispersity values. To ensure a high end group fidelity, a degree of 
polymerisation (DP) of 10 was targeted for the PEtOx precursor. 
From the 1H NMR spectrum of the polymerisation mixture, a DP of 8 was determined by 
comparing the aromatic signals of the propargyl group with the signal of the polymer 
backbone (Figure A3.1). This value compares well with the value obtained by SEC 
(Mn = 1200 g/mol, Ð = 1.19). After purification, 
1H-NMR spectroscopy was used to 
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determine the degree of functionalisation for both end groups. In both cases the degree of 
functionalisation was found to be higher than 95%, as expected when using a cationic 
polymerisation technique. In order to generate the thiol end group on the PEtOx chains, 
aminolysis of the xanthate group was carried out in the presence of dimethylamine. 1H-
NMR spectroscopy shows the complete disappearance of the peaks associated with the 
xanthate group. The presence of the thiol end group was confirmed using electrospray 
ionisation mass spectrometry (ESI-MS) of the macromonomer, which showed a single 
distribution corresponding to PEtOx with alkyne and thiol chain-ends (Figure 3.1a). 
 
Scheme 3.3. Preparation of AB2 poly(2-ethyl-2-oxazoline) thiol-yne macromonomer 
and subsequent batch photopolymerisation to from hyperbranched poly(2-ethyl-2-
oxazoline). 
 
Telechelic thiol-yne PEtOx macromonomers were then polymerised following a 
procedure depicted in Scheme 3.1. The polymerisation proceeded under UV light 
irradiation using 0.5 equivalents of photoinitiator DMPA per macromonomer chain, the 
mechanism of the radical mediated thiol-yne addition can be seen in the previous chapter. 
A macromonomer concentration of 0.3 M in DMF was chosen according to an initial 
polymerisation optimisation study (Figure A3.5). The inherent reactivity of pi bonds to 
thiyl radicals, which proceeds via a two-step mechanism, is expected to result in very 
high degrees of branching in the final compounds. Bowman et al. showed that the second 
addition of a thiyl radical to a vinylthioether species proceeds much faster that the first 
addition of a thiyl radical to an alkyne.26 Therefore, most thiol-yne photo-additions 
proceed to the fully branched dendritic species. It is worth noting that the thioether units 
in both the polymers in this chapter, and the previous, could play a role in the final 
properties of the polymer, including possible sensitivity to oxidation. 
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The formation of hyperbranched PEtOx was followed via SEC, as shown in Figure 3.1b. 
Upon UV irradiation, the chromatogram peak associated with the macromonomer 
decreases while the DRI trace shifts to shorter retention times and thus higher molecular 
weights. In addition, a broadening of the chromatograms with increasing reaction time, 
due to the step growth nature of the thiol-yne polymerisation, was detected. Values for 
molecular weight and dispersity of the polymerisation kinetic study are summarised in 
Table A3.1. The Mn values reported correspond to SEC measurements compared to linear 
polymer calibration standards, which is expected to significantly underestimate the value 
as hyperbranched polymers have smaller hydrodynamic radii than their equivalent linear 
polymers. Figure 3.1c shows the Kuhn-Mark-Houwink-Sakurada plots of intrinsic 
viscosity against molecular weight for both the macromonomer and the final 
hyperbranched PEtOx after purification. The degree of branching, as described by 
Hawker,27 can be calculated from the integral of the linear units in the 1H NMR spectra 
which can be identified at around 6-6.5 ppm (Figure 3.1d and A3.6). 
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Figure 3.5. a) Size-exclusion chromatograms (normalised DRI detector response vs 
retention time) of the photopolymerisation of PEtOx thiol-yne macromonomer 
following various irradiation time; b) ESI mass spectra of telechelic PEtOx thiol-yne 
macromonomer; c) Kuhn-Mark-Houwink-Sakurada (KMHS) plots of log intrinsic 
viscosity against log molecular weight from SEC viscosity detector in DMF eluent of 
PEtOx thiol-yne macromonomer and hyperbranched PEtOx; d) 1H NMR spectrum of 
hyperbranched PEtOx showing peak assignments, inset showing zoomed view of vinyl 
region. 
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Table 3.4. Polymer compositions, molecular weights, dispersity, and hydrodynamic 
radius values for both linear PEtOx and hyperbranched thiol–yne polymers prepared by 
photopolymerisation of PEtOx thiol-yne macromonomers. 
Sample 
% 
PEI a 
% 
PEtOx 
a 
M
n
 NMR 
(g/mol) 
a 
M
n
 GPC 
(g/mol) 
b 
Đ b 
M
w
 SLS 
(g/mol) c 
 PEtOx macromonomer 0 100 800 1,200 1.19 - 
 Hyperbranched PEtOx 0 100 17,100 14,000 1.5 20,400 
HB 32% Hyperbranched 
P(EI
0.32
-co-EtOx
0.68
) 
32 68 14,100 - - 21,900 
HB 58% Hyperbranched 
P(EI
0.58
-co-EtOx
0.42
) 
58 42 12,500 - - 65,300 
HB 76% Hyperbranched 
P(EI
0.76
-co-EtOx
0.24
) 
76 24 10,900 - - 106,200 
 Linear PEtOx 0 100 15,800 13,700 1.25 19,100 
L 81% Linear 
P(EI
0.81
-co-EtOx
0.19
) 
81 19 9,200 - - 12,400 
a  Determined by 1H NMR spectroscopy. b From DMF SEC with DRI detector and 
PMMA standard. c From SLS in water (further SLS details in Supplementary Info). 
 
To create polymers able to interact with genetic material, cationic charges have to be 
introduced into the structure. In the present case, this is done using partial hydrolysis of 
the repeating unit of PEtOx, creating poly(ethylenimine) units along the polymer 
backbone. Hydrolysis of hyperbranched PEtOx was carried out in 1M aqueous solution 
of HCl  at 120 °C. Microwave irradiation was chosen as the heating method of choice as 
it allows for increased pressure, thus reducing reaction times.28 These hydrolysis 
conditions allow control over the rate and degree of hydrolysis. A kinetic study, in which 
the hydrolysis is determined from analysing the increase of the integral of the hydrolysed 
propionic acid small molecule over time in 1H-NMR spectra, was undertaken with both 
hyperbranched PEtOx and linear PEtOx (Figure A3.8). Interestingly, the branched 
structure does not appear to affect the hydrolysis rate of the EtOx side chains. Using this 
method, three hyperbranched poly(ethylenimine-co-oxazoline) copolymers were 
produced. The final composition of the three hyperbranched copolymers was calculated 
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from the integrals of CH2 groups from the polyethylenimine backbone and the CH2 groups 
from the polyoxazoline backbone, between 2.5 ppm and 3.5 ppm (Figure 3.2b).  
Copolymers were analysed by SEC (Table 3.1). Resulting chromatograms show a 
monomodal size distribution for all polymers (Figure A3.9) with varying values for Mn. 
SEC characterisation of highly charged polymers is often complicated by non-size 
exclusion interferences, such as intramolecular electrostatic interactions, column 
adsorption, or ion exchange effects, which are known to cause increased retention times 
and poor chromatographic peak shape, resulting in large errors in molecular weight 
estimation.29-31 Therefore, static light scattering was employed to further investigate the 
molecular weight of the synthesized poly(ethylenimine-co-oxazoline) copolymers, as 
well as poly(2-ethyl-2-oxazoline) precursor materials. SLS is generally a good 
complementary method of molecular weight determination for hyperbranched polymers 
as it does not rely on calibration. However, the molecular weights obtained from SLS 
measurement show an unexpected increase with increasing degree of hydrolysis. This can 
be attributed to the presence of a combination of closely-spaced protonated amines and a 
hydrophobic backbone, which can lead to solution polyelectrolyte states that shift 
between aggregated and free forms.32 For comparison, a linear polymer control of 
equivalent molecular weight was synthesised by CROP of EtOx (Mn,SEC 14,000 g/mol, Đ 
1.25). The linear control was hydrolysed using the previously described methodology to 
yield poly(ethylenimine-co-oxazoline) with a degree of hydrolysis similar to that of the 
hyperbranched copolymer with the highest PEI content.  
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Figure 3.2. a) Schematic representation of the acid-catalysed hydrolysis of 
hyperbranched poly(2-ethyl-2-oxazoline) polymer into hyperbranched 
poly(ethylenimine-co-oxazoline) copolymers; b) 1H NMR spectra of final 
hyperbranched poly(ethylenimine-co-oxazoline) copolymers, showing peaks used for 
calculation of the composition. 
 
3.2.2. Effect of type of amine and branching on polymer buffering capacity 
Successful gene expression in target cells requires escape of polyplexes from the 
endosomal/lysosomal pathway after cell internalisation.33 For PEI polyplexes, this is 
assumed to occur via the ‘proton sponge’ effect, although this still receives considerable 
debate.34-36 In brief, the abundance of amines groups in PEI results in a high buffering 
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capacity of the polymers, which is thought to cause an increase in lysosomal pH as 
protons are pumped into the lysosome from the cytosol. A combination of PEI swelling 
due to electrostatic repulsion of protonated amine groups, and osmotic pressure change 
in the vesicles is expected to cause interruption and rupture of the lysosomal membrane, 
releasing the polyplex into the cytosol. In the present study, for the first time 
hyperbranched PEI structures containing only secondary amines are used, allowing 
observation of the influence of architecture on the performance of the polymers isolated 
from the nature of the amines. To evaluate the buffering effect of hyperbranched 
poly(ethylenimine-co-oxazoline) and compare it to that of PEI, pH titrations were carried 
out by addition of NaOH solution into solutions of the acidified polymers. The titration 
of bPEI shows a very broad change in pH transition (between 0.2 - 1 mmol/dm3 of NaOH 
added), which is expected from a polymer containing amine groups with the three 
different pKa values. In contrast, ethylenimine oxazoline copolymers showed a sharper 
titration curve, with a pH transition occurring between 0.3 – 0.5 mmol/dm3 of NaOH 
added, which can be attributed to the presence of secondary amine groups only. Most 
importantly, the negligible difference between the titration curves of linear and 
hyperbranched PEI structures shows that, indeed the polymer architecture has only a low 
influence on the overall pKa values,which makes the presented polymers an ideal platform 
to study the impact of polymer architecture on transfection. These results support the 
hypothesis that hyperbranched poly(ethylenimine-co-oxazoline) could be an interesting 
candidate for non-viral gene delivery applications as it shows characteristics of linear PEI 
but with an globular hyperbranched polymer architecture. 
Chapter 3 
103 
 
Figure 3.3. pH titration experiments for hyperbranched poly(ethyleneimine-co-
oxazoline) copolymer (76% hydrolysed), linear equivalent (81% hydrolysed) as well as 
commercial branched PEI. A control of NaOH titration into HCl acid is shown for 
reference. 
 
3.2.3. Polymer-pDNA complexation and resulting particle morphology 
The ability of hyperbranched and linear poly(ethylenimine-co-oxazoline) to bind GFP 
plasmid DNA was first assessed using agaraose gel electrophoresis. Polymers were 
complexed with pDNA at varying N/P ratios (ratio of positively charged nitrogen groups 
on polymer to negatively charged phosphate groups on DNA). Images of the resulting 
agarose gels are shown in Figure 3.4a. As expected, hyperbranched poly(ethylenimine-
co-oxazoline) with a degree of hydrolysis of 32% shows moderate ability to bind nucleic 
acids, with free pDNA still detectable at N/P ratio as high as 20. With a degree of 
hydrolysis of 58%, the polymer is able to fully complex pDNA at an N/P ratio of 10 to 
20. Hyperbranched poly(ethylenimine-co-oxazoline) with a degree of hydrolysis of 76%, 
its linear equivalent, and the commercial bPEI all show formation of polyplexes and full 
binding of free pDNA at an N/P ratio of 5 to 10.  
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Figure 3.4. a) Polyplex formation with pDNA, as characterised by agarose gel 
electrophoresis using the various PEI polymers; b) Ethidium bromide displacement 
assay, as a complimentary technique to characterise polymer ability to complex pDNA.
  
A complimentary method to characterise DNA/RNA binding relies on competitive 
displacement of ethidium bromide, bound to DNA, by cationic polymers. A reduced 
fluorescence is observed when ethidium bromide is excluded from binding sites located 
in the groove of the oligonucleotides, due to addition of polymer.37 The results, shown in 
Figure 3.4B, show a decrease in fluorescence intensity with increasing N/P ratio, typical 
of polyplex formation. A number of trends can be observed in this data: (i) For 
hyperbranched poly(ethylenimine-co-oxazoline), pDNA binding ability increases with 
increasing amine content from 32% to 58% and to 76%, which is in agreement with the 
results of the gel electrophoresis, (ii) linear poly(ethylenimine-co-oxazoline) binds to 
pDNA less strongly than the equivalent hyperbranched polymer, (iii) hyperbranched 
poly(ethylenimine-co-oxazoline) 76% binds more strongly than bPEI.  
In addition, the presence of a plateau of residual fluorescence indicates the presence of 
remaining intercalated ethidium bromide which cannot be displaced. This is especially 
apparent in the case of hyperbranched p(EI0.32-co-EtOx0.68), linear p(EI0.81-co-EtOx0.19), 
and commercial bPEI. This phenomenon is due to the polymers forming complexes in 
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which fewer amines are available to interact with pDNA, and displace ethidium bromide. 
In the case of the linear polymer, its extended conformation is expected to result in looser 
and larger complexes. In the case of bPEI, the presence of tertiary amines which are not 
protonated at pH ~7, is expected to weaken the complexation of pDNA. This result 
highlights the importance of precise understanding polymer and pDNA interactions, and 
prompt a more thorough characterisation of the polyplex formed. 
 
Table 3.5. Size and surface charge (zetapotential) of polyplexes formed with pDNA at 
both N/P = 20 and N/P = 40, as determined by dynamic light scattering and 
electrophoretic light scattering. 
 
N/P 
ratio 
Z-average size 
(d.nm) 
PDI 
Zetapotential 
(mV) 
HB 32% 20 499.6 0.18 5.4 ±0.421 
40 419.7 0.14 7.3 ±0.572 
HB 58% 20 64.6 0.27 22.3 ±1.75 
40 72.3 0.36 24.3 ±1.91 
HB 76% 20 53.6 0.36 24.4 ±1.91 
40 71.9 0.41 25.5 ±2.00 
bPEI 20 82.3 0.51 39.7 ±3.11 
40 85.6 0.54 39.4 ±3.09 
L 81% 20 246.7 0.36 45.9 ±3.60 
40 514.3 0.51 45.6 ±3.78 
 
To further investigate the influence of polymer architecture on pDNA binding, polyplex 
physical characteristics were determined using dynamic light scattering and zetapotential 
measurements, to elucidate size and surface charge properties. Previous studies indicate 
that efficient cellular uptake occur for particles typically between 50 to 200 nm in size. 
Excess positive charge was also demonstrated to enhance cellular uptake.38 Table 3.2 
shows the size and surface charge of the various polyplexes formed. For hyperbranched 
poly(ethylenimine-co-oxazoline), diameters follow a trend similar to the ethidium 
bromide assay, with size of the particles decreasing as the amine content increases from 
32% to 58% and to 76%. Linear poly(ethylenimine-co-oxazoline) polyplexes appear to 
Chapter 3 
106 
form slightly larger particles, which can be attributed to the weaker DNA binding strength 
of the polymer when compared to the hyperbranched equivalent, as well as potential 
intermolecular crosslinking of DNA molecules with the extended linear polymer. 
AFM imaging of polymer pDNA complexes was carried out to complement the size 
measurements obtained using DLS. Uncomplexed plasmid DNA deposited on a mica 
surface is distributed in a network type of structure (Figure 3.5). This is consistent with 
previous reports of uncondensed DNA morphologies in the literature.39,40 In samples 
where the pDNA was previously mixed with hyperbranched p(EI0.76-co-EtOx0.24), 
polyplexes with a size of approximately 100 nm were observed. A similar structure was 
obtained using the commercial branched PEI. Similarly to DLS data, polyplexes formed 
with linear p(EI0.81-co-EtOx0.19) showed a size of approximately 200 nm instead. Height 
profiles available in the appendix. Furthermore, branched PEI and small cyclic 
polycations have previously been reported to more effectively condense DNA.17,41 For 
example, Li et al. found that linear polycations/DNA complexes form larger aggregates 
than the cyclic polymer equivalent, which was attributed to the stretched conformation 
being able to intermolecularly crosslink DNA molecules.42 Taken together, these data 
demonstrate the fundamental influence of polymer architecture on DNA complexation 
and polyplexes formation.  
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Figure 3.5. AFM images of polyplex morphology at N/P20, a) pDNA only, b) L 81% 
polyplex, c) HB 76% polyplex, d) bPEI polyplex. Each scan represents an area of 10 
µm by 10 µm. Scale bars all 2 µm. 
 
3.2.4. Effect of polymer architecture on toxicity and pDNA transfection in vitro 
A common limitation of cationic polymers is their ability to permeabilise phospholipid 
cellular membranes.43,44 Here, toxicity of the polymers was assessed using the XTT assay 
on human embryo kidney cells HEK293T as model (Figure 3.6a). Viability studies 
confirmed that commercial bPEI is toxic at concentrations as low as 0.2 mg/mL. In 
contrast, cells treated with poly(ethylenimine-co-oxazoline) polymers were found to have 
viability of over 80 % at concentration up to 0.8 mg/mL, which is far above the relevant 
concentrations used both in vitro and in vivo.45 At higher polymer concentrations (>2 
mg/mL), hyperbranched p(EI0.76-co-EtOx0.24) becomes slightly toxic, whereas the linear 
equivalent polymer causes complete cell death at the same concentration. The reduced 
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toxicity of the hyperbranched architecture compared to the linear architecture follows 
similar observations made for branched/linear polymers of alternative monomers.46,47 
This can be attributed to differences in the 3D structure and flexibility of the polymers, 
resulting in different interaction of the polymers with the cell surface. It was previously 
shown that rigid polymers interact with lipid membranes with more difficulty than 
flexible equivalents.48 Thus, it appears reasonable that the less flexible hyperbranched 
poly(ethylenimine-co-oxazoline) show decreased toxicity as compared to its flexible 
linear equivalent. 
 
Figure 3.6. a) Cell viability as determined using XTT assay on human embryo kidney cells 
HEK293T treated with hyberbranched poly(ethyleneimine-co-oxazoline) copolymers, 
linear poly(ethyleneimine-co-oxazoline) copolymer, and bPEI for 24 hours at 37 °C; b) and 
c) GFP plasmid DNA transfection in HEK293T cell-line following 5 hours polyplex 
incubation (N/P 20, 10 µg/mL DNA concentration in well) and 24 hours subsequent 
growth. Intracellular fluorescence was determined by flow cytometry. 
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Finally, transfection of plasmid DNA containing GFP reporter gene using the polymers 
prepared in this study was evaluated on transfectable derivative of human embryonic 
kidney (HEK293T) cell line as model (Figure 3.6b) and reported relative to commercial 
bPEI. Cellular fluorescence histograms, obtained by flow cytometry following 5 hours of 
cell incubation with the polyplexes followed by 24 hours of subsequent growth, were used 
to determine transfection efficiencies (Figure A3.21). An N/P ratio of 20 was chosen for 
the transfection studies in order to have enough polymer to bind the plasmid even for 
copolymer samples with lower percentages of PEI. In the case of hyperbranched p(EI0.32-
co-EtOx0.68), transfection efficiencies only 2.5 fold better than naked pDNA were 
obtained, which can be attributed to incomplete complexation of the pDNA at this N/P 
ratio. Hyperbranched p(EI0.58-co-EtOx0.42) showed a relatively similar transfection 
efficiency (around 6 fold better than naked pDNA). Accordingly, in the case of 
hyperbranched p(EI0.76-co-EtOx0.24) and linear p(EI0.81-co-EtOx0.19) copolymers where 
the degree of oxazoline hydrolysis is higher, transfection efficiencies reach values of 75% 
that of bPEI. This is a significant result when also taking into account the much reduced 
toxicity of the thiol-yne hyperbranched polymers, and suggests these materials are ideal 
candidates as lower toxicity alternatives to PEI.  
 
3.3. Conclusions 
Synthesis of hyperbranched poly(ethyleneimine-co-oxazoline) by AB2 thiol-yne photo-
addition chemistry is reported for the first time. This synthetic route allows for the 
preparation of hyperbranched polymers from macromolecular monomer units, with 
degrees of branching in the region of dendrimers. In contrast with the amine mixture and 
uncontrolled patterns typically obtained via the ring opening polymerisation of aziridine, 
the method presented here results in hyperbranched PEI structures containing only 
secondary amines and well defined branching patterns. Hyperbranched 
poly(ethyleneimine-co-oxazoline) and bPEI were found to complex GFP plasmid DNA 
to form positively charged particles. In comparison, linear forms were found to form 
larger aggregates. Differences were also found in polymer in vitro cytotoxicity, with 
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poly(ethyleneimine-co-oxazoline)s having reduced toxicity compared to bPEI, and the 
hyperbranched poly(ethyleneimine-co-oxazoline) having reduced toxicity compared to 
the linear equivalent. Delivery of pDNA encoding for GFP showed that 
poly(ethyleneimine-co-oxazoline) copolymers with high percentages of ethyleneimine 
units were have transfection efficiencies slightly lower than the commercial standard 25K 
branched PEI. When considering this in conjunction with the lower toxicities, the 
hyperbranched poly(ethyleneimine-co-oxazoline) represents an promising candidate for 
further non-viral gene delivery studies. In agreement with the literature, it is believed that 
the compact hyperbranched polymer conformation contributes, in some extent, to both 
the improved toxicity and also high transfection efficiencies. The synthesised 
hyperbranched PEI copolymers also highlight the importance of understanding polymer 
architecture when developing gene delivery systems 
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3.4. Experimental 
3.4.1. Materials 
Propargyl tosylate, methyl tosylate (MeTos), potassium ethyl xanthogenate, 2-ethyl-2-
oxazoline (EtOx), dimethylamine (33% in ethanol), 2,2-dimethoxy-2-
phenylacetophenone (DMPA), ethidium bromide (EtBr), polyethylenimine branched 
(bPEI, Mw ~25,000 by LS, Mn ~10,000 by SEC) were obtained from Sigma-Aldrich. All 
other materials were purchased from Fisher Scientific, or Sigma-Aldrich. Green 
fluorescent protein (GFP) expressing plasmid DNA (pWPI) was a gift from Didier Trono 
(Addgene plasmid # 12254). 2-Ethyl-2-oxazoline (EtOx) and methyl tosylate (MeTos) 
were distilled to dryness prior to use. EtOx was dried using CaH before distillation. 50X 
Tris-Acetate-EDTA (TAE) buffer for gel electrophoresis was made up at concentration 
of 2.0M Tris acetate (Sigma Aldrich) and 0.05M EDTA (Sigma Aldrich) in deionised 
water, pH 8.2 - 8.4 and stored at room temperature. Agarose loading buffer for samples 
(colourless) were made up at 30% (vol/vol) glycerol (Sigma Aldrich) in deionised water 
and stored at room temperature.  
 
3.4.2. Characterisation 
Size Exclusion Chromatography (SEC) was performed in DMF, using an Agilent 390-
LC MDS instrument equipped with differential refractive index (DRI), viscometry, dual 
angle light scattering, and dual wavelength UV detectors. The system was equipped with 
2 x PLgel Mixed D columns (300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent 
was DMF with 5 mmol NH4BF4 additive, and samples were run at 1 mL/min at 50 °C. 
Analyte samples were filtered through a nylon membrane with 0.22 μm pore size before 
injection. Apparent molar mass values (Mn,SEC and Mw,SEC) and dispersity (Đ) of 
synthesized polymers were determined by DRI detector and conventional calibration 
using Agilent SEC software. Poly(methyl methacrylate) (PMMA) standards (Agilent 
EasyVials) were used for calibration. The Kuhn-Mark-Houwink-Sakurada parameter , 
relating to polymer conformation in solution was determined from the gradient of the 
double logarithmic plot of intrinsic viscosity as a function of molecular weight, using the 
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SEC viscometry detector and Agilent SEC software. Proton nuclear magnetic resonance 
spectra (1H NMR) were recorded on a Bruker Advance 400 spectrometer (400 MHz) at 
27 °C, with chemical shift values (δ) reported in ppm, and the residual proton signal of 
the solvent used as internal standard. Proton-decoupled carbon nuclear magnetic 
resonance spectra (13C NMR) were recorded on a Bruker Advance 400 spectrometer (100 
MHz) at 27 °C, with chemical shift values (δ) reported in ppm, and the residual proton 
signal of the solvent used as internal standard. Fourier transform infrared spectra (FTIR) 
were recorded on a Bruker Alpha FTIR ATR. Electrospray ionisation time-of-flight mass 
spectra (ESI-MS) were recorded using a Bruker MicroToF. 
 
3.4.3. Oxazoline polymerisation 
For a typical polymerisation, dry 2-ethyl-2-oxazoline (7.93 g, 80 mmol), porpargyl 
tosylate (1.68 g, 8 mmol), and acetonitrile (10.54 mL) were added to a Schlenk flask 
under nitrogen and left to stir in an oil bath at 80 °C. After a predetermined time, the 
solution was removed from the oil bath, a sample for the determination of the conversion 
was taken, and a solution of potassium ethyl xanthate (1.54 g, 9.6 mmol) was added to 
terminate the polymer chain. The product was left to stir for 1 h before being diluted with 
chloroform (100 mL). The organic layer was then washed with sat. Na2CO3 (3 × 100 mL) 
and brine (3 × 100 mL), and then dried over MgSO4. The chloroform was removed to 
leave a colourless oil. The oil was re-dissolved in DCM (10 mL), precipitated into ether, 
the polymer was collected by gravity filtration as a white solid and then dried under 
vacuum. 1H NMR spectrum shown in Figure A3.1. Propargyl-pEtOx-xanthate (1.1 g, 
1.38 mmol) was dissolved in dimethylamine (33% in EtOH) (12 mL) deoxygenated with 
nitrogen bubbling and stirred at 40 °C for 3 h. The reaction mixture was then poured over 
a solution of sulphuric acid (H2SO4) (8 mL) and ice-water (80 mL). The polymer was 
extracted by washing with CHCl3 (3 × 50 mL), followed by washing of the CHCl3 layer 
with sat. Na2CO3 (2 × 50 mL) and brine (2 × 50 mL). The organic layer was then dried 
over MgSO4 and filtered before the solvent was removed to yield the thiol-yne 
poly(oxazoline) macromonomer which was stored under nitrogen to reduced chance of 
disulfide formation. Mn = 1,200 g/mol, Ð = 1.19 (DMF SEC, + NH4BF4 additive eluent, 
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PMMA calibration). Full functionalisation of both chain ends was confirmed using ESI-
MS. 1H NMR spectrum (400 MHz, CDCl3, δ ppm): 4.12 (2H, -CH2-C≡CH), 3.40-3.60 
(4H, N-CH2-CH2-N), 2.25-2.45 (2H, NC(O)-CH2-CH3), 1.05-1.20 (3H, NC(O)-CH2-
CH3). 13C NMR spectrum (100 MHz, CDCl3, δ ppm): 174.51 (NC(O)), 73.41 (-C≡CH), 
70.46 (-C≡CH), 45.3 (N-CH2-CH2-N), 25.90 (NC(O)-CH2-CH3), 13.75 (-CH2-SH), 9.39 
(NC(O)-CH2-CH3). FTIR cm-1: 3491 (broad, N-H amide), 3270-3290 (weak, ≡C-H 
alkyne), 2980 (medium, C-H alkane), 2835 (weak, N-CH2- amine), 1624 (strong, C=O 
amide I), 1418 (medium, N-H amide II). The linear control poly(oxazoline) was 
synthesised in the same manner using methyl tosylate as the initiator and termination 
under ambient humid conditions. The 1H NMR spectrum is shown in Figure A3.3, SEC 
chromatogram is shown in Figure A3.2, Mn = 13,700 g/mol, Ð = 1.25 (DMF SEC, DRI 
detector). 
 
3.4.4. Thiol-yne polymerisation 
A typical polymerisation is as follows: thiol-yne macromonomer (600 mg, 0.75 mmol) 
was dissolved with DMPA (90 mg, 0.352 mmol) in DMF (2.5 mL) in a vial equipped 
with a small stirrer bar and a rubber septum screw cap. Monomer to initiator ratio was 
kept the same for all polymerisations. The vial was wrapped in aluminium foil and 
deoxygenated with nitrogen for 5 min. The vial was placed under a 365 nm UV lamp 
(UVP, UVGL-55, 6 watt, 365 nm) in an aluminium foil lined dark box over a magnetic 
stirrer plate. For the kinetic samples, each time point corresponds to a separate vial 
removed after the allocated polymerisation time. After the predetermined reaction time, 
the vial was removed and analysed by SEC. Polymer reaction mixture was precipitated 
in diethyl ether and the polymer recovered by centrifugation. Mw = 14,000 g/mol, Ð = 1.5 
(DMF SEC, DRI detector). 1H NMR spectrum (400 MHz, CDCl3, δ ppm): 5.60-6.20 (2H, 
-CH=CH-, weak), 3.95 (2H, -CH2-C≡CH, weak), 3.40-3.55 (4H, N-CH2-CH2-N), 2.15-
2.40 (2H, NC(O)-CH2-CH3), 0.90-1.20 (3H, NC(O)-CH2-CH3).
 13C NMR spectrum (100 
MHz, CDCl3, δ ppm): 174.59 (NC(O)), 45.41 (N-CH2-CH2-N), 25.90 (NC(O)-CH2-
CH3), 9.30 (NC(O)-CH2-CH3). FTIR cm-1: 3490 (broad, N-H amide), 3270-3290 
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(weak, ≡C-H alkyne), 2976 (medium, C-H alkane), 2830 (weak, N-CH2- amine), 1621 
(strong, C=O amide I), 1425 (medium, N-H amide II). 
 
3.4.5. Poly(oxazoline) hydrolysis 
The hydrolysis kinetics were performed in a microwave synthesiser (Biotage Initiator+ 
Eight). Hydrochloric acid (0.025 mL, 36 wt%) solution was mixed with 0.275 mL of 
PEtOx stock solution, giving a total volume in each vial (0.5 mL microwave vial) of 0.3 
mL with a concentration of 1 M HCl. The vials were heated at 120 °C for varying reaction 
times. The reaction mixtures were cooled down by compressed air and made basic with 
0.1 mL of a 4 M NaOH solution to a pH of 8-9, and freeze dried for 1H NMR 
spectroscopy. The conversion was calculated from the 1H NMR spectra signals of the 
hydrolysis products in deuterated methanol. Spectra can be found in Figure A3.7-A3.8. 
All signals described for PEtOx are present, together with the signals corresponding to 
the respective hydrolysis products. The dried crude polymer was then redissolved in water 
and dialysed against a 0.5 - 1 kDa membrane to remove propionic acid salts, and then 
freeze dried. Final poly(ethylenimine-co-2-ethyl-2-oxazoline) copolymer compositions 
were calculated from the appropriate backbone signals from the 1H NMR spectra of the 
purified polymers. Once the kinetics of the hydrolysis had been established the hydrolysis 
was scaled up to 20 mL microwave vials, to obtain the appropriate polymers for the rest 
of the studies. For a typical ethylenimine oxazoline copolymer: 1H NMR spectrum (400 
MHz, CDCl3, δ ppm): 3.45-3.71 (4H, N-CH2-CH2-N (POx)), 2.75-2.92 (4H, N-CH2-
CH2-N (PEI)), 2.31-2.55 (2H, NC(O)-CH2-CH3), 1.04-1.20 (3H, NC(O)-CH2-CH3). 
13C 
NMR spectrum (100 MHz, CDCl3, δ ppm): 175.97 (NC(O)), 48.33 (N-CH2-CH2-N), 
26.20 (NC(O)-CH2-CH3), 9.30 (NC(O)-CH2-CH3). FTIR cm-1: 3484 (broad, N-H 
amide), 3282 (broad, N-H amine secondary), 2987 (medium, C-H alkane), 2833 (weak, 
N-CH2- amine), 1624 (strong, C=O amide I), 1420 (medium, N-H amide II). 
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3.4.6. pH titration 
Potentiometric titration was performed manually at room temperature with a micropipette 
to control the added volume and a pH meter (HI2211 Hanna Instruments) to determine 
the pH. The pH of the polymer solutions (with 0.15 M NaCl) was set at 2.0 with 
concentrated HCl, and the solutions titrated with NaOH at 0.1 M or 0.2 M in various 
added volumes (from 0.01 mL to 0.2 mL) in order to obtain a constant increase of pH 
between each addition. 40 mL of polymer solution (1 mg/mL polymer) was used for each 
potentiometric titration experiment. For comparison, branched PEI (25 kDa) dissolved in 
0.15 M NaCl aqueous solution adjusted to pH 2.0, was also titrated using the same 
method. 
 
3.4.7. Static Light Scattering 
The incremental refractive index, dn/dC, was determined by measuring the refractive 
index of the polymer over a range of concentrations. The RI was determined using a 
Shodex RI detector, operating at a wavelength of 632 nm. Multiplying the gradient, of 
the plot of RI vs conc., by the refractive index of the solvent (water = 1.3325) and dividing 
by the RI constant of the instrument (-1,398,000) gives the dn/dC of the polymer. 
Light scattering measurements were obtained using an ALV-CGS3 system operating with 
a vertically polarized laser with wavelength λ = 632 nm. The measurements were taken 
at 20 °C over a range of scattering wave vectors (q = 4πn sin(θ/2)/λ, with θ the angle of 
observation and n the refractive index of the solvent). The Rayleigh ratio, Rθ, was 
determined using eq. 1,  
 
2
( ) ( )
( )
solution solvent solvent
toluene
toluene toluene
I I n
R R
I n

 

 
   
    (1) 
where Isolution, Isolvent and Itoluene are the scattering intensities of the solution, solvent and 
reference (toluene) respectively, n is the refractive index (nwater = 1.333, ndmf = 1.431, 
ntoluene = 1.496) and Rtoluene the Rayleigh ratio of toluene (Rtoluene = 1.35 x 10
-5 cm-1 for λ 
= 632.8 nm). 
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The optical constant, K, is defined by eq. 2, where Na is Avogadro number and dn/dC is 
the incremental refractive index.  
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    (2) 
At a given concentration the Rayleigh ratio, Rθ, is related to the apparent molecular weight 
of the sample, given by eq. 3. It is only at infinite dilutions, where the interactions between 
scattering particles are negligible, that the apparent molecular weight is equal to the true 
molecular weight. Multiple concentrations were measured and a plot of linear regression 
used to determine the apparent molecular weight at conc. = 0 mg/mL. Data and dn/dC 
values for all polymers shown in the supplementary information as Figures S10-S15. 
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3.4.8. DLS/Zetapotential 
Dynamic light scattering measurements of resulting polymers and polyplexes at various 
N/P ratios were carried out using a Malvern nanoZS zetasizer instrument (scattering angle 
of 173°, 10 mW He-Ne laser). For polyplex formation, appropriate amount of polymer 
stock solution and DNA stock solution were mixed and made up to a total volume of 1 
mL in PBS (final concentration of polymer was 1 mg/mL, in all solutions). The resulting 
solutions were vortexed, incubated for 30 minutes at room temperature, and analysed at 
25 °C. Each sample was run in triplicate and data was acquired using the software 
(Malvern Zetasizer) provided. Zeta potential measurements were carried out of the same 
DLS samples at various N/P ratios using the same instrument, and Malvern disposable 
folded capillary cell (DTS1070) cuvettes.  
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3.4.9. Ethidium Bromide displacement assay 
Polyplex formation of DNA with cationic polymers was followed using quenching of the 
ethidium bromide fluorescence, as described in the literature. DNA (7.5 µg/mL) and EB 
(0.4 µg/mL) were dissolved in HEPES buffer, pH 7, and incubated for 10 min at room 
temperature. 100 µL of the DNA+EB solution was transferred to the wells of a 96-well 
plate containing different polymer concentrations. Fluorescence was measured after 20 
min of incubation with the polymer solution using a Biotek Synergy HTX fluorescence 
microplate reader (Ex. 525 nm, Em. 605 nm). Control samples containing only DNA and 
EB were used to calibrate the measurements. Relative fluorescence = (FSAMPLE − FDNA) / 
(FDNA+EB − FDNA). 
 
3.4.10. Agarose gel electrophoresis 
Agarose gels (1% w/v) were prepared with agarose and 0.5 × TAE buffer. The solution 
was cooled on the bench for 5 minutes and 100 µL of 0.5 μg/mL ethidium bromide 
solution was added. The mixture was poured into the casted agarose tray and a comb 
inserted. The gel was left to set for a minimum of 30 minutes at room temperature. The 
agarose gels were run in 0.5× TAE buffer. The final gel was visualized under UV 
illumination at 365 nm using a UVP benchtop UV transilluminator system. Polyplexes of 
DNA were prepared at various N/P ratios. DNA stock solution of 60 µg/mL was prepared 
in PBS, and polymer stock solution of 300 µg/mL. For polyplex formation, the 
appropriate amount of polymer stock solution and DNA stock solution were mixed and 
made up to a total volume of 100 µL in PBS (final concentration of DNA was 0.030 
µg/µL in all solutions). Polyplexes were vortexed and incubated at room temperature for 
30 min. Prior to loading, 30 µL of loading buffer was added to each sample and 20 µL of 
polyplexes were loaded into the agarose gel wells. Gel electrophoresis was performed at 
100 V for 30 minutes. 
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3.4.11. Atomic Force Microscopy  
AFM images were taken using an Asylum Research MFP-3D Stand Alone atomic force 
microscope with an extended z-range of 40 μm, with closed loop scanning in x and y over 
a range of 90 μm. 20 μL of polymer/pDNA complexes in Hepes buffer solution (4 mM 
Hepes, 10 mM NaCl, and 2 mM MgCl2 (pH 7.4)) containing 0.08 μg of pDNA at various 
N/P ratios were dropped onto freshly cleaved mica sheets for 5 min, then rinsed with 
distilled water several times and dried naturally in air overnight. The tapping mode was 
used for all measurements.  
 
3.4.12. Cell culture and polymer toxicity 
HEK293T cells were cultured in DMEM medium supplemented with 10% fetal bovine 
serum, % of 2 mM glutamine and 1% penicillin/streptomycin. The cells were grown as 
adherent monolayers at 310 K under a 5% CO2 humidified atmosphere and passaged at 
approximately 70–80% confluence. For cell viability evaluation, HEK293T cells were 
seeded in a 96 well plate at a density of 1 × 104 cells per well. After 16 hours, the culture 
medium was replaced by fresh media containing a series of dilution of the polymers (2, 
0.8, 0.2, 0.08, 0.02 mg/mL), prepared from stock solutions in PBS. Following 24 hours 
incubation, the medium was removed and replaced with fresh medium. The cells were 
then incubated with a freshly prepared solution of XTT (0.2 mg/mL-1) and N-methyl 
dibenzopyrazine methyl sulfate (250 µM) in medium for 16 hours. Absorbance of the 
samples was finally measured using a plate reader at 450 nm and 650 nm. The data 
presented are representative of a minimum of two independent experiments where each 
sample was measured in triplicate. Errors reported correspond to the standard deviation 
of the mean. 
 
3.4.13. In vitro transfection 
Polyplex samples were prepared prior to incubation with the cells, via mixing of plasmid 
DNA solution (final concentrationDNA = 100 µg/mL) with the appropriate amount of 
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polymer predissolved in sterile water (N/P ratio = 20), and left to complex at room 
temperature for one hour. HEK293T cells were seeded in a 24 well plate at a density of 1 
× 105 cells per well. After 16 hours, the culture medium was replaced by Optimem® cell 
culture media (Thermo Fisher Scientific) without fetal bovine serum. After one hour, the 
media was replaced by fresh Optimem® media containing the polyplex solutions (final 
concentrationDNA = 10 µg/mL), the cells left to incubate for 5 hours under 5% CO2 
humidified atmosphere, then the media replaced with fresh culture media containing fetal 
bovine serum. Following overnight incubation, cells were washed with PBS, trypsinised, 
centrifuged, re-dispersed in ice-cold PBS and filtered into FACS tubes for analysis. 
Intracellular fluorescence was quantified using a BD LSR II cytometer (BD Biosciences) 
at excitation 488 nm and emission 525 nm. The geometric mean fluorescence was used 
as the sample value. The data in presented are representative of two separate experiments 
where each sample was measured in duplicate (n = 4). All errors reported correspond to 
the standard deviation from the mean 
 
Appendix to Chapter 3 
1H NMR spectrum of macromonomer, 1H NMR spectra and SEC chromatogram of linear 
PEtOx control, thiol-yne polymerisation concentration study SEC chromatograms and 
kinetic SEC data, hyperbranched polymer DB calculation, PEtOx hydrolysis kinetics 
data, SEC/DLS/SLS data for p(EI-co-EtOx) copolymers, additional polyplex AFM 
images, flow cytometry dot plots and histograms. 
 
 
 
 
 
 
Chapter 3 
120 
3.5. References 
(1) Somia, N.; Verma, I. M., Gene therapy: Trials and tribulations, Nature Reviews 
Genetics 2000, 1, 91. 
(2) Putnam, D., Polymers for gene delivery across length scales, Nat. Mater. 2006, 5, 
439. 
(3) Griesenbach, U.; Alton, E., Gene transfer to the lung: Lessons learned from more 
than 2 decades of CF gene therapy, Adv. Drug Del. Rev. 2009, 61, 128. 
(4) Johnson, L. A.; Morgan, R. A.; Dudley, M. E.; Cassard, L.; Yang, J. C.; Hughes, 
M. S.; Kammula, U. S.; Royal, R. E.; Sherry, R. M.; Wunderlich, J. R.; Lee, C. C. R.; 
Restifo, N. P.; Schwarz, S. L.; Cogdill, A. P.; Bishop, R. J.; Kim, H.; Brewer, C. C.; Rudy, 
S. F.; VanWaes, C.; Davis, J. L.; Mathur, A.; Ripley, R. T.; Nathan, D. A.; Laurencot, C. 
M.; Rosenberg, S. A., Gene therapy with human and mouse T-cell receptors mediates 
cancer regression and targets normal tissues expressing cognate antigen, Blood 2009, 114, 
535. 
(5) Maguire, A. M.; High, K. A.; Auricchio, A.; Wright, J. F.; Pierce, E. A.; Testa, 
F.; Mingozzi, F.; Bennicelli, J. L.; Ying, G. S.; Rossi, S.; Fulton, A.; Marshall, K. A.; 
Banfi, S.; Chung, D. C.; Morgan, J. I. W.; Hauck, B.; Zelenaia, O.; Zhu, X. S.; Raffini, 
L.; Coppieters, F.; De Baere, E.; Shindler, K. S.; Volpe, N. J.; Surace, E. M.; Acerra, C.; 
Lyubarsky, A.; Redmond, T. M.; Stone, E.; Sun, J. W.; McDonnell, J. W.; Leroy, B. P.; 
Simonelli, F.; Bennett, J., Age-dependent effects of RPE65 gene therapy for Leber's 
congenital amaurosis: a phase 1 dose-escalation trial, Lancet 2009, 374, 1597. 
(6) Kaplitt, M. G.; Feigin, A.; Tang, C.; Fitzsimons, H. L.; Mattis, P.; Lawlor, P. A.; 
Bland, R. J.; Young, D.; Strybing, K.; Eidelberg, D.; During, M. J., Safety and tolerability 
of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's 
disease: an open label, phase I trial, Lancet 2007, 369, 2097. 
(7) Bowles, D. E.; McPhee, S. W. J.; Li, C. W.; Gray, S. J.; Samulski, J. J.; Camp, A. 
S.; Li, J.; Wang, B.; Monahan, P. E.; Rabinowitz, J. E.; Grieger, J. C.; Govindasamy, L.; 
Agbandje-McKenna, M.; Xiao, X.; Samulski, R. J., Phase 1 Gene Therapy for Duchenne 
Muscular Dystrophy Using a Translational Optimized AAV Vector, Mol. Ther. 2012, 20, 
443. 
Chapter 3 
121 
(8) Jinek, M.; Chylinski, K.; Fonfara, I.; Hauer, M.; Doudna, J. A.; Charpentier, E., 
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial 
Immunity, Science 2012, 337, 816. 
(9) Cong, L.; Ran, F. A.; Cox, D.; Lin, S. L.; Barretto, R.; Habib, N.; Hsu, P. D.; Wu, 
X. B.; Jiang, W. Y.; Marraffini, L. A.; Zhang, F., Multiplex Genome Engineering Using 
CRISPR/Cas Systems, Science 2013, 339, 819. 
(10) Yin, H.; Kanasty, R. L.; Eltoukhy, A. A.; Vegas, A. J.; Dorkin, J. R.; Anderson, 
D. G., Non-viral vectors for gene-based therapy, Nature Reviews Genetics 2014, 15, 541. 
(11) Fischer, D.; Bieber, T.; Li, Y. X.; Elsasser, H. P.; Kissel, T., A novel non-viral 
vector for DNA delivery based on low molecular weight, branched polyethylenimine: 
Effect of molecular weight on transfection efficiency and cytotoxicity, Pharm. Res. 1999, 
16, 1273. 
(12) Anderson, D. G.; Akinc, A.; Hossain, N.; Langer, R., Structure/property studies 
of polymeric gene delivery using a library of poly(beta-amino esters), Mol. Ther. 2005, 
11, 426. 
(13) Intra, J.; Salem, A. K., Characterization of the transgene expression generated by 
branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after 
intraperitoneal injection in vivo, J. Control. Release 2008, 130, 129. 
(14) Goula, D.; Remy, J. S.; Erbacher, P.; Wasowicz, M.; Levi, G.; Abdallah, B.; 
Demeneix, B. A., Size, diffusibility and transfection performance of linear PEI/DNA 
complexes in the mouse central nervous system, Gene Ther. 1998, 5, 712. 
(15) Wightman, L.; Kircheis, R.; Rossler, V.; Carotta, S.; Ruzicka, R.; Kursa, M.; 
Wagner, E., Different behavior of branched and linear polyethylenimine for gene delivery 
in vitro and in vivo, J. Gene Med. 2001, 3, 362. 
(16) Tang, M. X.; Redemann, C. T.; Szoka, F. C., In vitro gene delivery by degraded 
polyamidoamine dendrimers, Bioconjugate Chem. 1996, 7, 703. 
(17) Godbey, W. T.; Wu, K. K.; Mikos, A. G., Poly(ethylenimine) and its role in gene 
delivery, J. Control. Release 1999, 60, 149. 
(18) Cortez, M. A.; Godbey, W. T.; Fang, Y. L.; Payne, M. E.; Cafferty, B. J.; 
Kosakowska, K. A.; Grayson, S. M., The Synthesis of Cyclic Poly(ethylene imine) and 
Chapter 3 
122 
Exact Linear Analogues: An Evaluation of Gene Delivery Comparing Polymer 
Architectures, J. Am. Chem. Soc. 2015, 137, 6541. 
(19) Konkolewicz, D.; Gray-Weale, A.; Perrier, S., Hyperbranched Polymers by Thiol-
Yne Chemistry: From Small Molecules to Functional Polymers, J. Am. Chem. Soc. 2009, 
131, 18075. 
(20) Cook, A. B.; Barbey, R.; Burns, J. A.; Perrier, S., Hyperbranched Polymers with 
High Degrees of Branching and Low Dispersity Values: Pushing the Limits of Thiol–Yne 
Chemistry, Macromolecules 2016, 49, 1296. 
(21) Hartlieb, M.; Floyd, T.; Cook, A. B.; Sanchez-Cano, C.; Catrouillet, S.; Burns, J. 
A.; Perrier, S., Well-defined hyperstar copolymers based on a thiol-yne hyperbranched 
core and a poly(2-oxazoline) shell for biomedical applications, Polymer Chemistry 2017, 
8, 2041. 
(22) Barbey, R.; Perrier, S., Synthesis of Polystyrene-Based Hyperbranched Polymers 
by Thiol-Yne Chemistry: A Detailed Investigation, Macromolecules 2014, 47, 6697. 
(23) Bus, T.; Englert, C.; Reifarth, M.; Borchers, P.; Hartlieb, M.; Vollrath, A.; 
Hoeppener, S.; Traeger, A.; Schubert, U. S., 3rd generation poly(ethylene imine)s for 
gene delivery, J. Mater. Chem. B 2017, 5, 1258. 
(24) Rinkenauer, A. C.; Tauhardt, L.; Wendler, F.; Kempe, K.; Gottschaldt, M.; 
Traeger, A.; Schubert, U. S., A Cationic Poly(2-oxazoline) with High In Vitro 
Transfection Efficiency Identified by a Library Approach, Macromol. Biosci. 2015, 15, 
414. 
(25) Hartlieb, M.; Kempe, K.; Schubert, U. S., Covalently cross-linked poly(2-
oxazoline) materials for biomedical applications - from hydrogels to self-assembled and 
templated structures, J. Mater. Chem. B 2015, 3, 526. 
(26) Fairbanks, B. D.; Scott, T. F.; Kloxin, C. J.; Anseth, K. S.; Bowman, C. N., Thiol-
Yne Photopolymerizations: Novel Mechanism, Kinetics, and Step-Growth Formation of 
Highly Cross-Linked Networks, Macromolecules 2009, 42, 211. 
(27) Hawker, C. J.; Lee, R.; Frechet, J. M. J., One-step synthesis of hyperbranched 
dendritic polyesters, J. Am. Chem. Soc. 1991, 113, 4583. 
Chapter 3 
123 
(28) de la Rosa, V. R.; Bauwens, E.; Monnery, B. D.; De Geest, B. G.; Hoogenboom, 
R., Fast and accurate partial hydrolysis of poly(2-ethyl-2-oxazoline) into tailored linear 
polyethylenimine copolymers, Polymer Chemistry 2014, 5, 4957. 
(29) Dubin, P. In Journal of Chromatography Library; Dubin, P. L., Ed.; Elsevier: 
1988; Vol. Volume 40, p xiii. 
(30) Perevyazko, I.; Gubarev, A. S.; Tauhardt, L.; Dobrodumov, A.; Pavlov, G. M.; 
Schubert, U. S., Linear poly(ethylene imine)s: true molar masses, solution properties and 
conformation, Polymer Chemistry 2017, 8, 7169. 
(31) Striegel, A. M.; Yau, W. W.; Kirkland, J. J.; Bly, D. D. In Modern Size-Exclusion 
Liquid Chromatography; John Wiley & Sons, Inc.: 2009, p i. 
(32) Curtis, K. A.; Miller, D.; Millard, P.; Basu, S.; Horkay, F.; Chandran, P. L., 
Unusual Salt and pH Induced Changes in Polyethylenimine Solutions, PLoS One 2016, 
11. 
(33) Niidome, T.; Huang, L., Gene therapy progress and prospects: Nonviral vectors, 
Gene Ther. 2002, 9, 1647. 
(34) Benjaminsen, R. V.; Mattebjerg, M. A.; Henriksen, J. R.; Moghimi, S. M.; 
Andresen, T. L., The Possible "Proton Sponge" Effect of Polyethylenimine (PEI) Does 
Not Include Change in Lysosomal pH, Mol. Ther. 2013, 21, 149. 
(35) Akinc, A.; Thomas, M.; Klibanov, A. M.; Langer, R., Exploring 
polyethylenimine-mediated DNA transfection and the proton sponge hypothesis, J. Gene 
Med. 2005, 7, 657. 
(36) Behr, J. P., The proton sponge: A trick to enter cells the viruses did not exploit, 
Chimia 1997, 51, 34. 
(37) Tse, W. C.; Boger, D. L., A fluorescent intercalator displacement assay for 
establishing DNA binding selectivity and affinity, Acc. Chem. Res. 2004, 37, 61. 
(38) Frohlich, E., The role of surface charge in cellular uptake and cytotoxicity of 
medical nanoparticles, International Journal of Nanomedicine 2012, 7, 5577. 
(39) Zhao, X.; Cui, H. X.; Chen, W. J.; Wang, Y.; Cui, B.; Sun, C. J.; Meng, Z. G.; 
Liu, G. Q., Morphology, Structure and Function Characterization of PEI Modified 
Magnetic Nanoparticles Gene Delivery System, PLoS One 2014, 9. 
Chapter 3 
124 
(40) Rackstraw, B. J.; Martin, A. L.; Stolnik, S.; Roberts, C. J.; Garnett, M. C.; Davies, 
M. C.; Tendler, S. J. B., Microscopic investigations into PEG-cationic polymer-induced 
DNA condensation, Langmuir 2001, 17, 3185. 
(41) Dunlap, D. D.; Maggi, A.; Soria, M. R.; Monaco, L., Nanoscopic structure of 
DNA condensed for gene delivery, Nucleic Acids Res. 1997, 25, 3095. 
(42) Li, C.; Ma, C. Y.; Xu, P. X.; Gao, Y. X.; Zhang, J.; Qiao, R. Z.; Zhao, Y. F., 
Effective and Reversible DNA Condensation Induced by a Simple Cyclic/Rigid 
Polyamine Containing Carbonyl Moiety, J. Phys. Chem. B 2013, 117, 7857. 
(43) Klemm, A. R.; Young, D.; Lloyd, J. B., Effects of polyethyleneimine on 
endocytosis and lysosome stability, Biochem. Pharmacol. 1998, 56, 41. 
(44) Kafil, V.; Omidi, Y., Cytotoxic Impacts of Linear and Branched Polyethylenimine 
Nanostructures in A431 Cells, Bioimpacts 2011, 1, 23. 
(45) Nomoto, T.; Fukushima, S.; Kumagai, M.; Machitani, K.; Arnida; Matsumoto, Y.; 
Oba, M.; Miyata, K.; Osada, K.; Nishiyama, N.; Kataoka, K., Three-layered polyplex 
micelle as a multifunctional nanocarrier platform for light-induced systemic gene 
transfer, Nature Communications 2014, 5. 
(46) Synatschke, C. V.; Schallon, A.; Jerome, V.; Freitag, R.; Muller, A. H. E., 
Influence of Polymer Architecture and Molecular Weight of Poly(2-
(dimethylamino)ethyl methacrylate) Polycations on Transfection Efficiency and Cell 
Viability in Gene Delivery, Biomacromolecules 2011, 12, 4247. 
(47) Fischer, D.; Li, Y. X.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T., In vitro 
cytotoxicity testing of polycations: influence of polymer structure on cell viability and 
hemolysis, Biomaterials 2003, 24, 1121. 
(48) Singh, A. K.; Kasinath, B. S.; Lewis, E. J., Interaction of polycations with cell-
surface negative charges of epithelial cells, Biochim. Biophys. Acta 1992, 1120, 337. 
 
112 Appendix to Chapter 3 
 
Figure A3.1. 1H NMR spectrum (400 MHz, CDCl3) of xanthate-protected thiol-yne 
macromonomer synthesized by cationic ring opening polymerization of 2-ethyl-2-
oxazoline monomer. 
 
Figure A3.2. Size exclusion chromatogram (DMF +NH4BF4 additive eluent, PMMA 
calibration) of linear POx control polymer synthesized by cationic ring opening 
polymerization of 2-ethyl-2-oxazoline monomer. 
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Figure A3.3. 13C NMR spectrum (125 MHz, CDCl3) of thiol-yne macromonomer 
synthesized by cationic ring opening polymerization of 2-ethyl-2-oxazoline monomer. 
 
Figure A3.4. 1H NMR spectrum (400 MHz, CDCl3) of linear POx control polymer 
synthesized by cationic ring opening polymerization of 2-ethyl-2-oxazoline monomer. 
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Figure A3.5. 13C NMR spectrum (125 MHz, CDCl3) of thiol-yne hyperbranched POx. 
 
Figure A3.6. 1H NMR spectrum (400 MHz, CDCl3) of linear POx PEI 81% control 
polymer synthesized by cationic ring opening polymerization of 2-ethyl-2-oxazoline 
monomer, and subsequent hydrolysis in 1M HCl. 
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Figure A3.7. 13C NMR spectrum (125 MHz, CDCl3) of hyperbranched POx PEI 76%  
polymer. 
 
Figure A3.8. Size exclusion chromatogram (DMF + NH4BF4 additive eluent, PMMA 
calibration) of xanthate-protected thiol-yne macromonomer synthesized by cationic ring 
opening polymerization of 2-ethyl-2-oxazoline monomer, and subsequent hyperbranched 
polymers formed at various monomer concentrations. 
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Table A3.1. Size exclusion chromatography data (DMF +NH4BF4 additive eluent, 
PMMA calibration) of xanthate-protected thiol-yne macromonomer synthesized by 
cationic ring opening polymerization of 2-ethyl-2-oxazoline monomer, and subsequent 
hyperbranched polymers formed at various monomer concentrations. Degrees of 
branching (DB) were calculated from 1H NMR spectroscopy (400 MHz, CDCl3) as 
exemplified in Figure 1d and Figure S6. 
 
 Mn,SEC (g/mol) Mw,SEC (g/mol) Đ DB 
Monomer 1200 1500 1.19  
0.075 M 5400 8200 1.51 0.83 
0.15 M 5900 10500 1.78 0.83 
0.3 M 6800 16400 2.41 0.87 
 
 
Table A3.2. Size-exclusion chromatography data (DMF +NH4BF4 additive eluent, 
PMMA calibration) for photopolymerisation of poly(2-ethyloxazoline) thiol-yne 
macromonomer with varying irradiation times. 
 Mn,SEC (g/mol) Mw,SEC (g/mol) Đ 
Monomer 1,200 1,500 1.19 
0.5 hr 2,900 4,800 1.67 
1 hr 3,900 8,300 2.11 
2 hr 4,200 17,000 4.07 
4 hr 4,700 23,800 5.10 
8 hr 4,700 23,600 5.05 
8 hr purified 11,600 28,400 2.45 
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Figure A3.9. Example of calculation for degree of branching using 1H NMR 
spectroscopy (400 MHz, CDCl3). Example calculation using NMR spectrum from Figure 
1d and reference of 16.00 from Mn,NMR of 800 for the macromonomer. 
 
 
Figure A3.10. Hydrolysis kinetic study of HB POx (1H NMR spectra (400 MHz, CDCl3)) 
in 1M HCl,  
𝐷𝐵 =    
𝑛𝑜.  𝑜𝑓 𝑑𝑒𝑛𝑑𝑟𝑖𝑡𝑖𝑐 𝑢𝑛𝑖𝑡𝑠
+  𝑛𝑜.  𝑜𝑓 𝑡𝑒𝑟𝑚𝑖𝑛𝑎𝑙 𝑢𝑛𝑖𝑡𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑜.  𝑜𝑓 𝑢𝑛𝑖𝑡𝑠
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Figure A3.11. Hydrolysis kinetic study of both POx macromonomer and HB PEtOx (1H 
NMR spectrum (400 MHz, CDCl3)) in 1M HCl, percentage hydrolysis calculated from 
integral of propionic acid salt in crude hydrolysis product.  
 
 
Figure A3.12. Size exclusion chromatograms (DMF +NH4BF4 additive eluent, PMMA 
calibration) of purified hydrolysed hyperbranched polymers and HB POx, showing 
previously reported low signals and increased retention times due to increased polymer 
cationic charges. 
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Figure A3.13. Evolution of KC/R of HB POx in water as a function of q² and 
concentration obtained by Static Light Scattering. MW = 20,400 g/mol, dn/dC = 0.143. 
 
 
 
Figure A3.14. Evolution of KC/R of HB 32% in water as a function of q² and 
concentration obtained by Static Light Scattering. MW = 21,900 g/mol, dn/dC = 0.175. 
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Figure A3.15. Evolution of KC/R of HB 58% in water as a function of q² and 
concentration obtained by Static Light Scattering. MW = 65,300 g/mol, dn/dC = 0.185. 
 
 
 
 
 
 
Figure A3.16. Evolution of KC/R of HB 76% in water as a function of q² and 
concentration obtained by Static Light Scattering. MW = 106,200 g/mol, dn/dC = 0.198. 
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Figure A3.17. Evolution of KC/R of linear POx control in water as a function of q² and 
concentration obtained by Static Light Scattering. MW =  19,100 g/mol, dn/dC = 0.143. 
 
 
 
 
 
 
Figure A3.18. Evolution of KC/R of linear POx PEI 81% control in water as a function 
of q² and concentration obtained by Static Light Scattering. MW =  12,400 g/mol, dn/dC 
= 0.128. 
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a)  
b)  
c)  
d)  
e)  
Figure A3.19. Representative DLS data for polyples solutions (HB76 polymer with 
DNA, N/P 20, three repeats shown), a) intensitie distribution, b) volume distribution, c) 
number distribution, d) correlalograms, e) cummulants fit. 
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Figure A3.20. AFM images of pDNA on mica surface, at two different resolutions. 
 
 
 
Figure A3.21. AFM images of linear 81% control polymer pDNA polyplex (N/P 20) on 
mica surface, at two different resolutions. Height profile included. 
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Figure A3.22. AFM images of hyperbranched POx PEI 76% polymer pDNA polyplex 
(N/P 20) on mica surface, at two different resolutions. Height profile included. 
 
Figure A3.23. AFM images of bPEI polymer pDNA polyplex (N/P 20) on mica surface, 
at two different resolutions. Height profile included. 
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Figure A3.24. Representative (two separate experiments where each sample was 
measured in duplicate (n = 4)) dot plots and histograms of flow cytometry measurements 
determining positive GFP-expressing HEK cells after 24 h post-transfection with bPEI 
and synthesised polymers (all N/P 20).  
 4. 
Cationic and hydrolysable branched polymers by 
RAFT for complexation and controlled release of 
dsRNA 
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Abstract 
The controlled release of nucleic acids from cationic polymers is an important criteria for 
the design of gene delivery systems, and can be difficult to achieve due to the persistent 
positive charges required to initially complex the nucleic acids. Here is described the use 
of highly branched tertiary amine-rich polymers for the complexation and release of 
dsRNA over a prolonged period of time. Controlled release of dsRNA is obtained via 
hydrolysis of the polymer side chains and associated change in electrostatic charge. 
Reversible addition-fragmentation chain transfer (RAFT) polymerization was utilised to 
synthesise a series of branched polymers of 2-(dimethylamino)ethyl acrylate (DMAEA), 
3-(dimethylamino)propyl acrylate (DMAPA), and 2-(dimethylamino)ethyl methacrylate 
(DMAEMA) (MW ~ 60,000 – 200,000 g/mol, and Ð ~ 2 – 8). The hydrolysis kinetics of 
all synthesised polymer materials were followed by 1H NMR spectroscopy. 
Complexation with dsRNA resulted in the formation of polyplex nanoparticles (N/P ratio 
of 5) with sizes of approximately 400 nm and surface charges of +15 mV. An agarose gel 
release study showed sustained release of dsRNA from p(DMAEA-co-DMAEMA) for a 
period of more than 2 weeks. Unlike branched PEI commonly used for gene delivery, the 
majority of these systems showed little toxicity to cells (NIH3T3 fibroblasts). The results 
point towards pDMAPA and p(DMAEA-co-DMAEMA) being promising polymers for 
the controlled release of oligonucleotides over prolonged periods. 
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4.1 Introduction 
Synthetic vectors that can activate the RNA interference pathway, or transcribe for new 
proteins, by delivering nucleic acids (dsRNA, siRNA, mRNA, DNA) in target cells are 
gaining significant attention due to a number of potential advantages over viral vectors.1 
Particular benefits of synthetic vectors over viral vectors include: low immunogenicity,2 
high nucleotide loading,3 as well as ease and reproducibility of production.4 Yet, there are 
many barriers associated with gene-based therapies, which at the moment limits greatly 
the number of products successfully passing through clinical trials. These include 
degradation of nucleic acids by nucleases in physiological fluids as well as the short half-
life of naked plasmid DNA in vivo, which was estimated to be in the region of 10 minutes 
post systemic injection.1,5 Synthetic vectors partly mediate these limitations by protecting 
nucleotides from enzymatic degradation, whilst also avoiding renal clearance and non-
specific interactions with serum proteins and extracellular compounds. In addition, 
synthetic vehicles need to extravasate from the vasculature, promote cell internalisation 
of otherwise negatively charged non-endocytosable nucleic acid biomolecules, and 
finally release the therapeutic nucleic acid in the intracellular environment. The latter is 
increasingly identified as a difficult hurdle to overcome as the strong electrostatic 
interactions between cationic synthetic systems and negatively charged oligonucleotides 
make it difficult to release the therapeutic cargo, dramatically decreasing the transfection 
yields.6-8  
Thanks to advances in polymer and materials chemistry, stimuli responsive gene delivery 
systems have made significant progress in the last few years.9,10 These systems are able 
to respond to various stimuli and either trigger release of the transported nucleic acid, or 
promote endosomal escape of the carrier to the cell cytoplasm.11 Examples of endogenous 
stimuli include: intracellular changes in pH environment,12 change in redox 
environment,13 temperature difference,14 or the presence of enzymatic triggers;15 while 
exogenous stimuli include: light,16 ultrasound,17 or even magnetism.18  
A major shortcoming of these stimuli-responsive systems lies in the toxicity of the 
cationic polymers remaining after the oligonucleotide release. In response, increasing 
attention is being directed towards developing degradable or charge altering polymers 
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with biocompatible by-products. Degradability can either be introduced in the polymer 
backbone, or through degradable polymer side chains. In the early 2000’s, the Langer 
group prepared poly(-amino esters) via Michael addition step growth polymerisation of 
diamines and diacrylates, resulting in cationic polymers with a degradable backbones and 
cationic groups for DNA complexation.19,20 In another example,  Saltzman et al. 
encapsulated genetic material in poly(lactic-co-glycolic acid) (PLGA) to deliver siRNA 
efficiently through cervical mucus barrier in mice models.21 Backbone degradable 
polymers based on oligo(carbonate-b--amino ester)s were also shown to be efficient 
gene delivery vectors.22 Introduction of polymer degradability through the polymer side 
chains, leading to biocompatible and non-toxic degradation products, has also been 
studied extensively by the group of Hennink among others.23-25 The degradable side chain 
route however also has the added advantage of being able to incorporate a change in 
functionality and/or charge with side chain degradation. For example, polymers 
synthesised from 2-(dimethylamino)ethyl acrylate (DMAEA) have been investigated for 
the complexation and release of nucleic acids via hydrolysis of the ester connection 
between acrylate backbone and side chains.26-28 Poly(DMAEA) proved to be an attractive 
polymer for non-viral gene delivery whose initial structure combines hydrolysable side 
chains with cationic groups. Upon hydrolysis, cationic side chains turn into negatively 
charged acrylic acid moeities which enhance nucleic acid release via electrostatic 
repulsion. The self-catalysed hydrolysis of pDMAEA in water was initially reported to 
reach a limiting degree of hydrolysis of  60 to 70 % after one week in aqueous conditions 
at room temperature.29 More recent studies confirmed that the hydrolysis and nucleic acid 
release occurs rapidly (1 to 10 hours28), and is consistent with a self-catalysed mechanism 
at a rate that is independent of pH, salt concentration, or any other external stimulus.27,30-
32 A number of strategies have been employed to lengthen this release time, but it is yet 
to be extended past 72 hours.33,34  
Sustained release of nucleic acids for inducing RNA interference is acknowledged as a 
major challenge for the gene delivery field, in the context of both human therapies and 
agrochemical applications. For example, in mammalian biological systems, slow release 
is needed when considering drug eluting device coatings/stents, local injection hydrogel 
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systems, or implantable macroscale devices.35-37 In the agrochemical sector this nucleic 
acid slow release is useful for one application sprays, and also seed coatings. Here, the 
prolonged protection and sustained release of dsRNA from synthetic polymers prepared 
via reversible addition-fragmentation chain transfer (RAFT) polymerisation is reported. 
Highly branched polymers of 2-(dimethylamino)ethyl acrylate (DMAEA), 3-
(dimethylamino)propyl acrylate (DMAPA), 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), and also statistical copolymers of DMAEA and DMAEMA were 
synthesised using di(ethylene glycol) diacrylate  (DEGDA) or ethyleneglycol 
dimethacrylate (EGDMA) as cross-linkers. Two different synthetic routes will be 
attempted in order to slow the side chain hydrolysis of tertiary amine containing 
polymers. Firstly, by polymerising DMAPA, a monomer with a propyl chain rather than 
the ethyl of DMAEA. Secondly, by copolymerising DMAEA with DMAEMA, a non-
hydrolysing equivalent monomer.38 The branched polymers were characterized using 
multi-detector size exclusion chromatography (SEC) and their hydrolysis kinetics were 
followed with 1H NMR spectroscopy. Polyplex formation and dsRNA release was then 
investigated using agarose gel electrophoresis. Finally, polymer cytotoxicity was 
determined before and after side chain hydrolysis in relation to a model fibroblast cell 
line.  
 
4.2 Results and Discussion 
4.2.1 Synthesis of highly branched polymers by RAFT 
RAFT polymerisation was used to synthesise a series of highly branched polymers from 
a range of tertiary amine-containing vinyl monomers and divinyl branching comonomers 
(Scheme 4.1). Reaction temperature, initiator, chain transfer agent (CTA), and branching 
comonomer, were varied depending on monomer composition. Acrylate monomers 
(DMAEA, DMAPA and DEGDA) were polymerised at 70 ºC using PABTC as CTA, and 
ACVA as initiator. Methacrylate monomers (DMAEMA and EGDMA) were 
polymerised at 90 ºC using CPAETC as CTA, and VA088 as initiator. Copolymers of 
acrylate and methacrylate were polymerised at 70 ºC using CPAETC as CTA and ACVA 
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as initiator. Either EGDMA or DEGDA was used as branching comonomer depending on 
the major proportion of monomer being acrylate or methacrylate. Having a branching 
monomer with similar reactivity as the main monomer feed increases its insertion into the 
backbone during the propagation step. Based on previous work, a degree of 
polymerisation (DP) of 50 with 0.95 – 2.5 branching monomers per CTA was targeted in 
order to form soluble highly branched polymers with similar and high molecular weights 
but without gelation.39 Linear equivalents of the branched DMAEMA/DMAEA 
copolymers were also synthesised, in order to identify any possible differences of 
polymer architecture on rate of hydrolysis. 
 
Scheme 4.4. Synthesis of highly branched polymers (B1-B5) via RAFT polymerisation 
of tertiary amine-containing monomers (DMAEA, DMAPA, and DMAEMA) and 
divinyl branching monomers along with decomposition products from hydrolysis in 
aqueous/physiological conditions. 
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SEC traces for the resulting branched polymers show a broad molecular weight 
distribution, as expected for branched polymerisation systems (Figure 4.1a). The 
molecular weights of the polymers were determined to be between 100,000 – 200,000 
g/mol using light scattering detection SEC, as seen in Table 4.1. Information about the 
branched nature of the polymers was extracted from the intrinsic viscosity values 
measured by the viscometry detector. The Kuhn-Mark-Houwink-Sakurada  values for 
each polymer was calculated from plotting the log of intrinsic viscosity against the log of 
molecular weight ( = gradient) (Figure 4.1b). An   value of between 0.6 and 0.8 
corresponds to random coil in good solvent whereas lower values indicates more dense 
structures close to the hard sphere model typically used for branched or star architectures. 
Table 4.1 shows the  values obtained for the synthesised polymers. For most linear 
polymers  values typically fall between 0.6 – 0.8. The synthesised branched polymers 
had  values of between 0.36 – 0.53 as expected for more dense globular structures. 1H 
NMR spectra of the purified polymers are shown in Figure 4.1c, however because of the 
branched nature of the polymers it was not possible to get molecular weight values from 
the NMR spectra. 
 
Figure 4.1. a) Size-exclusion chromatograms (normalised DRI detector response vs 
retention time) for the branched polymers; b) Kuhn-Mark-Houwink-Sakurada (KMHS) 
plots of log intrinsic viscosity against log molecular weight from SEC viscosity detector 
in CHCl3 eluent; c) 1H NMR spectra of tertiary amine containing highly branched 
polymers in deuterated chloroform. 
 
Chapter 4 
146 
Table 4.6. Characterisation of branched and linear polymers prepared in this study, 
including compositions, molecular weights, dispersity, and Kuhn-Mark-Houwink-
Sakurada alpha values. 
 
Sample Structure 
M1 : M2 : 
M3 : B : 
CTA a 
Mn,SEC 
(g/mol) b 
Mw,SEC 
(g/mol) b 
Đ b 
Mw,MALLS 
(g/mol) c 
 d 
B1 p(DMAEA50-co-
DEGDA2.5) 
0 : 50 : 0 : 
2.5 : 1 
19,000 268,000 14 299,000 0.36 
B2 p(DMAPA50-co-
DEGDA2.5) 
0 : 0 : 50 : 
2.5 : 1 
22,000 168,000 7.6 193,000 0.53 
B3 p(DMAEMA10-
co-DMAEA40-
co-DEGDA1.5) 
10 : 40 : 0 
: 1.5 : 1 
18,100 31,100 1.7 66,600 0.53 
B4 p(DMAEMA40-
co-DMAEA10-
co-EGDMA1.5) 
40 : 10 : 0 
: 1.5 : 1 
17,600 54,900 3.1 134,000 0.42 
B5 p(DMAEMA50-
co-EGDMA0.95) 
50 : 0 : 0 : 
0.95 : 1 
27,000 218,000 8.2 275,000 0.41 
L1  p(DMAEMA10-co-
DMAEA40) 
10 : 40 : 0 : 0 
: 1 
7,300 9,000 1.24 8,200 0.56 
L2 p(DMAEMA40-co-
DMAEA10) 
40 : 10 : 0 : 0 
: 1 
7,100 9,800 1.37 8,400 0.61 
a  Ratio of monomer 1 (DMAEMA) to monomer 2 (DMAEA) to monomer 3 (DMAPA) 
to brancher (EGDMA or DEGDA) to CTA. b  From CHCl3 SEC, DRI detector, linear 
PS standard. c Absolute molecular weight from light scattering detection on CHCl3 SEC.  
d  = Kuhn-Mark-Houwink-Sakurada parameter, from CHCl3 SEC viscometry detector.  
 
4.2.2 Determination of DMAEMA and DMAEA reactivity ratios 
To better understand the copolymerisation of DMAEA and DMAEMA, the kinetics of 
their polymerisation was studied using 1H NMR spectroscopy. A statistical copolymer of 
DP 50 containing 50% DMAEA and 50% DMAEMA was targeted (see polymerisation 
conditions in appendix). The conversion rate of each monomer, reported in Figure 4.2a, 
shows that the methacrylate is incorporated into the polymer faster than the acrylate. This 
trend, expected in the case of acrylate and methacrylate copolymerisations, could lead to 
slightly gradient like nature of the polymer.40 For example, differences in monomer 
reactivity ratios in the copolymerisation of butyl acrylate and methyl methacrylate of rBA 
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= 0.36 and rMMA = 2.07 (rBA x rMMA = 0.75) lead to a copolymer with a higher 
proportion of MMA incorporation in the beginning of the polymerisation.41 
To further investigate the possible gradient-like nature of the copolymers of DMAEA and 
DMAEMA, the reactivity ratios of this comonomer system have been determined in 
typical RAFT conditions using three different calculation methods based on the same 
experimental data. For this purpose, a series of copoplymers containing 10%, 30%, 50%, 
70%, and 90% of DMAEA were prepared. DP 50 was targeted and the polymerization 
were stopped at less than 10% total monomer conversion. The reactivity ratios were then 
calculated using the Fineman Ross method (rDMAEMA = 2.55 and rDMAEA = 0.93), 
the Kelen Tudos linearization method (rDMAEMA = 2.29, rDMAEA = 0.71), and using 
a non-linear regression method based on a data fit of the copolymer equation (rDMAEMA 
= 2.13, rDMAEA = 0.69) (see appendix). The last method, generalized by Van Herk in 
the 1990’s, is considered to be more accurate as is doesn’t rely of linearization of the 
data.42,43 Figure 4.2b shows the plot of monomer incorporation ratio against monomer 
feed ratio and the non-linear regression fit of the data which gives values for the reactivity 
ratios. All three methods give values which are in good agreement, and indicate that 
DMAEMA has a tendency for self-propagation. The multiplication of reactivity ratios 
(rDMAEMA x rDMAEA = 1.47) indicates a slight gradient tendency in the 
polymerisation.44 However, when many chains (DP = 50) with slight monomer gradient 
are linked together in a statistical manner (as in the branched polymer synthesis), the 
effect of the gradient in the branched polymers should be greatly reduced. 
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Figure 4.6. a) Monomer conversion against time for a statistical copolymer of DP = 50 
containing 50 % DMAEA and 50 % DMAEMA, as determined by 1H NMR 
spectroscopy; b) Monomer incorporation ratio (F1) against monomer feed ratio (f1) 
(dots), including the non-linear regression fit of the data (red curve, giving rDMAEMA 
= 2.13, rDMAEA = 0.69), dashed line represents F1 = f1. 
 
4.2.3. Polymer hydrolysis kinetic study 
The self-catalysed hydrolysis of pDMAEA in water was first reported in 1989, and was 
found to reach a limiting degree of hydrolysis of ~ 60 or 70 % after one week in aqueous 
conditions at room temperature.29 More recent studies have also found the hydrolysis to 
occur rapidly, and to be consistent with a self-catalysed mechanism at a rate that is 
independent of pH, salt concentration, or any other external stimulus.27,30-32 The 
hydrolysis kinetics of the branched tertiary amine-containing polymers were studied 
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using 1H NMR spectroscopy in D2O (pH ~ 7.4). Figure 4.3a shows the 
1H NMR spectra 
of branched p(DMAEMA10-co-DMAEA40) over a period of 20 days. 
1H NMR spectra of 
hydrolysis study of remaining polymers can be found in the appendix. The hydrolysis of 
DMAEA units in the polymer results in the appearance of sharp peaks at ~3.7 ppm, 2.9 
ppm, and 2.6 ppm, due to the creation of dimethylaminoethanol hydrolysis product. 
Integration of these peaks in comparison with the peak 4.2 ppm representing the total sum 
of monomer units was used to calculate the percentage hydrolysis. The resulting 
hydrolysis kinetic profiles are presented in Figure 4.3b. Branched pDMAEA hydrolyses 
relatively fast at first (40 % hydrolysed after 17 hours), then slows down to reach 
approximately 70 % hydrolysis after 20 days. As expected, the methacrylate polymer 
pDMAEMA does not shown any significant sign of hydrolysis after 20 days. While 
branched p(DMAEMA10-co-DMAEA40) hydrolyses with a similar initial rate as 
pDMAEA homopolymer, introduction of 20% of methacrylate unit in p(DMAEMA10-co-
DMAEA40) resulted in an hydrolysis rate that is relatively similar to pDMAEA 
homopolymer in the first few hours, but which only reaches 50 % hydrolysis after 20 
days. Branched pDMAPA reached a similar value of around 50 % hydrolysis after 20 
days, but with a slower initial gradient. Branched copolymer p(DMAEMA40-co-
DMAEA10) showed very little hydrolysis and reaches a plateau of around 5 % hydrolysis 
after 3 days. 
 
Chapter 4 
150 
 
Figure 4.3. a) Hydrolysis of branched p(DMAEMA10-co-DMAEA40) in D2O (pH ~7.4) 
as determined using 1H NMR spectroscopy; (other polymers shown in appendix); b) 
Hydrolysis kinetics of synthesised branched and linear polymers in D2O (pH ~7.4) 
determined using 1H NMR spectroscopy. 
 
One hypothesis is that the hydrolysis of DMAEA in methacrylate acrylate copolymers is 
slowed by the more hydrophobic nature of the polymer backbone associated with 
methacrylate introduction. This is exemplified by the copolymer of 20% DMAEA (B4 
and L2) proceeding to 5% hydrolysis instead of the expected value or around 15-20%. 
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It is worth noting that hydrolysis of 50% of the side chains of these polymers would result 
in zwitterionic polymers with an overall neutral charge, thus losing their ability to 
complex negatively charge dsRNA. Therefore, the two systems reaching 50% hydrolysis 
after a period of weeks, both p(DMAEMA10-co-DMAEA40) and pDMAPA, were thought 
to be good candidates for slow dsRNA release. 
 
4.2.4. Polyplex formation and dsRNA release 
Complexation of the branched polymers with dsRNA to form polyplexes was 
characterised by DLS and zetapotential measurements, as well as agarose gel 
electrophoresis. The later technique showed complete complexation of dsRNA by all the 
branched polymers for N/P ratios of either 1 or 2 (Figure A4.7). Therefore, an N/P ratio 
of 5 was chosen to characterise polyplex physiochemical properties in terms of size and 
surface charge (Table 4.2). 
 
Table 4.7. Size and surface charge (zetapotential) of polyplexes formed by 
complexation of dsRNA with polymers at N/P = 5, as measured by dynamic light 
scattering and electrophoretic light scattering. 
Polyplex (N/P 5) 
Zetapotential 
(mV) 
Size by 
number 
(d.nm) 
PDI 
B1 pDMAEA +15.1 ±1.4 488.9 ±87.1 0.53 
B2 pDMAPA +14.8 ±1.3 456.8 ±123.1 0.41 
B3 p(DMAEMA10-co-
DMAEA40) 
+15.3 ±1.5 448.4 ±65.3 0.85 
B4 p(DMAEMA40-co-
DMAEA10) 
+15.8 ±1.3 336.9 ±45.8 0.55 
B5 pDMAEMA +15.0 ±1.3 399.7 108.9 0.33 
L1 p(DMAEMA10-co-
DMAEA40) 
+14.3 ±1.3 541.1 ±100.6 0.58 
L2 p(DMAEMA40-co-
DMAEA10) 
+15.7 ±1.4 488.7 ±90.5 0.47 
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All of the synthesised polymers appeared to form polyplexes with an overall positive 
charge of between 14 to 16 mV. Polyplex sizes were also found to be similar, with most 
polyplex diameters measured between 300 and 500 nm. The polydispersity values (Table 
4.2) indicate a very broad distribution of sizes for the polyplexes in solution. 
Representative intensity distributions, volume distributions, number distributions, 
correlallograms, and cummulants fits can be found in the appendix. It is worth noting that 
this set of values represents a crude estimation of the real size of the polyplexes, as 
measurement by DLS is subject to significant error when assuming spherical shape.  
Next, an agarose gel electrophoresis experiment was designed to correlate polymer side 
chain hydrolysis and charge reversal of the polymers to an observable release of dsRNA. 
Polyplexes were formed in sterile water at an N/P ratio of 5, and divided into separate 
microtubes for each sample time point, following which the samples were frozen at the 
appropriate time before being simultaneously analysed by agarose gel electrophoresis.  
Pictures of the gels are shown in Figure 4.4. When the dsRNA is bound in a positively 
charged polyplex nanoparticle, the dsRNA band can be seen at the top of the gels in the 
well. Whereas negatively charged unbound dsRNA will move through the gel, resulting 
in a band at the bottom of the gel. It can be seen that all the synthesised polymers form 
strongly bound dsRNA polyplexes on day 0, apart from branched pDMAEA 
homopolymer which has already started to release the dsRNA over the course of sample 
preparation and/or gel preparation (Figure 4.4a). Both linear and branched 
p(DMAEMA10-co-DMAEA40) (Figure 4.4b and 4.4c respectively) start to release 
dsRNA after one day, and continue to release dsRNA over the course of more than 14 
days as the polymer slowly hydrolyses and the band corresponding to dsRNA moves 
down the gel towards the location of uncomplexed dsRNA. For these samples, complete 
dissociation from the dsRNA is observed after 21 days. Branched p(DMAPA) 
homopolymer showed a slower initial release (Figure 4.4d) with dsRNA remaining 
complexed for three days prior to releasing dsRNA. Full dissociation of dsRNA from the 
polymer was observed after 14 days. Both linear and branched p(DMAEMA40-co-
DMAEA10) show no dsRNA release over the course of the study (Figure 4.4e and 4.4f), 
which is consistent with the very low percentage of hydrolysis for these polymers. 
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Accordingly, branched pDMAEMA homopolymer, which does not undergo hydrolysis 
of the side chains, showed no dsRNA release.  
 
 
Figure 4.4. Agarose gel electrophoresis assay of branched cationic polymer – dsRNA 
polyplex nanoparticles (all at N/P ratio 5) over time periods up to 28 days; a) branched 
pDMAEA; b) linear p(DMAEMA10-co-DMAEA40); c) branched p(DMAEMA10-co-
DMAEA40); d) branched pDMAPA; e) linear p(DMAEMA40-co-DMAEA10); f) 
branched p(DMAEMA40-co-DMAEA10); g) branched pDMAEMA. 
 
Overall, the results appear in accordance with the hydrolysis kinetic profiles of the 
polymers, and confirm the potential of the synthesised polymers for gene delivery 
applications. Branched pDMAPA shows potential for delayed gene delivery applications, 
where release of oligonucleotides is required approximately one week after application. 
To the best of our knowledge, this study is the first to characterise the hydrolysis of 
pDMAPA and demonstrate its use for oligonucleotide complexation and controlled 
release. 
Copolymers of DMAEA and DMAEMA appear to be better suited for extended release 
of oligonucleotides, as they were shown to release dsRNA from day 1 to past day 14. This 
slow release profile can be attributed to the presence of non-hydrolysable DMAEMA 
groups, which remain positively charged throughout the degradation process. These 
polymers show dsRNA release for over two weeks, which is a significant improvement 
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over the pDMAEA and pDMAPA release profiles. Such sustained dsRNA release profiles 
would be useful for single injection gene silencing over periods of weeks.  
The ability of the synthesised branched polymers to protect dsRNA from nuclease 
degradation in soil applications was also studied. Polyplexes were formed in sterile water 
at an N/P ratio of 5 with a final concentration of 1 mg/mL dsRNA, then incubated in live 
soil or enzyme free soil. A protocol for the extraction of dsRNA from the soil was carried 
out after the appropriate incubation period, and finally and agarose gel was run in order 
to determine whether the recovered dsRNA was intact (Figure A4.13 and A4.14). The 
results show that uncomplexed dsRNA is degraded in soil after one day, but when the 
dsRNA is condensed in a polyplex with branched pDMAEMA, pDMAPA, or pDMAEA, 
it is protected from enzymatic degradation for up to seven days. 
 
4.2.5. Polymer cytotoxicity 
The hydrolysis of pDMAEA into biocompatible and non-cytotoxic poly(acrylic acid) 
(pAA) and N,N-dimethylamino ethanol (DMAE) is a feature used in biomedical 
applications. PAA has been shown to be non-toxic to mammalian cell lines both in vitro 
and also in vivo,45,46 While DMAE is approved and safely used in the cosmetics and the 
neutraceutical industries. Toxicity of synthesised polymers was investigated before and 
after hydrolysis against a model non-cancerous cell line, NIH-3T3 fibroblast. Branched 
polyethylenimine (bPEI), commonly used for gene delivery purposes, was also included 
for comparison. Figure 4.5a shows the relative percentage of viable cells following 24 
hours incubation with the polymers before hydrolysis. Branched pDMAEMA and 
p(DMAEMA40-co-DMAEA10) showed a toxicity profile similar to that of bPEI, with 
complete death of the cells at concentrations above 50 g/mL. Branched pDMAPA and 
p(DMAEMA10-co-DMAEA40) showed a less toxic profile with zero cell survival at 
concentrations above 200 g/mL and 2 mg/mL, respectively. In contrast, the other 
polymers appeared to be relatively non-cytotoxic under the conditions tested. The trend 
of polymer toxicities appear to match the trend of hydrolysis profiles with the more 
hydrolysable polymers being less toxic. This can be attributed to the conversion of 
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potentially toxic cationic polymers into biocompatible poly(acrylic acid) over the time of 
the experiment.  
Figure 4.5b shows the toxicity profiles determined for the same polymers but after a 2 
week pre-incubation in water at room temperature, following which polymers are 
expected to be almost completely hydrolysed. As expected, the non-hydrolysable 
polymers pDMAEMA and bPEI, have similar toxicity profiles to before incubation in 
water. The branched copolymer with majority DMAEMA monomer, p(DMAEMA40-co-
DMAEA10), showed a slightly reduced toxicity compared to the non-hydrolysed version, 
which can be attributed to the hydrolysis of the small amount of DMAEA units. All other 
polymers tested showed no toxicity under the conditions studied, illustrating the 
conversion from toxic cationic polymer to non-toxic pAA. 
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Figure 4.5. NIH-3T3 cell viability following 24h incubation in the presence of branched 
and linear polymers, as determined using XTT assay; a) initial polymers; b) polymers 
pre-incubated for 2 weeks in D2O at pH ~ 7.4. 
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4.3. Conclusions 
Highly branched polymers were synthesised with RAFT polymerisation of hydrolysable 
acrylate monomers containing tertiary amine functionality (DMAEA, DMAPA), non-
hydrolysable methacrylate counterpart (DMAEMA), and branching divinyl comonomers 
(EGDMA and DEGDA). The highly branched nature of these polymers was characterised 
using multi-detector SEC, and the copolymers were found to have a slightly gradient 
nature from calculation of the monomer reactivity ratios of the DMAEA and DMAEMA. 
Hydrolysis kinetics of the polymers were studied with 1H NMR spectroscopy, and 
showed pDMAPA and p(DMAEMA-co-DMAEA) to have hydrolysis profiles favourable 
for extended release of dsRNA compared to the fast hydrolysing pDMAEA. All the 
materials were shown to form polyplexes in presence of dsRNA and were characterized 
by DLS and agarose electrophoresis gels. The dsRNA release profiles of polyplex 
nanoparticles were also determined using agarose gel electrophoresis and both branched 
pDMAPA and p(DMAEMA10-co-DMAEA40) showed excellent prolonged release of 
oligonucleotide in aqueous conditions. Finally, the polymer cytotoxicity to NIH-3T3 
fibroblast cell line was determined both before and after side chain hydrolysis. The most 
promising materials, pDMAPA and p(DMAEMA10-co-DMAEA40), show negligible 
toxicity in the appropriate concentration range (50 - 200 g/mL)  even before complete 
hydrolysis to biocompatible p(acrylic acid). Whereas non-hydrolysable branched 
pDMAEMA, bPEI, and also branched p(DMAEMA40-co-DMAEA10), had significant 
toxicity with zero cell proliferation above concentrations of 50 g/mL. These polymeric 
materials show great potential for therapeutic nucleic acid delivery as polyplexes, but 
could also represent an improved material for hydrogel formulations, nucleic acid 
releasing films, or other implantable or injestable polymeric constructs for controlled 
release. 
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4.4. Experimental 
4.4.1. Materials 
2-(dimethylamino)ethyl acrylate (DMAEA), 2-(dimethylamino)ethyl methacrylate 
(DMAEMA), 3-(dimethylamino)propyl acrylate (DMAPA), ethyleneglycol 
dimethacrylate (EGDMA), di(ethylene glycol) diacrylate (DEGDA), 4,4′-Azobis(4-
cyanovaleric acid) (ACVA), 1,1′-Azobis(cyclohexanecarbonitrile) (VA088), 
polyethylenimine branched (bPEI, Mw ~25,000 by LS, Mn ~10,000 by SEC), Agarose, 
Ethidium bromide solution (500 μg/mL in H2O), were all obtained from Sigma-Aldrich. 
All other materials were purchased from Fisher Scientific, or Sigma-Aldrich. dsRNA was 
provided by Syngenta. 2-(((butylthio)-carbonothioyl)thio)propanoic acid (PABTC) was 
prepared according to a previously reported procedure.47 (4-cyano pentanoic acid)yl ethyl 
trithiocarbonate (CPAETC) was prepared according to a previously reported procedure.48 
50X Tris-Acetate-EDTA (TAE) buffer for gel electrophoresis was made up at 
concentration of 2.0M Tris acetate (Sigma Aldrich) and 0.05M EDTA (Sigma Aldrich) 
in deionised water, pH 8.2 - 8.4, stored at room temperature. Gel loading buffer for 
samples (colourless) was made up at 30% (vol/vol) glycerol (Sigma Aldrich) in deionised 
water and stored at room temperature. 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-
tetrazolium-5-carboxanilide inner salt (XTT sodium salt), and Phenazine methosulfate 
(PMS) were obtained from Sigma. 
 
4.4.2. Characterisation 
Size Exclusion Chromatography (SEC) was performed in CHCl3, using an Agilent 390-
LC MDS instrument equipped with differential refractive index (DRI), viscometry, dual 
angle light scattering, and dual wavelength UV detectors. The system was equipped with 
2 x PLgel Mixed D columns (300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent 
was CHCl3 with 2% TEA (trimethylamine) additive, and samples were run at 1 mL/min 
at 30 °C. Analyte samples were filtered through a nylon membrane with 0.22 μm pore 
size before injection. Apparent molar mass values (Mn,SEC and Mw,SEC) and dispersity (Đ) 
of synthesized polymers were determined by DRI detector and conventional polystyrene 
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(Agilent EasyVials) calibration and using Agilent SEC software. The absolute/true 
molecular weight (Mw,MALLS) and the intrinsic viscosity (IV) were determined by triple-
detection SEC method using Agilent software and considering 100% polymer mass 
recovery (knowing the concentration). The Kuhn-Mark-Houwink-Sakurada parameter , 
relating to polymer conformation in solution was determined from the gradient of the 
double logarithmic plot of intrinsic viscosity as a function of molecular weight, using 
Agilent SEC software. Proton nuclear magnetic resonance spectra (1H NMR) were 
recorded on a Bruker Advance 400 or 300 spectrometer (400 MHz or 300 MHz) at 27 °C, 
with chemical shift values (δ) reported in ppm, and the residual proton signal of the 
solvent used as internal standard. Proton-decoupled carbon nuclear magnetic resonance 
spectra (13C NMR) were recorded on a Bruker Advance 400 (100 MHz) at 27 °C in 
CDCl3, with chemical shift values (δ) reported in ppm, and the residual proton signal of 
the solvent used as internal standard (δC 77.16). Fourier transform infrared spectra (FTIR) 
were recorded on a Bruker Alpha FTIR ATR. 
 
4.4.3. Synthesis of branched acrylates pDMAEA and pDMAPA 
Conditions for polymerisations can be found in Supporting Information.  
For a typical polymerisation in which [M]: [DEGDA]: [PABTC]: [I] = 50: 2.5: 1: 0.1, 
PABTC (33.3 mg, 0.140 mmol), DMAEA (1 g, 6.98 mmol), DEGDA (74.8 mg, 0.35 
mmol), ACVA (3.9 mg, 0.0140 mmol), and dioxane (1.19 mL) were added to a vial 
deoxygenated by bubbling with nitrogen and left to stir in an oil bath at 70 °C. After a 
predetermined time, the solution was removed from the oil bath and the polymer 
precipitated in hexane (x3), and dried under vacuum. Mw,MALLS = 299,000 g/mol, Ð,RI = 
14 (CHCl3 SEC, multi-detector). 
1H NMR spectrum (400 MHz, CDCl3, δ ppm): 4.15 (m, 
2H, -C(O)O-CH2-CH2-NMe2), 2.55 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.27 (m, 6H, -
CH2-NMe2), 2.11−0.91 (m, 3H, backbone). 13C NMR spectrum (100 MHz, CDCl3, δ 
ppm): 174.28 (-C(O)O-), 62.33 (-C(O)O-CH2-CH2-), 57.52 (-CH2-N(CH3)2), 45.71 (-
N(CH3)2), 41.28 (backbone tertiary), 67.07 (backbone -CH2-). FTIR cm-1: 2948 
(medium, C-H alkane), 2821 and 2768 (medium, N-CH3 amine), 1728 (strong, C=O 
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ester), 1455 (medium, C-H alkane), 1251 (medium, C-N, amine), 1153 (strong, C-O 
ester). 
 
4.4.4. Synthesis of branched methacrylate pDMAEMA  
For a typical polymerisation in which [M]: [EGDMA]: [CPAETC]: [I] = 50: 0.95: 1: 
0.025, CPAETC (33.5 mg, 0.127 mmol), DMAEMA (1 g, 6.36 mmol), EGDMA (24.0 
mg, 0.121 mmol), VA-088 (0.777 mg, 0.00318 mmol),  and dioxane (0.974 mL) were 
added to a vial deoxygenated by bubbling with nitrogen and left to stir in an oil bath at 
90 °C. After a predetermined time, the solution was removed from the oil bath and the 
polymer precipitated in hexane (x3), and dried under vacuum. Mw,MALLS = 275,000 g/mol, 
Ð,RI = 8.2 (CHCl3 SEC, multi-detector). 
1H NMR spectrum (400 MHz, CDCl3, δ ppm): 
4.07 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.57 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.29 (m, 
6H, -CH2-NMe2), 2.17−0.74 (m, 5H, backbone). 13C NMR spectrum (100 MHz, CDCl3, 
δ ppm): 177.36 (-C(O)O-), 63.03 (-C(O)O-CH2-CH2-), 57.09 (-CH2-N(CH3)2), 45.79 (-
N(CH3)2), 44.73 (backbone quaternary), 67.09 (backbone -CH2-), 18.47 (backbone -
CH3). FTIR cm-1: 2944 (medium, C-H alkane), 2820 and 2769 (medium, N-CH3 
amine), 1722 (strong, C=O ester), 1455 (medium, C-H alkane), 1270-1265 (medium, C-
N, amine), 1153 (strong, C-O ester).  
 
4.4.5. Synthesis of branched copolymer p(DMAEMA40-co-DMAEA10) 
For a typical polymerisation in which [DMAEMA]: [DMAEA]: [EGDMA]: [CTA]: [I] 
= 40: 10: 1.5: 1: 0.05, CPAETC (21.06 mg, 0.0801 mmol), DMAEMA (0.503 g, 3.204 
mmol), DMAEA (0.115 g, 0.801 mmol), EGDMA (23.76 mg, 0.120 mmol), ACVA (1.12 
mg, 0.0040 mmol),  and dioxane (0.673 mL) were added to a vial deoxygenated by 
bubbling with nitrogen and left to stir in an oil bath at 70 °C. After a predetermined time, 
the solution was removed from the oil bath and the polymer precipitated in hexane (x3), 
and dried under vacuum. Mw,MALLS = 134,000 g/mol, Ð,RI = 3.1 (CHCl3 SEC, multi-
detector). 1H NMR spectrum (400 MHz, CDCl3, δ ppm): 4.13 (m, 2H, -C(O)O-CH2-CH2-
NMe2), 2.69 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.29 (m, 6H, -CH2-NMe2), 2.18−0.77 
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(m, 5H, backbone). 13C NMR spectrum (100 MHz, CDCl3, δ ppm): 177.31 (-C(O)O-), 
63.02 (-C(O)O-CH2-CH2-), 57.07 (-CH2-N(CH3)2), 45.78 (-N(CH3)2), 44.70 (backbone 
tertiary), 67.08 (backbone -CH2-), 18.46 (backbone -CH3). FTIR cm-1: 2944 (medium, 
C-H alkane), 2820 and 2769 (medium, N-CH3 amine), 1722 (strong, C=O ester), 1455 
(medium, C-H alkane), 1263-1270 (medium, C-N, amine), 1144 (strong, C-O ester). 
 
4.4.6. Synthesis of branched copolymer p(DMAEMA10-co-DMAEA40) 
For a typical polymerisation in which [DMAEMA]: [DMAEA]: [DEGDA]: [CTA]: [I] = 
10: 40: 1.5: 1: 0.05, CPAETC (21.06 mg, 0.0801 mmol), DMAEMA (0.126 g, 0.801 
mmol), DMAEA (0.458 g, 3.204 mmol), DEGDA (25.68 mg, 0.120 mmol), ACVA (1.12 
mg, 0.0040 mmol),  and dioxane (0.713 mL) were added to a vial deoxygenated by 
bubbling with nitrogen and left to stir in an oil bath at 70 °C. After a predetermined time, 
the solution was removed from the oil bath and the polymer precipitated in diethyl ether 
(x3), and dried under vacuum. Mw,MALLS = 66,600 g/mol, Ð,RI = 1.7 (CHCl3 SEC, multi-
detector). 1H NMR spectrum (400 MHz, CDCl3, δ ppm): 4.17 (m, 2H, -C(O)O-CH2-CH2-
NMe2), 2.65 (m, 2H, -C(O)O-CH2-CH2-NMe2), 2.28 (m, 6H, -CH2-NMe2), 2.05−0.85 
(m, 3H, backbone). 13C NMR spectrum (100 MHz, CDCl3, δ ppm): 13C NMR spectrum 
(100 MHz, CDCl3, δ ppm): 174.26 (-C(O)O-), 62.35 (-C(O)O-CH2-CH2-), 57.53 (-CH2-
N(CH3)2), 45.72 (-N(CH3)2), 67.08 (backbone -CH2-), 19.17 (backbone tertiary). FTIR 
cm-1: 2944 (medium, C-H alkane), 2820 and 2767 (medium, N-CH3 amine), 1726 
(strong, C=O ester), 1455 (medium, C-H alkane), 1263 (medium, C-N, amine), 1155 
(strong, C-O ester). 
 
4.4.7. DLS/Zetapotential 
Dynamic light scattering measurements of resulting polymers and polyplexes at various 
N/P ratios were carried out using a Malvern NanoZS Zetasizer instrument (scattering 
angle of 173°, 10 mW He-Ne laser). For polyplex formation: appropriate amount of 
polymer stock solution and DNA stock solution were mixed and made up to a total 
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volume of 1 mL in DI water (final concentration of polymer was 1 mg/mL, in all 
solutions). The resulting solutions were vortexed incubated for 30 minutes at room 
temperature and were analysed at 25°C. Each sample was run in triplicate and data was 
acquired using the software (Malvern Zetasizer) provided. Zeta potential measurements 
were carried out of the same DLS samples at various N/P ratios using the same 
instrument, and Malvern disposable folded capillary cell (DTS1070) cuvettes.  
 
4.4.8. Agarose gel electrophoresis 
Agarose gels (1% w/v) were prepared with agarose and 1 × TAE buffer with 
DNAse/RNAse free water. The solution was cooled on the bench for 5 minutes and 100 
µL of 0.5 μg/mL ethidium bromide solution was added. The mixture was poured into the 
casted agarose tray and a comb inserted. The gel was left to set for a minimum of 30 
minutes at room temperature. The agarose gels were run in 1× TAE buffer. The final gel 
was visualized under UV illumination at 365 nm using a UVP benchtop UV 
transilluminator system. Polyplexes of dsRNA were prepared at various N/P ratios. 
dsRNA stock solution of 60 µg/mL was prepared sterile water, and polymer stock solution 
of 300 µg/mL. For polyplex formation: appropriate amount of polymer stock solution and 
dsRNA stock solution were mixed and made up to a total volume of 100 µL (final 
concentration of dsRNA was 0.030 µg/µL, in all solutions). Polyplexes were vortexed 
and incubated at room temperature for 30 minutes. Prior to loading, 30 µL of loading 
buffer was added to each sample and 20 µL of polyplexes were loaded into the agarose 
gel wells. Gel electrophoresis was performed at 100 V for 30 minutes. 
 
4.4.9. Agarose gel dsRNA release study 
Polyplexes were formed in sterile water at an N/P ratio of 5 with a final concentration of 
1 mg/mL dsRNA. Samples were then divided into separate microtubes for each sample 
time point and stored at room temperature, until the microtubes were frozen at the 
appropriate time. When all the time points has been collected, samples were defrosted 
diluted to 100 µg/mL dsRNA. Prior to loading, loading buffer was added to each sample 
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and 20 µL of polyplexes were loaded into the agarose gel wells. Gel electrophoresis was 
performed at 100 V for 20 minutes on a 1% agarose gel containing ethidium bromide. 
 
4.4.10. Cell culture 
NIH-3T3 mouse fibroblast cells were obtained from the Sigma-Aldrich and used between 
passages 5 and 15. Cells were grown in DMEM (Dulbecco's Modified Eagle Medium) 
supplemented with 10% of bovine calf serum, 1% of 2 mM glutamine and 1% 
penicillin/streptomycin. The cells were grown as adherent monolayers at 310 K under a 
5% CO2 humidified atmosphere and passaged at approximately 70–80% confluence. 
 
4.4.11. In vitro toxicity assays  
NIH-3T3 mouse fibroblast cells were seeded in a 96 well plate at a density of 1 × 104 
cells per well. After 16 hours, the culture medium was replaced by fresh media containing 
a series of dilution of the polymers. Following 24 hours incubation, the medium was 
removed and replaced with fresh medium. The cells were incubated with a freshly 
prepared solution of XTT (0.2 mg/mL) and N-methyl dibenzopyrazine methyl sulfate 
(250 µM) in medium for 16 hours. Absorbance of the samples was finally measured using 
a plate reader at 450 nm and 650 nm. The data presented are representative of a minimum 
of two independent experiments where each sample was measured in triplicate. Errors 
reported correspond to the standard deviation of the mean. For toxicity assays of polymers 
after 2-week hydrolysis, the polymers were incubated in sterile water (pH ~7.4) at 
concentrations of 8 mg/mL. Before incubating with cells, hydrolysed polymer solution 
was diluted to the appropriate concentration in media. 
 
4.4.12. Polyplex soil stability assay 
Polyplexes were formed in sterile water at an N/P ratio of 5 with a final concentration of 
1 mg/mL dsRNA. 200 µL of polyplexes were mixed with 0.5 g soil (live soil containing 
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enzymes, and also sterilised soil (sterilisation conditions: 200 ˚C, 2 hr)) in 2 mL 
microtubes. Separate microtubes were used for each sample time point and stored at room 
temperature. At the appropriate time, the reaction was stopped by addition of 1 mL 
trireagent, vortexing, and incubating for 5 minutes, before storing the sample time point 
at -20 ˚C. 
 
4.4.13. dsRNA extraction 
dsRNA was extracted from the soil in order to analyse the dsRNA by agarose gel 
electrophoresis. Polyplex/soil/trireagent samples were defrosted, 200 µL of chloroform 
added, and incubated for 3 minutes at room temperature. Samples were then centrifuged 
for 15 minutes at 12000 g and 4 ˚ C. Supernatant was added to new microtube, isopropanol 
added (1/1 ratio) to precipitate the RNA, and incubated at for 10 minutes at room 
temperature. Microtubes were then centrifuged at 12000 g and 4 ˚C for 10 minutes. 
Supernatant was removed and 500 µL of 70 % ethanol (in RNAse free water) added to 
the pellet, then centrifuged for 5 minutes at 12000 g and 4 ˚C. The supernatant was 
removed and the pellet left to dry for 10 minutes before being suspended in 200 µL of 
RNAse free water. These RNA samples were then enriched for dsRNA following a LiCl 
purification protocol. LiCl (8M, 67 µL) was added to the 200 uL RNA samples, which 
were mixed on ice, and incubated for 30 minutes at -20 ˚C. Microtubes were then 
centrifuged for 20 minutes at 14000 g and 4 ˚C, the supernatant was brought to a new 
microtube, and LiCl (8M, 133.5 µL) was added. The samples were mixed on ice, 
incubated for 30 minutes at -20 ˚C, and then centrifuged for 20 minutes at 14000 g and 4 
˚C. The supernatant was removed, the dsRNA pellet washed with 70% ethanol (in RNAse 
free water, 150 µL), and then centrifuged for 5 minutes at 12000 g and 4 ˚C. The 
supernatant was removed and the dsRNA pellet left to dry for 5 minutes before being 
suspended in 20 µL of RNAse free water. These final dsRNA samples were analysed by 
spectrophotometry (NanoPhotometer NP60 spectrophotometer), and agarose gel 
electrophoresis. Gel electrophoresis was performed at 100 V for 20 minutes on a 1% 
agarose gel (1x TAE buffer) containing ethidium bromide. 
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Polymerisation conditions, linear polymer equivalent SEC chromatograms, 
polymerisation kinetic data of DMEAMA DMAEA copolymerisation, polymerisation 
conditions and data for reactivity ratio calculation polymerisations, agarose gel images of 
polyplex formation, further 1H NMR spectra of polymer hydrolysis, polyplex dsRNA soil 
stability study agarose gel images. 
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Table A4.1. Experimental conditions used for the synthesis of the branched polymers and 
copolymers, and also linear equivalents. 
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Figure A4.1. 13C NMR spectrum of highly branched pDMAEA in deuterated 
chloroform. 
 
 
Figure A4.2. 13C NMR spectrum of highly branched pDMAEMA in deuterated 
chloroform. 
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Figure A4.3. 13C NMR spectrum of highly branched copolymer p(DMAEMA40-co-
DMAEA10) in deuterated chloroform. 
  
 
Figure A4.4. 13C NMR spectrum of highly branched copolymer p(DMAEMA10-co-
DMAEA40) in deuterated chloroform. 
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Figure A4.5. Size exclusion chromatograms of linear copolymers of DMAEMA and 
DMAEA by RAFT (From CHCl3 SEC, DRI detector, linear PS standard). 
 
Figure A4.6. Polymerisation kinetic analysis via 1H NMR Spectroscopy of 
copolymerisation of DMAEMA and DMAEA (DP 50, 50:50 ratio), CPAETC RAFT 
agent, ACVA initiator at 70 oC. 
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Table A4.2. Polymerisation kinetic analysis via 1H NMR Spectroscopy of 
copolymerisation of DMAEMA and DMAEA (DP 50, 50:50 ratio), CPAETC RAFT 
agent, ACVA initiator at 70 oC. 
Time (hr) 
Conv. DMAEMA 
(%) 
Conv. DMAEA (%) Total conv. (%) 
0 0 0 0 
0.5 4.0 2.8 3.7 
1.5 7.0 3.0 5.3 
2 20 10 16 
3 41 23 33 
6 77 48 63 
9 89 61 75 
18 93 71 82 
24 98 83 91 
 
 
Table A4.3. Experimental conditions used for the synthesis of the linear DMAEMA 
DMAEA copolymers (used for NMR kinetic study, and reactivity ratio calculations). 
Sample 
Linear 
p(DMAEMA10-
co-DMAEA90)  
Linear 
p(DMAEMA30-
co-DMAEA70)  
Linear 
p(DMAEMA50-
co-DMAEA50)  
Linear 
p(DMAEMA70-
co-DMAEA30)  
Linear 
p(DMAEMA90-
co-DMAEA10)  
[M]:[M]:[CTA]:[I] 5:45:1:0.05 15:35:1:0.05 25:25:1:0.05 35:15:1:0.05 45:5:1:0.05 
Mass DMAEMA (mg) 31.4 94.3 157.2 220.1 283 
Mass DMAEA (mg) 257.8 200.5 143.2 57.3 28.6 
CTA CPAETC CPAETC CPAETC CPAETC CPAETC 
Mass CTA (mg) 10.53 10.53 10.53 10.53 10.53 
Initiator ACVA ACVA ACVA ACVA ACVA 
Mass Initiator (mg) 0.56 0.56 0.56 0.56 0.56 
Solvent Dioxane Dioxane Dioxane Dioxane Dioxane 
Temperature (oC) 70 70 70 70 70 
Time (hr) 24 24 24 24 24 
V. total (mL) 0.667 0.667 0.667 0.667 0.667 
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Figure A4.7. Time 0 hour, 1H NMR spectra for the synthesis of the linear DMAEMA 
DMAEA copolymers (used for reactivity ratio calculations). 
 
Figure A4.8. Time 1 hour, 1H NMR spectra for the synthesis of the linear DMAEMA 
DMAEA copolymers (used for reactivity ratio calculations). 
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Table A4.4. Parameters from the synthesis of the linear DMAEMA DMAEA copolymers 
(used for reactivity ratio calculations). 
f1 (DMAEMA) f2  (DMAEA) F1 (DMAEMA) F2 (DMAEA) Total conv. (%) 
0.000 1.000 0.000 1.000 - 
0.102 0.898 0.156 0.844 9.5 
0.314 0.686 0.426 0.574 5.8 
0.502 0.498 0.674 0.326 5.2 
0.704 0.296 0.806 0.194 6.9 
0.901 0.099 0.957 0.043 6.5 
1.000 0.000 1.000 0.000 - 
 
The monomer feed ratio and incorporation ratios were then used to calculate reactivity 
ratios by the Fineman-Ross method, Kelen-Tudos method, and by fitting with a non-linear 
least squares fit (solver in MS Excel) of the copolymer equation:  𝐹1 =
𝑟1𝑓1
2+ 𝑓1𝑓2
𝑟1𝑓1
2+2𝑓1𝑓2+ 𝑟2𝑓2
2 
 
Figure A4.9. Fineman-Ross plot for estimation of reactivity ratios for linear 
copolymerisation of DMAEMA and DMAEA (DP 50, 50:50 ratio), CPAETC RAFT 
agent, ACVA initiator at 70 oC. 
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Figure A4.10. Kelen-Tudos plot for estimation of reactivity ratios for linear 
copolymerisation of DMAEMA and DMAEA (DP 50, 50:50 ratio), CPAETC RAFT 
agent, ACVA initiator at 70 oC. 
 
 
Table A4.5. Reactivity ratio values acquired (from three different methods) for linear 
copolymerisation of DMAEMA and DMAEA (DP 50, 50:50 ratio), CPAETC RAFT 
agent, ACVA initiator at 70 oC. 
 
Non linear 
least squares 
Fineman Ross Kelen Tudos 
r1 (DMAEMA) 2.13 2.55 2.29 
r2 (DMAEA) 0.69 0.93 0.71 
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Figure A4.11. Agarose gel electrophoresis images of polyplex formation of synthesised 
branched polymers with dsRNA, with varying N/P ratios. 
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a)  
b)  
c)  
d)  
e)  
Figure A4.12. Representative DLS data for polyples solutions (branched DMAEMA with 
dsRNA, N/P 20, three repeats shown), a) intensitie distribution, b) volume distribution, 
c) number distribution, d) correlalograms, e) cummulants fit. 
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Figure A4.13. Hydrolysis of branched pDMAEA in D2O (pH ~7.4) determined using 
1H 
NMR spectroscopy. 
 
Figure A4.14. Hydrolysis of branched pDMAPA in D2O (pH ~7.4) determined using 
1H 
NMR spectroscopy. 
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Figure A4.15. Hydrolysis of linear p(DMAEMA40-co-DMAEA10) in D2O (pH ~7.4) 
determined using 1H NMR spectroscopy. 
 
Figure A4.16. Hydrolysis of linear p(DMAEMA10-co-DMAEA40) in D2O (pH ~7.4) 
determined using 1H NMR spectroscopy. 
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Figure A4.17. Hydrolysis of branched p(DMAEMA40-co-DMAEA10) in D2O (pH ~7.4) 
determined using 1H NMR spectroscopy. 
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Figure A4.18. Polyplex soil stability assay (dsRNA protection), polyplexes were formed 
in sterile water at an N/P ratio of 5 with a final concentration of 1 mg/mL dsRNA, 
incubated in live soil or enzyme free soil, then dsRNA was extracted and run on an 
agarose gel. 
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Figure A4.19. Control dsRNA soil stability assay, with a final concentration of 1 mg/mL 
dsRNA, incubated in live soil or enzyme free soil, then dsRNA was extracted and run on 
an agarose gel. 
 
 5. 
Branched poly(trimethylphosphonium 
ethylacrylate-co-PEGA) by RAFT: alternative to 
cationic polyammoniums for nucleic acid 
complexation 
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Abstract 
Cationic and highly branched poly(trimethylphosphonium ethylacrylate-co-PEGA) 
(p(TMPEA-co-PEGA)), and its ammonium equivalent, have been synthesised from post-
polymerisation modification of a poly(bromo ethylacrylate-co-PEGA) (p(BEA-co-
PEGA)) precursor polymer produced using reversible addition fragmentation chain 
transfer (RAFT) polymerisation. The cationic polymers were evaluated for their ability 
to complex nucleic acids, in vitro cytotoxicityas well as GFP pDNA transfection 
efficiency. The results show RAFT copolymerisation of BEA and PEGA is a simple route 
to polyphosphoniums showing reduced cytotoxicities and higher transfection efficiencies 
than their polyammonium alternatives. 
 
5.1 Introduction 
The development of polymeric materials for non-viral gene delivery applications has 
become a prolific area of research over the last two decades.1 These compounds facilitate 
the use of nucleic acids such as siRNA, mRNA, and plasmid DNA as therapeutics to treat 
a range of diseases with currently limited traditional small molecule therapeutic options.2 
Historically, non-viral gene delivery polymers have been cationic polymers or lipids that 
can compact negatively charged nucleotides to form nanoparticle polyplexes, which can 
be uptaken by cells. Commonly utilised systems include polyethyleneimine (PEI), 
chitosan, polylysine (PLL), and poly(dimethylaminoethyl methacrylate) 
(pDMAEMA).3,4 The vast majority of polymer based nucleic acid delivery systems rely 
on amine-based cationic moieties to complex the phosphate groups of the desired 
polynucleotides. Although polyamines and polyammoniums show good ability to 
complex nucleotides, they also have significant cytotoxic effects arising either 
immediately from the free cationic amine polymer or as a delayed toxicity associated with 
the intracellular processing of polyplexes.5-8 
A number of strategies have been used to circumvent or alter the cytotoxicity of 
polyamine non-viral vectors, most of which include variation of the amine pKa or 
introduction of PEG units.9 Using a cationic heterocycle, for example pyridinium or 
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imidazolium, was shown to result in a better dispersion of the positive charge over the 
ring and a decreased toxicity.10 However, the use of non-nitrogen centred cations for 
nucleic acid complexation has yet to be thoroughly explored.11 Phosphonium containing 
compounds are generally less toxic than their ammonium equivalents due to differences 
in ionic radius and charge distribution.11-13 In addition, phosphonium based lipids have 
been shown to transfect cells with high efficacies and lower toxicity than ammonium 
analogues.14 Interestingly, the few polymeric phosphonium materials reported so far in 
the literature showed a similar trend in relation to toxicity.15-18 Yet, this was only studied 
in the case of linear polymers. 
Phosphonium containing polymers are beginning to be investigated as delivery vectors, 
showing good transfection capabilities but with lower toxicities, the monomers used are 
either styrene based or required multistep syntheses and purification. The group of 
Long,17,18 conducted research involving phosphonium containing monomers for nucleic 
acid complexation using modified styrene monomers, which can be difficult to 
polymerise, often require high temperatures and high initiator concentrations.  Fréchet et 
al.,15 and also Mantiovanni et al.,16 synthesised phosphonium containing monomers with 
triethylene glycol spacers between the (meth)acrylate group and the  phosphonium 
moieties. While these monomers showed excellent promise for gene delivery 
applications, they typically require multistep syntheses and purification. Poly(bromo 
ethylacrylate) (pBEA) has recently been shown to be an excellent reactive precursor 
material for post polymerisation modification with a variety of functionalities, including 
phosphonium moeities.19 The monomer is compatible with controlled radical 
polymerisation techniques such as Reversible Addition Fragmentation Chain Transfer 
(RAFT) polymerisation, which enable great control of molecular weight as well as access 
to complex architectures.20,21 In addition, RAFT polymerisation with divinyl 
comonomers allows simple access to branched architectures,22 which have been shown 
to be more efficient gene delivery vectors than linear polymers.23-25 In this chapter, the 
facile synthesis of branched phosphonium containing polymers using RAFT and a post-
polymerisation modification strategy is reported. The highly branched p(TMPEA-co-
PEGA), and its ammonium equivalent, were investigated for their ability to complex 
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DNA, toxicity of the polymers, and their potential to transfect cells in vitro with GFP 
plasmid DNA. 
 
5.2 Results and discussion 
5.2.1 Highly branched polymer synthesis 
RAFT polymerisation was first used to synthesise highly branched structures by our 
group in 2005,22,26,27 following the considerable work of Sherrington et al.,28-30 who 
developed facile and versatile branched polymeric systems using free radical 
polymerisation. Here, the chain transfer agent, 2-(((butylthio)carbonothioyl)thio) 
propanoic acid (PABTC) is employed to copolymerise bromoethyl acrylate (BEA) and 
poly(ethylene glycol) acrylate (PEGA) with cross-linker diethyleneglycol diacrylate 
(DEGDA) to form soluble highly branched polymers in a one-pot methodology (Figure 
5.1a). A molar ratio of 80:20 BEA:PEGA was chosen, which achieves similar weight 
ratio (and therefore charge to PEG ratio) as previous reports in the literature,15,16 but from 
a facile copolymerisation strategy and post-polymerisation modification. The RAFT 
polymerisation was conducted at 70 oC in dioxane, with the conditions [BEA]: [PEGA]: 
[DEGDA]: [CTA]: [I] = 40: 10: 2.5: 1: 0.1, and reached conversions of > 90 % in 24 hrs 
with no macroscopic gelation. Size exclusion chromatography (SEC) showed a broad 
molecular weight distribution and high molecular weights (Mw = 127,900 g/mol, Ð = 5.4) 
for the resulting polymers, as expected for highly branched polymeric systems (Figure 
5.1b).  
Information about the branched nature of these polymers and their globular conformation 
in solution can be obtained from viscometry detection on the SEC system. Figure 5.1b 
shows the Kuhn-Mark-Houwink-Sakurada (KMHS) double Log plot of intrinsic viscosity 
against molecular weight. The gradient of the line ( value) gives information about the 
extent of polymer branching by inferring information about the polymer entanglements 
in solution. Linear polymers entangle more than branched polymers of similar molecular 
weight, leading to higher viscosity values which increase with increasing molecular 
weight more than equivalent branched systems. Linear polymers typically have  values 
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of ~ 0.7. Here, linear p(BEA-co-PEG) was found to have   = 0.6 - 0.7 (see supporting 
info) while the highly branched p(BEA-co-PEGA) reactive polymer precursor has an  
= 0.35, indicating a highly branched polymer with a globular conformation. 
 
 
Figure 5.1. a) Reaction scheme for the RAFT polymerisation of BEA and PEGA with 
crosslinker DEGDA, and subsequent post-polymerisation modification with 
trimethylamine and trimethylphosphine; b) size exclusion chromatogram of p(BEA-co-
PEGA) precursor polymer from refractive index detector, including KMHS plot of 
p(BEA-co-PEGA) from viscometry detector (DMF, PMMA calibration, Mn = 127,900 
g/mol, Ð = 5.4,  = 0.35). 
 
5.2.2 Post polymerisation modification 
With the highly branched reactive polymer precursor in hand, post-polymerisation 
modification with trimethylamine and trimethylphosphine in DMSO/ethanol and 
DMSO/THF solvent mixtures, respectively, was used to form structurally equivalent 
polyphosphoniums and polyammoniums. Due to the highly charged nature of the 
resulting cationic polymers, purification from excess nucleophile could be achieved by 
precipitation of the charged polymer in THF. The lack of solubility in organic solvents of 
the resulting polymers, however, presented difficulties with characterisation of the 
molecular weight distribution using SEC. Using 1H NMR  spectroscopy, substitution of 
the BEA alkyl halide with trimethylamine and trimethylphosphine nucleophiles was 
shown to proceed to high degrees of substitution (> 95 %) (Figure 5.2, A5.3 and A5.4), 
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which agrees with previously reported results.19 Phosphorous (31P) NMR spectroscopy 
confirmed the presence of phosphonium moieties on the purified polymer (Figure A5.5). 
In addition, elemental analysis was carried out to confirm the structure of both precursor 
BEA copolymer and post-polymerisation modified polymers (Table A5.2). In the case of 
p(TMAEA-co-PEGA) appearance of nitrogen confirmed successful substitution. 
However, the technique was unable to provide a quantitative assessment of substitution 
value, as the generation of highly charged cationic moieties, leads to the bromine anion 
being retained in the polymer as a counterion. Electrophoretic light scattering 
(zetapotential) measurments were employed to determine the charge of branched p(BEA-
co-PEGA) precursor, and substituted polymers (Table A5.3 and Figure A5.6). The 
charge increases from -3.05 mV for p(BEA-co-PEGA) to positively charged, p(TMAEA-
co-PEGA) = +41.1 mV, p(TMPEA-co-PEGA) = +40.6 mV, further demonstrating 
substitution.  
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Figure 5.7. a) 1H NMR spectra in DMSO-d6 of branched p(BEA-co-PEGA) before and 
after substitution to form p(TMPEA-co-PEGA), b) 1H NMR spectra in DMSO-d6 of 
branched p(BEA-co-PEGA) before and after substitution to form p(TMAEA-co-
PEGA). 
 
5.2.3 DNA complexation 
Ability of the synthesised highly branched polymers to complex DNA was investigated 
using a combination of agarose gel electrophoresis, DLS, and zetapotential 
measurements. The formation of polyplexes at various N/P ratios, where N refers to 
nitrogens in the polymer/vector and P refers to negatively charged phosphate groups in 
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the nucleic acid, was tested.31 For clarity, the different charge ratios are referred to as 
either P+/P for phosphonium polymers or N+/P quaternary ammonium polymers here. 
Figure 5.3a and 5.3b show the agarose gel retardation assays for branched p(TMPEA-
co-PEGA) and p(TMAEA-co-PEGA) respectively, with both polymers showing 
complexation of DNA at a charge ratio value of 2.  
 
Figure 5.3. a) p(TMPEA-co-PEGA) polyplex formation with DNA as characterised by 
agarose gel electrophoresis at varying P+/P charge ratios; b) p(TMAEA-co-PEGA) 
polyplex formation with DNA as characterised by agarose gel electrophoresis at varying 
N+/P charge ratios; c) structures of repeating units; d) surface charge (zetapotential) and 
e) size of polyplexes formed with DNA at varying N+/P or P+/P ratios as measured by 
dynamic light scattering and electrophoretic light scattering, respectively. 
 
The overall size and surface charge of formed polyplexes was then determined using 
zetapotential and DLS measurements at various charge ratios (Figure 5.3d and 5.3e). At 
low P+/P and N+/P ratios, observation of negatively charged polyplex nanoparticles with 
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sizes of apporiximately 200 nm demonstrate the incomplete complexation of the 
oligonucleotide by both polymers, as excess of nucleic acid accounts for the negative 
charge observed. At a charge ratio of 2, both p(TMPEA-co-PEGA) and p(TMAEA-co-
PEGA) form aggregates with sizes of over 2 m with approximately neutral overall 
charges (~ -5mV from zetapotential). At higher ratio values, branched polymers complex 
all the nucleic acid and form electrostatically stabilised charged polyplexes with sizes of 
around 200 nm and a surface charge of approximately +40 mV. Taken together, these 
results show that both p(TMPEA-co-PEGA) and p(TMAEA-co-PEGA) have very similar 
ability to complex nucleic acids. 
The ability of the highly branched p(TMPEA-co-PEGA) and p(TMAEA-co-PEGA)  to 
protect nucleic acids from degradation in soil applications was investigated. Polyplexes 
(N/P 5) were incubated in live soil or enzyme free soil. The nucleic acids were extracted 
from the soil after the appropriate incubation period, and then an agarose gel was run to 
compare to the non-degraded pristine nucleic acid (Figure A5.8). Uncomplexed nucleic 
acid is degraded in soil after one day, but when complexed to branched p(TMPEA-co-
PEGA) and p(TMAEA-co-PEGA), it seems to be protected soil related degradation for, 
potentially, up to 21 days. 
 
5.2.4 Polymer toxicity and transfection in vitro 
Difference in the toxicity and pDNA transfection efficiency of phosphonium-containing 
cationic polymers, as compared to ammonium equivalents, was investigated next. Acute 
toxicity of the polymers was assessed in vitro using 3T3 fibroblast cell line as model.  
Cells were incubated with the polymers (0.5 g/mL – 2 mg/mL) for 24 hr and viability 
was assessed using a typical protocol for the XTT assay (Figure 5.4a). At concentrations 
of 5 g/mL and below, all polymers present cell viability above 80%. While bPEI shows 
significant toxicity at concentrations above 50 g/mL, both p(TMPEA-co-PEGA) and 
p(TMAEA-co-PEGA) showed no adverse effects to cell viability at concentration as high 
as 0.5 and 0.2 mg/mL, respectively. The fact that phosphonium polymer is observed to 
be less toxic than the ammonium-containing equivalent is in accordance with previous 
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report in the literature. For example, Stekar et al. first reported that trimethylphosphonium 
cationic headgroups in phospholipids had lower cytotoxicity in mouse models compared 
to equivalent ammonium choline phospholipids, while the lipids also retained similar 
antineoplastic activity in both in vitro and in vivo induced carcinoma models.12 A similar 
increase in cell viability was observed for triethylphosphonium polymers as compared to 
triethylammonium polymers, for a range of polymer concentrations.15 
The polymers were finally assessed for their propensity to help deliver plasmid DNA 
encoding for green fluorescent protein (GFP) in cells. This was done by incubating model 
HEK293T cells with polyplexes, at a N/P ratio of 20, for 4 h, following which the cells 
were allowed to further grow for 16 hours prior to cellular fluorescence quantificatino 
using flow cytometry. The results, shown in Figure 5.4b, show that polyplexes of 
branched p(TMPEA-co-PEGA) enhance transfection efficiency by a factor of 
approximately six times as compared to naked pDNA. Interestingly, the transfection 
efficiency of branched p(TMAEA-co-PEGA) was shown to only increase the efficiency 
of naked pDNA by a factor of 3. Such a higher transfection for the phosphonium polymer 
when compared to the ammonium polymer follows the same trend as previously reported 
in the literature.15 Both of the synthesised branched polymers showed lower transfection 
compared to commercial branched PEI. This is potentially due to the p(TMPEA-co-
PEGA) and p(TMAEA-co-PEGA) polymers being too hydrophilic, and subsequently 
being unable to efficiently enter cells via endocytosis – a process which typically requires 
a balance of cationic charge and hydrophobicity.32 Long et al. reported a similar trend, 
where polymers with hydrophobic alkyl moieties attached to phosphonium cations had 
higher transfection efficiencies compared to more hydrophilic substituents.17 
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Figure 5.4.. a) Cytotoxicity as determined by the percentage of cell viability for 3T3 
fibroblast cells treated with branched p(TMPEA-co-PEGA), branched p(TMAEA-co-
PEGA), and bPEI for 24 hours at 37 °C. b) Intracellular fluorescence in HEK-293T cells 
following incubation with polyplexes of GFP-plasmid DNA and branched p(TMPEA-
co-PEGA), branched p(TMAEA-co-PEGA) or bPEI (N/P 20, 10 µg/mL DNA 
concentration in well) for 4 hours at 37 °C and overnight incubation in polyplex-free 
media, as measured by flow cytometry. 
 
5.3 Conclusions 
In conclusion, this chapter demonstrated the facile synthesis of highly branched cationic 
poly(trimethylphosphonium ethylacrylate-co-PEGA) using a simple post-polymerisation 
modification strategy of a p(bromo ethylacrylate-co-PEGA) precursor polymer produced 
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using RAFT polymerisation. This synthesis represents a significant 
improvement/simplification of current phosphonium containing polymer synthetic 
methods. The phosphonium and ammonium containing polymers were evaluated for 
ability to complex nucleic acids, polymer cytotoxicity, and pDNA transfection. The 
results show that phosphonium-bearing polymers have increased biocompatibility and 
higher transfection efficiencies when compared to their exact ammonium equivalents. 
While transfection efficiencies were lower than those observed with commercial bPEI, 
their much lower toxicity highlights them as promising alternatives for gene delivery 
applications.  
 
5.4 Experimental 
5.4.1 Materials 
Poly(ethylene glycol) methyl ether acrylate with average Mn = 480 (PEGA), di(ethylene 
glycol) diacrylate (DEGDA), 4,4′-azobis(4-cyanovaleric acid) (ACVA), trimethylamine 
solution (31-35 wt. % in ethanol 4.2 M), trimethylphosphine solution (1.0 M in THF), 
polyethylenimine branched (bPEI, Mw ~25,000 by LS, Mn ~10,000 by SEC), agarose, 
ethidium bromide solution (500 μg/mL in H2O), deoxyribonucleic acid (DNA, low 
molecular weight from salmon sperm), were all obtained from Sigma-Aldrich. All other 
materials were purchased from Fisher Scientific. Green fluorescent protein (GFP) 
expressing plasmid DNA (pWPI) Addgene plasmid #12254. Bromoethyl acrylate was 
synthesised according to a previously published procedure.19 2-(((Butylthio)-
carbonothioyl)thio)propanoic acid (PABTC) was prepared according to a previously 
reported procedure.33 50X Tris-Acetate-EDTA (TAE) buffer for gel electrophoresis was 
made up at concentration of 2.0M Tris acetate (Sigma Aldrich) and 0.05M EDTA (Sigma 
Aldrich) in deionised water, pH 8.2 - 8.4, and stored at room temperature. Agarose 
loading buffer for samples (colourless) was made up at 30% (vol/vol) glycerol (Sigma 
Aldrich) in deionised water, and stored at room temperature. 2,3-Bis(2-methoxy-4-nitro-
5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT sodium salt), and 
Phenazine methosulfate (PMS) were obtained from Sigma-Aldrich. 
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5.4.2 Characterisation 
Size Exclusion Chromatography (SEC) was performed in DMF, using an Agilent 390-
LC MDS instrument equipped with differential refractive index (DRI), viscometry, dual 
angle light scattering, and dual wavelength UV detectors. The system was equipped with 
2 x PLgel Mixed D columns (300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent 
was DMF with 5 mmol NH4BF4 additive, and samples were run at 1 mL/min at 50 °C. 
Analyte samples were filtered through a nylon membrane with 0.22 μm pore size before 
injection. Apparent molar mass values (Mn,SEC and Mw,SEC) and dispersity (Đ) of 
synthesized polymers were determined by DRI detector and conventional calibration 
using Agilent SEC software. Poly(methyl methacrylate) (PMMA) standards (Agilent 
EasyVials) were used for calibration. The Kuhn-Mark-Houwink-Sakurada parameter , 
relating to polymer conformation in solution was determined from the gradient of the 
double logarithmic plot of intrinsic viscosity as a function of molecular weight, using the 
SEC viscometry detector and Agilent SEC software. Proton nuclear magnetic resonance 
spectra (1H NMR) were recorded on a Bruker Advance 400 or 300 spectrometer (400 
MHz or 300 MHz) at 27 °C, with chemical shift values (δ) reported in ppm, and the 
residual proton signal of the solvent used as internal standard. Proton-decoupled carbon 
nuclear magnetic resonance spectra (13C NMR) were recorded on a Bruker Advance 400 
(100 MHz) at 27 °C in CDCl3, with chemical shift values (δ) reported in ppm, and the 
residual proton signal of the solvent used as internal standard (δC 77.16). Phosphorous 
31P NMR spectroscopy was performed on a Bruker Advance 400 (162 MHz) in DMSO-
d6, at 27 °C, with chemical shift values (δ) reported in ppm. Fourier transform infrared 
spectra (FTIR) were recorded on a Bruker Alpha FTIR ATR.  Elemental analyses for 
CHN were carried out on a CE440 CHN elemental analyser, and bromine was analysed 
using classical oxygen flask methods by Warwick Analytical Service. 
 
5.4.3 Polymer synthesis  
For a typical polymerisation, with the conditions [BEA]: [PEGA]: [DEGDA]: [CTA]: [I] 
= 40: 10: 2.5: 1: 0.1, CTA (10.7 mg, 0.0447 mmol), BEA (0.319 g, 1.78 mmol), PEGA 
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(0.214 g, 0.446 mmol), DEGDA (23.9 mg, 0.112 mmol), ACVA (1.25 mg, 0.00447 
mmol),  and dioxane (0.445 mL) were added to a vial deoxegenated by bubbling with 
nitrogen and left to stir in an oil bath at 70 °C. After a predetermined time, the solution 
was removed from the oil bath and the polymer precipitated in diethyl ether (x3), and 
dried under vacuum. Mw = 127,900 g/mol, Ð = 5.4 (DMF SEC, +NH4BF4 additive eluent, 
PMMA calibration). 1H NMR spectrum (400 MHz, DMSO-d6, δ ppm): 4.34 (m, 2H, -
C(O)O-CH2-CH2-Br), 4.12 (m, 2H, -C(O)O-CH2-CH2-O-), 3.65 (m, 2H, -C(O)O-CH2-
CH2-Br), 3.52 (m, 32H, -CH2- (PEG)), 3.24 (s, 3H, -(CH2-CH2-O)-CH3), 2.39−1.54 (m, 
3H, backbone), 0.89 (t, 3H, -CH3 (CTA)). 13C NMR spectrum (100 MHz, CDCl3, δ ppm): 
173.79 (-C(O)O-), 70.26 (-CH2- (PEG)), 66.82 (-C(O)O-CH2-), 30.82 (-CH2-Br), 41.23 
(backbone tertiary), 39.91 (backbone -CH2-). FTIR cm-1: 2867 (medium, C-H alkane), 
1728 (strong, C=O ester), 1447 (medium, C-H alkane), 1093 (strong, C-O-C PEG). 569 
(weak, C-Br). Elemental analysis shown in Table A5.2. 
In order to further characterise the branched nature of the synthesised polymers, two 
linear p(BEA-co-PEGA) polymers were synthesised to give a comparison for the KMHS 
intrinsic viscosity vs molecular weight plots, and associated values. The polymerisation 
conditions were identical to the above branched polymers, but without DEGDA 
crosslinker (conditions and characterisation data can be seen in Table A5.1, and Figures 
A5.1 and A5.2). Mn = 9,700 g/mol, Ð = 1.12; and Mn = 16,800 g/mol, Ð = 1.32; (DMF 
SEC, +NH4BF4 additive eluent, PMMA calibration).
 1H NMR spectrum (400 MHz, 
DMSO-d6, δ ppm): 4.34 (m, 2H, -C(O)O-CH2-CH2-Br), 4.12 (m, 2H, -C(O)O-CH2-CH2-
O-), 3.65 (m, 2H, -C(O)O-CH2-CH2-Br), 3.52 (m, 32H, -CH2- (PEG)), 3.24 (s, 3H, -
(CH2-CH2-O)-CH3), 2.39−1.54 (m, 3H, backbone), 0.89 (t, 3H, -CH3 (CTA)). 13C NMR 
spectrum (100 MHz, CDCl3, δ ppm): 174.90 (-C(O)O-), 70.19 (-CH2- (PEG)), 65.52 (-
C(O)O-CH2-), 31.32 (-CH2-Br), 41.28 (backbone tertiary), 22.87 (backbone -CH2-). 
FTIR cm-1: 2880 (medium, C-H alkane), 1725 (strong, C=O ester), 1440 (medium, C-
H alkane), 1095 (strong, C-O-C PEG), 576 (weak, C-Br). 
 
 
Chapter 5 
199 
5.4.4 Post-polymerisation modification 
Typical post-polymerization substitution of branched p(BEA-co-PEGA) with 
trimethylamine: p(BEA-co-PEGA)  (0.10 g of polymer, 0.447 mmol of BEA units) was 
dissolved in 2 mL of DMSO in a small vial with a stirrer bar, to which was added 2.5 
equivalents of trimethylamine (4.2 M in ethanol, 266 μL, 1.12 mmol) and stirred for 48 h 
under a nitrogen atmosphere. Upon completion, the solution was concentrated by nitrogen 
flow, purified by precipitation into THF, and dried under vacuum, to give the desired 
p(TMAEA-co-PEGA). 1H NMR (400 MHz, DMSO-d6, ppm): δ = 4.53 (m, 2H, -C(O)O-
CH2-CH2-NMe3), 4.12 (m, 2H, -C(O)O-CH2-CH2-O-), 3.91 (m, 2H, -C(O)O-CH2-CH2-
NMe3), 3.52 (m, 32H, -CH2- (PEG)), 3.34 (m, 9H, CH2-CH2-NMe3), 3.24 (s, 3H, -(CH2-
CH2-O)-CH3), 2.41−1.51 (m, 3H, backbone), 0.89 (m, 3H, -CH3 (CTA)). 13C NMR 
spectrum (100 MHz, CDCl3, δ ppm): 174.04 (-C(O)O-), 70.22 (-CH2- (PEG)), 64.00 (-
C(O)O-CH2-CH2-), 58.92 (-C(O)O-CH2-CH2-), 53.42 (-N(CH3)3), 40.85 (backbone 
tertiary), 39.73 (backbone -CH2-). FTIR cm-1: 2871 (medium, C-H alkane), 1728 
(strong, C=O ester), 1477 (medium, C-H alkane), 1248 (medium, C-N, amine), 1092 
(strong, C-O-C PEG). Elemental analysis shown in Table A5.2. 
Typical post-polymerization substitution of branched p(BEA-co-PEGA) with 
trimethylphosphine: p(BEA-co-PEGA)  (0.10 g of polymer, 0.447 mmol of BEA units) 
was disolved in 2 mL of DMSO in a small vial with a stirrer bar, to which was added 2.5 
equiv of trimethylphosphine (1 M in THF, 1.12 mL, 1.12 mmol) and stirred for 48 h under 
a nitrogen atmosphere. Upon completion, the solution was concentrated by nitrogen flow, 
purified by precipitation into THF, and dried under vacuum, to give the desired 
p(TMPEA-co-PEGA). 1H NMR (300 MHz, DMSO-d6, ppm): δ = 4.36 (m, 2H, -C(O)O-
CH2-CH2-PMe3), 4.13 (m, 2H, -C(O)O-CH2-CH2-O-), 3.51 (m, 32H, -CH2- (PEG)), 3.24 
(s, 3H, -(CH2-CH2-O)-CH3), 2.83 (m, 2H, -C(O)O-CH2-CH2-PMe3), 2.07 (m, 9H, CH2-
CH2-PMe3), 2.46−1.44 (m, 3H, backbone), 1.06 (m, 3H, -CH3 (CTA)). 13C NMR 
spectrum (100 MHz, CDCl3, δ ppm): 174.13 (-C(O)O-), 70.23 (-CH2- (PEG)), 60.64 (-
C(O)O-CH2-CH2-), 54.87 (-C(O)O-CH2-CH2-), 40.84 (backbone tertiary), 39.93 
(backbone -CH2-), 8.99 (-P(CH3)3). FTIR cm-1: 2897 (medium, C-H alkane), 1728 
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(strong, C=O ester), 1420 (medium, C-H alkane), 1087 (strong, C-O-C PEG), 971 (strong, 
P-CH3). Elemental analysis shown in Table A5.2. 
 
5.4.5 DLS/Zetapotential 
Dynamic light scattering measurements were carried of resulting polymers and 
polyplexes at various N/P ratios using a Malvern nanoZS zetasizer instrument (scattering 
angle of 173°, 10 mW He-Ne laser). For polyplex formation: appropriate amount of 
polymer stock solution and DNA stock solution were mixed and made up to a total 
volume of 1 mL in DI water (final concentration of polymer was 1 mg/mL, in all 
solutions). The resulting solutions were vortexed incubated for 30 minutes at room 
temperature and were analysed at 25°C. Each sample was run in triplicate and data was 
acquired using the software (Malvern Zetasizer) provided. Zeta potential measurements 
were carried out on the same DLS samples at various N/P ratios using the same 
instrument, and Malvern disposable folded capillary cell (DTS1070) cuvettes.  
 
5.4.6 Agarose gel electrophoresis 
Agarose gels (1% w/v) were prepared with agarose and 1 × TAE buffer. The solution was 
cooled on the bench for 5 minutes and 100 µL of 0.5 μg/mL ethidium bromide solution 
was added. The mixture was poured into the casted agarose tray and a comb inserted. The 
gel was left to set for a minimum of 30 minutes at room temperature. The agarose gels 
were run in 1× TAE buffer. The final gel was visualized under UV illumination at 365 
nm using a UVP benchtop UV transilluminator system. Polyplexes of DNA were 
prepared at various N/P ratios. DNA stock solution of 60 µg/mL was prepared in PBS, 
and polymer stock solution of 300 µg/mL. For polyplex formation: appropriate amount 
of polymer stock solution and DNA stock solution were mixed and made up to a total 
volume of 100 µL in PBS (final concentration of DNA was 0.030 µg/µL, in all solutions). 
Polyplexes were vortexed and incubated at room temperature for 30 minutes. Prior to 
loading, 30 µL of loading buffer was added to each sample and 20 µL of polyplexes were 
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loaded into the agarose gel wells. Gel electrophoresis was performed at 100 V for 30 
minutes. 
 
5.4.7 Cell culture 
3T3 mouse endothelial cells were obtained from the European Collection of Cell Cultures 
(ECACC) and used between passages 5 and 25, grown in DMEM (Dulbecco's Modified 
Eagle Medium) supplemented with 10% of fetal calf serum, 1% of 2 mM glutamine. The 
cells were grown as adherent monolayers at 310 K under a 5% CO2 humidified 
atmosphere and passaged at approximately 70–80% confluence. 
 
5.4.8 Cytotoxicity assays  
For cell viability evaluation, 3T3 cells were seeded in a 96 well plate at a density of 1 × 
104 cells per well. After 16 hours, the culture medium was replaced by fresh media 
containing a series of dilution of the polymers (2, 0.8, 0.2, 0.08, 0.02 mg/mL), prepared 
from stock solutions in media. Following 24 hours incubation, the medium was removed 
and replaced with fresh medium. The cells were incubated with a freshly prepared 
solution of XTT (0.2 mg/mL-1) and N-methyl dibenzopyrazine methyl sulfate (250 µM) 
in medium for 16 hours. Absorbance of the samples was finally measured using a plate 
reader at 450 nm and 650 nm. The data presented are representative of a minimum of two 
independent experiments where each sample was measured in triplicate. Errors reported 
correspond to the standard deviation of the mean. 
 
5.4.9 In vitro transfection 
Polyplex samples were prepared prior to incubation with the cells, via mixing of plasmid 
DNA solution (final concentrationDNA = 100 µg/mL) with the appropriate amount of 
polymer predissolved in sterile water (N/P ratio = 20), and left to complex at room 
temperature for one hour. HEK293T cells were seeded in a 24 well plate at a density of 1 
Chapter 5 
202 
× 105 cells per well. After 16 hours, the culture medium was replaced by Optimem® cell 
culture media (Thermo Fisher Scientific) without fetal bovine serum. After one hour, the 
media was replaced by fresh Optimem® media containing the polyplex solutions (final 
concentrationDNA = 10 µg/mL), the cells left to incubate for 5 hours under 5% CO2 
humidified atmosphere, then the media replaced with fresh culture media containing fetal 
bovine serum. Following overnight incubation, cells were washed with PBS, trypsinised, 
centrifuged, re-dispersed in ice-cold PBS and filtered into FACS tubes for analysis. 
Intracellular fluorescence was quantified using a BD LSR II cytometer (BD Biosciences) 
at excitation 488 nm and emission 525 nm. The geometric mean fluorescence was used 
as the sample value. The data in presented are representative of two separate experiments 
where each sample was measured in duplicate (n = 4). All errors reported correspond to 
the standard deviation from the mean 
 
5.4.10 Polyplex soil stability assay 
Polyplexes were formed in sterile water at an N/P ratio of 5 with a final concentration of 
1 mg/mL dsRNA. 200 µL of polyplexes were mixed with 0.5 g soil (live soil containing 
enzymes, and also sterilised soil (sterilisation conditions: 200 ˚C, 2 hr)) in 2 mL 
microtubes. Separate microtubes were used for each sample time point and stored at room 
temperature. At the appropriate time, the reaction was stopped by addition of 1 mL 
trireagent, vortexing, and incubating for 5 minutes, before storing the sample time point 
at -20 ˚C. 
 
5.4.11 dsRNA extraction 
dsRNA was extracted from the soil in order to analyse the dsRNA by agarose gel 
electrophoresis. Polyplex/soil/trireagent samples were defrosted, 200 µL of chloroform 
added, and incubated for 3 minutes at room temperature. Samples were then centrifuged 
for 15 minutes at 12000 g and 4 ˚ C. Supernatant was added to new microtube, isopropanol 
added (1/1 ratio) to precipitate the RNA, and incubated at for 10 minutes at room 
temperature. Microtubes were then centrifuged at 12000 g and 4 ˚C for 10 minutes. 
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Supernatant was removed and 500 µL of 70 % ethanol (in RNAse free water) added to 
the pellet, then centrifuged for 5 minutes at 12000 g and 4 ˚C. The supernatant was 
removed and the pellet left to dry for 10 minutes before being suspended in 200 µL of 
RNAse free water. These RNA samples were then enriched for dsRNA following a LiCl 
purification protocol. LiCl (8M, 67 µL) was added to the 200 uL RNA samples, which 
were mixed on ice, and incubated for 30 minutes at -20 ˚C. Microtubes were then 
centrifuged for 20 minutes at 14000 g and 4 ˚C, the supernatant was brought to a new 
microtube, and LiCl (8M, 133.5 µL) was added. The samples were mixed on ice, 
incubated for 30 minutes at -20 ˚C, and then centrifuged for 20 minutes at 14000 g and 4 
˚C. The supernatant was removed, the dsRNA pellet washed with 70% ethanol (in RNAse 
free water, 150 µL), and then centrifuged for 5 minutes at 12000 g and 4 ˚C. The 
supernatant was removed and the dsRNA pellet left to dry for 5 minutes before being 
suspended in 20 µL of RNAse free water. These final dsRNA samples were analysed by 
spectrophotometry (NanoPhotometer NP60 spectrophotometer), and agarose gel 
electrophoresis. Gel electrophoresis was performed at 100 V for 20 minutes on a 1% 
agarose gel (1x TAE buffer) containing ethidium bromide. 
 
Appendix to Chapter 5 
Table of polymerisation conditions, linear polymer SEC chromatograms and KMHS 
plots, p(TMPEA-co-PEGA) and p(TMAEA-co-PEGA) 1H NMR spectra for degree of 
substitution, p(TMPEA-co-PEGA) 31P NMR spectrum, elemental analysis data, branched 
polymer DLS and zetapotential, 1H NMR spectroscopy hydrolysis resistance study for 
branched p(TMPEA-co-PEGA), polyplex soil stability assay. 
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Table A5.1. Polymerisation conditions for both branched and linear BEA PEGA 
copolymers, and characterisation data from SEC and NMR spectroscopy. 
Polymer Conditions DRI SEC TD SEC 1H NMR 
 [BEA]:[PEGA]:[DEGDA] 
:[CTA]:[I] 
Mn 
(g/mol) 
Mw 
(g/mol) 
Ð 
Mw 
(g/mol) 

DP Mn 
(g/mol) BEA PEGA 
Branched 40:10:2.5:1:0.1 23,600 127,900 5.41 220,900 0.35 58 17 - 
Linear 64:16:0:1:0.1 9,700 10,800 1.12 13,900 0.6 39 9 11,300 
Linear 240:60:0:1:0.1 16,800 22,100 1.32 31,800 0.78 160 35 45,400 
 
 
 
Figure A5.1. Size exclusion chromatograms of branched and linear p(BEA-co-PEGA) 
precursor polymers from refractive index detector (DMF, PMMA calibration, Mn = 
127,900 g/mol, Ð = 5.4). 
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Figure A5.2. KMHS plot of branched and linear p(BEA-co-PEGA) precursor polymers 
from viscometry detector in DMF. 
 
Figure A5.3. 13C NMR spectrum of branched p(BEA-co-PEGA) precursor polymer in 
deuterated DMSO. 
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Figure A5.4. 1H NMR in DMSO-d6 of branched p(TMPEA-co-PEGA). 
 
 
Figure A5.5. 13C NMR in DMSO-d6 of branched p(TMPEA-co-PEGA). 
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Figure A5.6. 1H NMR in DMSO-d6 of branched p(TMAEA-co-PEGA). 
 
 
Figure A5.7. 13C NMR in DMSO-d6 of branched p(TMAEA-co-PEGA). 
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Figure A5.8. Phosphorous (31P) NMR spectrum of branched p(TMPEA-co-PEGA) 
confirming the presence of phosphonium moieties on the purified polymer. 
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Table A5.2. Elemental analysis results for branched BEA PEGA copolymer, and post-
polymerisation modified polymers, branched p(TMPEA-coPEGA) and p(TMAEA-co-
PEGA). 
Polymer C (%) H (%) N (%) Br (%) S (%) 
 Calc. 
Foun
d 
Calc. 
Foun
d 
Calc. 
Foun
d 
Calc. 
Foun
d 
Calc. 
Foun
d 
Branched 
p(BEA-co-
PEGA) 
C445.5H739Br
40O198.25 S3 
42.60 41.95 5.93 6.08 0.00 0.00 25.45 24.91 0.77 1.01 
Branched 
p(TMAEA-
co-PEGA) 
C565.5H1099B
r40N40O198.25 
S3 
45.51 40.45 7.42 7.79 3.75 3.10 21.42 19.88 0.64 1.99 
Branched 
p(TMPEA-
co-PEGA) 
C565.5H1099 
Br40O198.25P
40S3 
43.53 38.04 7.10 7.22 0.00 0.00 20.48 19.21 0.62 1.10 
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Figure A5.9. Proton (1H) NMR spectra of branched p(TMPEA-co-PEGA) in D2O over 
4 weeks at room temperature and pH 7, confirming no hydrolysis of polymer side chains 
occurring. 
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a)  
b)  
c)  
d)  
e)  
Figure A5.10. Representative DLS data for polyples solutions (branched p(TMPEA-co-
PEGA) with DNA, N/P 10, three repeats shown), a) intensitie distribution, b) volume 
distribution, c) number distribution, d) correlalograms, e) cummulants fit. 
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Figure A5.11. Polyplex soil stability assay (dsRNA protection), polyplexes were formed 
in sterile water at an N/P ratio of 5 with a final concentration of 1 mg/mL dsRNA, 
incubated in live soil or enzyme free soil, then dsRNA was extracted and run on an 
agarose gel. 
 
115 Conclusions and future perspectives 
The objective of this work was to utilise advanced polymer synthesis methods to 
synthesise a range of new cationic polymers with well controlled branched architectures 
and different charged moieties for nucleic acid delivery applications. The synthesised 
polymers ability to complex nucleic acids, the resulting polyplex morphology, initial 
polymer toxicity, and associated gene transfection efficiencies were also investigated. 
Chapter 2 describes a method for the preparation of hyperbranched polymers with high 
degrees of branching, predictable molecular weights and narrow molecular weight 
distributions, involving slow monomer addition of a thiol/yne monomer to 
multifunctional core molecules in the presence of photoinitiator and UV irradiation. A 
small thiol/yne monomer was synthesized via simple esterification, giving a route to high 
purity monomers. Copolymerisation with multifunctional alkyne or alkene molecules was 
found to lower dispersity of the resulting hyperbranched polymers, whilst maintaining 
very high degrees of branching. This Chapter outlined a new process for the synthesis of 
hyperbranched polymers of remarkably well-controlled molecular weight and molecular 
weight distributions, with very high degrees of branching. 
Synthesis of hyperbranched polyethyleneimine containing structures by AB2 chemistry is 
reported for the first time in Chapter 3. This strategy allowed for the preparation of 
hyperbranched polymers, from macromolecular monomer units, with degrees of 
branching in the region of dendrimers. The synthetic strategy allowed synthesis of AB2 
hyperbranched PEI structures with only secondary amines, and well defined branching 
patterns, unachievable via the ring opening polymerisation of aziridine. The GFP plasmid 
DNA polyplex nanoparticles were analysed by DLS, zetapotential, and AFM. 
Hyperbranched poly(ethyleneimine-co-oxazoline) and bPEI from small positively 
charged particles, and linear forms were found to form larger aggregates. Differences 
were also found in polymer in vitro cytotoxicity due to polymer architecture, with 
poly(ethyleneimine-co-oxazoline)s having much reduced toxicity compared to bPEI, and 
the hyperbranched poly(ethyleneimine-co-oxazoline) having reduced toxicity compared 
to the linear equivalent. Delivery of pDNA encoding for GFP was assessed with in vitro 
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assays. Poly(ethyleneimine-co-oxazoline) copolymer with high percentages of 
ethyleneimine units were found to have transfection efficiencies slightly lower than the 
commercial standard 25K branched PEI. In agreement with the literature, it is believed 
that the compact hyperbranched polymer conformation contributes, in some extent, to 
both the improved toxicity and also high transfection efficiencies.  
Chapter 4 is a study outlining the syntheisis of highly branched polymers by RAFT 
polymerisation of hydrolysable amine containing monomers: DMAEA, DMAPA, 
DMAEMA, and also copolymers of DMAEA and DMAEMA. The highly branched 
nature of these polymers was characterised using multi detector size exclusion 
chromatography. Hydrolysis kinetics of the polymers studied with 1H NMR spectroscopy, 
showed pDMAPA and p(DMAEMA-co-DMAEA) to have hydrolysis profiles favourable 
for extended release of dsRNA compared to the fast hydrolysing pDMAEA. The release 
of dsRNA from polyplex nanoparticles was followed with agarose gel electrophoresis and 
both pDMAPA and p(DMAEMA-co-DMAEA) showed excellent release kinetics for 
prolonged oligonucleotide release in aqueous conditions. The highly branched polymeric 
materials synthesised in this study show great potential for therapeutic dsRNA delivery. 
Chapter 5 involves the facile synthesis of highly branched and cationic 
poly(trimethylphosphonium ethylacrylate-co-PEGA), and its ammonium equivalent, 
using a simple post-polymerisation modification strategy of a p(bromo ethylacrylate-co-
PEGA) precursor polymer produced using RAFT polymerisation. This synthesis 
represents a significant improvement/simplification of current phosphonium containing 
polymer synthetic methods. The results show polyphosphoniums have increased 
biocompatibility compared to their ammonium equivalents while maintaining the same 
ability to complex nucleic acids.  
The presented thesis has demonstrated a range of polymer synthesis methods including, 
RAFT polymerisation, thiol-yne polymerisation, and oxazoline polymerisation, to access 
highly branched and hyperbranched polymer architectures. The polymers were 
investigated for their ability to bind, protect, and deliver nucleic acids with particular 
attention to effect of polymer architecture. However, different aspects of this work could 
be pursued further. 
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Additional exploration of the thiol-yne polymerisations in Chapter 2 would be beneficial, 
in order to achieve higher molecular weights. Further work of this project could look at 
incorporating additional functionality into small molecule thiol-yne monomers for use 
with the slow monomer addition polymerisation procedure. 
To expand upon Chapter 3, alternative plasmid DNA molecules would be investigated. 
In particular, it would be good to investigate plasmid with therapeutic effect for a 
particular disease, rather than the GFP reporter gene used in this study. Further work 
could also look at alternative in vitro cell lines, and potentially in vivo mouse models. The 
possibility of reaching full hydrolysis of the hyperbranched poly(oxazoline) would also 
be interesting, in order to further compare the effect of amine type and polymer 
architecture on nucleic acid delivery. 
Further work on Chapter 4 would look at creating DMAEMA DMAEA copolymers of 
additional monomer ratios, and comparing the hydrolysis rates to expand the window of 
nucleic acid controlled release. It would also be beneficial to study the in vitro transfection 
efficiencies of nucleic acid polyplexes of these polymers, in order to correlate nucleic 
acid release to biologic effect. Another exciting avenue of research could look at using 
confocal microscopy to study the intracellular pathway and nucleic acid release of the 
described polymer systems. This would be achieved with Forster resonance energy 
transfer (FRET) imaging, by attaching the FRET donor dye to the polymer and the 
quencher to the nucleic acid, release of the nucleic acid could then be followed in the 
intracellular environment. 
In Chapter 5, it was concluded that the highly branched p(TMPEA-co-PEGA) and 
p(TMAEA-co-PEGA) polymers were too hydrophilic to efficiently enter cells via 
endocytosis – a process which typically requires a balance of cationic charge and 
hydrophobicity – leading to low pDNA transfection efficiencies. Additional work on 
Chapter 5 would therefore look at varying proportions of PEGA and charged monomer, 
and also investigating the effect of cationic monomer substituent on gene transfection. 
Another avenue of research would be to also investigate arsonium and sulfonium cationic 
monomers in comparison to ammonium and phosphonium. 
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